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ABSTRACT 
New Methods and Strategies for Orthogonal Oligosaccharide Synthesis 
Although scientists have been able to isolate certain classes of naturally occurring 
carbohydrates, the overall availability of pure natural isolates remains inadequate.  As a 
result, chemical synthesis has been employed to access complex carbohydrates.  
Unfortunately, traditional oligosaccharide synthesis often requires laborious protecting-
group manipulations that results in lower yields.  Expeditious strategies effectively 
shorten the task of oligosaccharide assembly by minimizing the need for protecting-group 
manipulations between glycosylation steps, or even purification of the intermediates.  
Additionally, prediction of the stereoselective outcome of the coupling reaction between 
two sugar units is a major obstacle facing carbohydrate chemists.  It is well known that 
1,2-trans (β) glycosides can be easily obtained with the assistance of a neighboring 
participating group at C-2, typically an acyl moiety such as O-acetyl or O-benzoyl.  In 
order to achieve 1,2-cis (α) glycosides, a glycosyl donor bearing a non-participating 
group at C-2 (e.g., O-benzyl, or azido) needs to be employed.  Unfortunately, these 
reactions often proceed via SN1 mechanism and result in poor stereoselectivity.   
Presented herein is the investigation into the use of S-benzimidazolyl (SBiz) glycosides 
as building blocks for oligosaccharide synthesis.  It has been determined that the SBiz 
leaving group can be manipulated to tune the reactivity of the building block.  This 
reactivity of the leaving group can be significantly enhanced (or reduced) toward 
selective activation by the use of an N-protecting group on the imidazole ring.  This, in 
turn, allows executing oligosaccharide assembly via the very effective active-latent 
concept and orthogonal activation-based strategies. 
Addressing the issue of stereocontrol of glycosylations, we report the use of silver(I) 
perchlorate (AgClO4) as a powerful promoter toward assembling 1,2-cis glycosides.  In 
this study, AgClO4 is employed to promote glycosyl thioimidates as well as 
thioglycosides.  Furthermore, we have investigated the use of various silver salts, such as 
AgBF4, AgPF6, AgOTf, and AgClO4 in the coupling reaction.  Surprisingly, although the 
series of promoters all contain silver, their counter ions vastly affect the stereoselectivity 
of the product.  AgClO4 was determined to induce a higher α to β ratio and in some cases 
this is a ten-fold increase.  
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Chapter 1 
 
 
 
Glycosyl thioimidates as versatile building blocks 
for organic synthesis 
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1.1  Introduction 
 Carbohydrates are the most abundant biomolecules on the planet, having long 
been known exclusively as a biochemical energy source.  Recently, researchers have 
become increasingly aware of the role carbohydrates play aside from energy supply and 
storage.  Carbohydrates are involved in a wide range of biological processes such as 
fertilization, anti-inflammation, immunoresponse, joint lubrication, cell growth, antigenic 
determination, etc.1  They also have a sizable contribution into harmful processes such as 
bacterial and viral infections, development of tumors, metastasis, tissue rejection, and 
congenital disorders.2  Because many of these cellular processes are directly associated 
with pathogenesis of deadly diseases including AIDS, cancer, pneumonia, septicemia, 
hepatitis and malaria, scientific efforts in the field of modern glycosciences have 
expanded.3  While scientists have been able to successfully isolate certain classes of 
natural carbohydrates, the availability of appreciable quantities of these pure natural 
isolates is still inadequate to address the challenges offered by modern glycosciences.  
For this reason, chemical and enzymatic syntheses of complex carbohydrates have been 
employed to gain access to large quantities of both natural compounds and mimetics 
thereof.  Even with significant advancements, controlled chemical synthesis of complex 
carbohydrates remains difficult.  Hence, further development of methods and strategies 
for oligosaccharide and glycoconjugate synthesis remains a demanding area of research. 
 The majority of the biologically and therapeutically active carbohydrates are 
oligosaccharides or complex glycoconjugates (glycolipids, glycoproteins, etc.) in which 
monomeric sugar units are joined via O-glycosidic bonds.  This linkage is formed by a 
glycosylation reaction, most commonly a promoter-assisted nucleophilic displacement of 
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a leaving group (LG) of the glycosyl donor with a hydroxyl moiety of the glycosyl 
acceptor (Scheme 1.1).4  Other functional groups on both the donor and acceptor are 
temporarily masked with protecting groups (PG, T). Since the new glycosidic linkage 
creates a chirality center, particular care has to be taken with regards to the 
stereoselectivity.   
 
Scheme 1.1.  The outline of a typical glycosylation reaction. 
 
 
This represents a major challenge in comparison to the synthesis of the intermonomeric 
linkages in other natural biopolymers, proteins and nucleosides. Although mechanistic 
studies of the glycosylation reaction are still scarce, certain conventions have already 
been established.5  For instance, 1,2-trans-linked glycosides are often stereoselectively 
obtained from 2-O-acylated glycosyl donors, as these reactions proceed via an 
acyloxonium intermediate (Scheme 1.1).6  In the case of ether-type (2-O-benzyl) non-
participating substituents, the glycosylation proceeds via the flattened oxacarbenium ion 
that often leads to anomeric mixtures.  Although 1,2-cis glycosides (for D-gluco/galacto 
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series) are favored by the anomeric effect, the stereoselectivity is often low, which makes 
their synthesis a notable challenge.7,8  In spite of significant progress, chemical O-
glycosylation remains among the top challenges of modern synthetic chemistry due to the 
requirement to achieve complete stereocontrol and the necessity to suppress side 
reactions. 
 Aside from glycosyl donor structure, a number of factors can influence the 
stereoselective outcome of the glycosylation reaction such as structure of glycosyl donor 
or acceptor, solvent, temperature, and many others.  Occasionally, the nature of a leaving 
group may also have an influence on the anomeric stereoselectivity, and these 
observations led to the development of a large number of different classes of glycosyl 
donors.4  Early methods developed by Fischer9 and Koenigs and Knorr10 had been the 
main driving forces in the area of carbohydrate chemistry until the 1970s through the 
early 1980s, when the traditional approach to glycosylation was revolutionized by the 
development of a series of new leaving groups.  The new generation of glycosyl donors 
included S-phenyl glycosides by Ferrier,11 Nicolaou,12 Garegg,13 and others,14 
cyanoethylidene derivatives by Kochetkov,15 O-imidates by Sinay16 and Schmidt,17 S-
benzothiazolyl derivatives (SBaz) by Mukaiyama,18 S-pyridyl and S-pyrimidin-2-yl 
derivatives by Hanessian19 and Woodward,20 and fluorides by Mukaiyama21 among 
others.  The fate of these methods for chemical glycosylation is very different.  While the 
development of trichloroacetimidates,22 thioglycosides,23 and fluorides24 has produced 
general glycosylation methodologies, glycosyl thioimidates, broadly defined as 
compounds equipped with S-C=N leaving groups, had been long out shadowed by other 
glycosyl donors that offered more promise for further development.  
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 For many years, glycosyl thioimidates have been viewed as an insignificant 
variation of the thioglycoside glycosidation methodology.  Because of this, glycosyl 
thioimidates received very little attention, in part due to marginal stability toward 
protecting group manipulations.  Over the last decade, the thioimidate method has 
evolved into a very robust methodology for glycosylation.25,26  Particularly with the 
introduction of novel S-benzoxazolyl (SBox) and S-thiazolinyl (STaz) leaving groups, it 
has become apparent that thioimidates can withstand many reaction conditions associated 
with protecting group manipulations.27,28  In addition, these thioimidates are easily 
accessible from a variety of simple precursors, can be glycosidated under a range of 
different, and often unique, reaction conditions.  Likewise, they are able to provide 
superior stereoselectivity and can be selectively activated in the presence of other types 
of leaving groups.  These listed factors are important traits for both glycoside and 
oligosaccharide synthesis and all are rarely found in one class of a leaving group.  
 Stereoselectivity is particularly important in light of the fact that a single-step 
glycosylation is only one challenge researchers working on oligosaccharide synthesis 
face wherein additional protecting and/or leaving group manipulations between each 
glycosylation step are required.  Resultantly, the synthesis becomes increasingly 
inefficient which is particularly evident at the advanced stages of the assembly29,30 and 
often leads to a dramatic drop in yield, and as a consequence, the availability of 
oligosaccharides.  Further study of glycosyl thioimidates allowed for the design of novel 
strategies for the synthesis of oligosaccharides including the temporary deactivation 
concept,31,32 the inverse armed-disarmed strategy,33 STICS: surface-tethered iterative 
carbohydrate synthesis,34 and the thioimidate-only orthogonal strategy.35  It also helped to 
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uncover the O-2/O-5 cooperative effect in glycosylation that allows for superarming and 
superdisarming of building blocks by simple alteration of protecting group pattern,36-39 
and to perform basic mechanistic aspects of glycosylation,33,40 the most common but least 
understood reaction in glycochemistry.4  Very recently, S-benzimidazolyl (SBiz) building 
blocks promises to become a new versatile platform for active-latent oligosaccharide 
synthesis.41  In addition, a number of medicinally relevant oligosaccharides and 
glycoconjugates have been obtained using the thioimidate approach.32,42-47  The 
remainder of this chapter discusses major aspects of the synthesis and glycosidation of 
SBaz, SBox, STaz, and SBiz thioimidates and the roles in which they fit into modern 
strategies for expeditious oligosaccharide synthesis.  Emphasis has been placed on 
methods, strategies, and phenomena that have been discovered thanks to unique structural 
features and reactivity pattern of glycosyl thioimidates. 
 
1.2  S-Benzothiazolyl (SBaz) derivatives 
Per-acetylated S-benzothiazolyl (SBaz) glycosides were first synthesized in 73% 
yield by Zinner from acetobromoglucose and mercury(II) salt of 2-
mercaptobenzothiazole (HSBaz) in the presence of sodium.48  Mukaiyama was the first to 
report glycosidation of a glycosyl donor equipped with SBaz leaving group.18  For this 
study, the glycosyl donor 1.2 was prepared from per-benzylated chloride 1.1 and HSBaz 
in the presence of 1,8-bis(dimethylamino)naphthalene in 80% yield (Scheme 1.2).  
Glycosylation studies were performed in the presence of Cu(OTf)2 with various acceptors 
in diethyl ether and in most cases glycosylations proceeded with high yields and good 
stereoselectivity.  For example, the reaction of 1.2 with glycosyl acceptor 1.3 in the 
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presence of Cu(OTf)2 resulted in the formation of disaccharide 1.4 in an excellent yield 
of 92% as an anomeric mixture (α/β = 4/1). 
 
Scheme 1.2.  S-Benzothiazolyl approach to glycoside synthesis reported by 
Mukaiyama.18 
 
 
A number of general modifications and ultimately improvements to this approach 
have emerged.  Various precursors and reaction conditions have been investigated.  For 
instance, Szeja reported the synthesis of 1.2 from the hemiacetal derivative, 2,3,4,6-tetra-
O-benzyl-D-glucopyranose under phase-transfer conditions in the presence of TsCl and 
Bu4NCl in benzene/50% aq. NaOH.49  Compound 1.2 was isolated in 95% yield as a 
mixture of anomers (α/β = 1/3).  Likewise, SBaz mannofuranoside and xylopyranoside 
were obtained as anomeric mixtures in 92 and 81% yield, respectively.49  Schmidt et al. 
reported the synthesis of SBaz mannoside 1.6 by opening 1,2-orthoester 1.5 in the 
presence of HgBr2 (Scheme 1.3).50  Bogusiak reported the synthesis of SBaz furanosides 
of the L-arabino, D-ribo, and D-xylo series from the reducing sugars and HSBaz in the 
presence of diphenyl phosphoryl chloride [(PhO)2P(=O)Cl] under phase transfer 
conditions.51  Ferrieres and Plusquellec described the synthesis of per-acetylated SBaz 
galactofuranosides from the corresponding β-pentaacetate in the presence of BF3-Et2O in 
83% yield as an anomeric mixture.52,53  The obtained thioimidates were then deprotected 
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and applied in anomeric phosphorylation.  A number of acylated SBaz and analogous 5-
methoxy-SBaz derivatives of D-gluco, D-galacto, and D-ribofurano series have been 
reported by Khodair et al.54  While the syntheses of hexoses were accomplished from 
acetobromosugar and the corresponding sodium thiolates in MeCN, the synthesis of 
thioribofuranoside derivative was achieved from the corresponding tetraacetate and 
trimethylsilylated thiols in the presence of TMSOTf.54  The synthesis of a range of 
differently protected SBaz derivatives from the corresponding glycosyl bromides and 
KSBaz in acetone has also been reported.55 
The glycosylation studies of SBaz derivatives have also been significantly 
expanded.  For instance, Gama et al. reported the glycosidation of 1.2 by using methyl 
iodide as an activator in several solvents under high pressure.56  It was found that high 
pressure-assisted glycosidation of 1.2 provided the corresponding disaccharides with an 
improved stereoselectivity compared to that reported by Mukaiyama.18  For example, 
coupling of 1.2 with 1.3 in dichloromethane at 1.3 GPa produced 1.4 in 71% yield as a 
mixture of anomers (α/β = 7/1).  SBaz mannoside 1.6 was employed in the elegant 
intramolecular glycosylation (molecular clamp) approach involving m-xylylene as a rigid 
spacer (Scheme 1.3).50  For this purpose, the free hydroxyl of 1.6 was reacted with α,α’-
dibromoxylene resulting in the intermediate 1.7, which was subsequently linked to 
acceptor 1.8.  The resulting compound 1.9 was subjected to NIS/TMSOTf-promoted 
intramolecular condensation to afford disaccharide 1.10 in 75% yield with high β-manno 
stereoselectivity (/ = 1/9).  
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Scheme 1.3.  Intramolecular β-mannosylation using SBaz methodology.50 
 
 
It was determined that AgOTf or NIS/TfOH can serve as suitable activators for S-
benzothiazolyl furanosides.51  As an example, AgOTf-promoted glycosylation of 
diacetone galactose acceptor (6-OH) with glycosyl donors of the L-arabino, D-ribo, and 
D-xylo series in toluene afforded the corresponding disaccharides in 75% (α/β = 4/3), 
98% (α/β = 7/2), and 70% (α/β = 3/10) yield, respectively.  It was also reported that the 
SBaz leaving group can be activated very rapidly for glycosylation in the presence of 
AgBF4 and is applicable to selective activation over other types of leaving group 
involving S-alkyl and O-pentenyl glycosides.55  It was also observed that the SBaz 
leaving group can be activated in the presence of MeOTf, but not in the presence of 
weaker alkylating reagents, which created a basis for selective activation of STaz donors 
with benzyl bromide or  methyl iodide in the presence of glycosyl acceptors equipped 
with the SBaz anomeric group.35 
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1.3  S-Benzoxazolyl (SBox) derivatives 
Per-acetylated SBox derivatives were first synthesized by Zinner from 
acetobromoglucose and 2-mercaptobenzoxazole (HSBox) in the presence of sodium.57,58 
Schmidt’s group had achieved the synthesis of SBox mannosides via orthoester 1.5 with 
HSBox and HgBr2 (Scheme 1.4).50  Shortly thereafter, it was reported the synthesis of 
SBox glycosyl donors of the D-gluco, D-galacto, and D-manno series  from the 
corresponding anomeric bromides 1.12 and KSBox in the presence of 18-crown-6.59  
Alternatively, glycosyl bromides can react directly with HSBox in the presence of K2CO3 
in acetone.28  In addition, SBox glycosides were obtained from anomeric acetates (e.g., 
1.13), thioglycosides 1.15, or 1,2-anhydro sugars 1.14 (Scheme 1.4).40  The introduction 
of the SBox moiety is completely stereoselective, except for the BF3-Et2O-promoted 
introduction from anomeric acetate 1.13 that results in the formation of anomeric 
mixtures of 1,2-cis and 1,2-trans SBox glycosides (α/β = 1/3).59 
 
Scheme 1.4.  Synthesis of SBox glycosides. 
 
 
Schmidt and co-workers reported the application of the SBox glycosides to 
indirect β-mannosylations, in which a glycosyl donor and a glycosyl acceptor were 
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tethered by a rigid spacer.50  The resulting disaccharide was obtained in 78% yield (/ = 
1/10). Demchenko et al. reported the use of SBox derivatives as glycosyl donors for the 
synthesis of 1,2-cis glycosides of D-gluco and D-galacto,28 as well as 1,2-trans 
glycosides of the D-gluco, D-galacto, and D-manno series.59  These studies showed that 
the SBox leaving group can be activated using a broad range of promoters including 
AgOTf, Cu(OTf)2, Bi(OTf)3, AgBF4, NIS/TfOH, TMSOTf, MeOTf, etc. and enabled the 
stereoselective synthesis of 1,2-trans and 1,2-cis glycosides.  For example, the 
glycosidation of SBox glycosyl donor 1.16 with acceptor 1.3 in the presence of MeOTf in 
dichloroethane afforded 1.17 in 95% yield (Scheme 1.5).  In attempts to improve the 
stereoselectivity of mannosylation, SBox glycosyl donors bearing remote protecting 
groups p-methoxybenzoyl or N,N-diethyl thiocarbamoyl at C-4 were investigated.60  
Since the SBox moiety can be activated in the presence of AgOTf or Cu(OTf)2, 
conditions that fail to activate the alkyl/aryl thioglycosides, selective activation of SBox 
over a range of other leaving groups has been investigated.  For example, the SBox donor 
1.18 could be selectively activated over O-pentenyl 1.19 or  S-ethyl acceptor 1.21 to give 
the corresponding disaccharides 1.20 or 1.22, respectively, in high yields (98-99%) and 
stereoselectivities (Scheme 1.5).28  Because the resulting disaccharides already bear a 
suitable leaving group at the anomeric center, no additional protecting/anomeric group 
manipulations are required for the continuation of the coupling sequence.  This is very 
beneficial as chain elongation can be conducted in a stepwise manner (vide infra).61  De 
Meo reported the application of the SBox approach to stereoselective α-sialylation and to 
the efficient synthesis of a GM3 analog.62  In this synthesis, selective activation of the 
SBox moiety of the sialyl donor over the S-ethyl moiety of the galactosyl acceptor was 
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achieved in the presence of AgOTf.  The obtained disaccharide was used in subsequent 
coupling directly to afford the desired GM3 trisaccharide sequence in good overall yield.  
A similar activation principle was also employed in a high output one-pot synthesis.63  
 
Scheme 1.5.  SBox glycosides in stereoselective glycoside synthesis.  
 
 
SBox glycosides also showed promising orthogonal combinations with glycosyl 
alkoxyimidates64 and STaz glycosides.35  The orthogonality with other thioimidates is a 
unique feature of this methodology because conventional orthogonal activation65,66 
requires two different classes of leaving groups, whereas here both leaving groups are of 
the same class.  The key to this methodology is the choice of activator.  In the case of 
STaz, activation an alkylation agent is used and SBox activation is carried out with 
Bi(OTf)3 (Scheme 1.6).35  Herein, STaz glycosyl donor 1.23 and SBox acceptor 1.24 are 
coupled in the presence of benzyl bromide.  In the subsequent step, disaccharide 1.25 is 
activated with Bi(OTf)3 and reacted with STaz acceptor 1.26 producing trisaccharide 1.27 
in 62% yield.  This methodology was largely based on extended mechanistic work, which 
Hasty, Scott, 2013, UMSL, p.25 
 
demonstrated that STaz glycosides are activated via the heterocyclic nitrogen atom 
(remote activation), whereas SBox glycosides are activated via exocyclic/anomeric sulfur 
(direct activation).35,40 
 
Scheme 1.6.  Orthogonal activation of STaz and SBox leaving groups.35 
 
 
As a directional modification of the traditional orthogonal approach based on the 
orthogonality of leaving groups, a reverse approach was reported wherein a protecting 
group-based chain elongation was conducted.  This strategy, termed reverse orthogonal, 
takes advantage of orthogonal stability of protecting groups along with simultaneous 
activation of the applicable anomeric leaving group.67  Glycosyl donors employed were 
SEt glycosides with 6-O-p-methoxybenzyl (pMB) protection 1.28 and SBox glycosides 
with 6-O-pentenoyl (Pent) protection 1.29.  The first disaccharide was obtained from 1.28 
and 1.30 in 81% yield using NIS/TfOH/H2O.  Disaccharide 1.31 was then glycosylated 
with SBox donor 1.29 equipped with an O-pentenoyl group.  The resulting trisaccharide 
1.32 was obtained in 82% yield and then reacted with 1.28 to afford tetrasaccharide 1.33 
in 71% yield.  Finally, tetrasaccharide 1.33 was coupled with 1.29 and the resulting 
pentasaccharide 1.34 was isolated in 75% yield. 
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Scheme 1.7.  Four-step synthesis of pentasaccharide 1.34 via the reverse orthogonal 
strategy.67 
 
 
Another general concept for oligosaccharide synthesis makes use of only one 
class of leaving group for both reaction components, which are either activated (armed 
donor) or deactivated (disarmed acceptor) by the influence of the protecting groups (PG1, 
PG2, Scheme 1.8).68  Usually, the protecting groups in both reaction components and 
careful selection of mild reaction conditions have to be taken into consideration to allow 
for direct chemoselective activation of the armed glycosyl donor over the disarmed 
glycosyl acceptor.  Many classes of leaving groups can be activated accordingly, and 
SBox is no exception.  For instance, armed donor 1.35 could be chemoselectively 
activated over the disarmed acceptor 1.24.  This activation was effected in the presence of 
Cu(OTf)2 and resulted in chemoselective formation of disaccharide 1.36 in 64%.  Further 
study of chemoselective activation of SBox glycosides revealed other reactivity levels 
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gor differently protected building blocks.  Thus, it was demonstrated that disarmed 
disaccharide 1.36 could be further chemoselectively activated over superdisarmed 
building block 1.37.  This activation was achieved in the presence of Cu(OTf)2/TfOH to 
produce trisaccharide 1.38 in 70% yield.36  This finding was somewhat surprising 
because it was anticipated that reactivity of building block such as 1.37 would fall 
somewhere between that of the armed (per-benzylated) and the disarmed (per-
benzoylated) glycosyl donors; similar to the results found in Ley’s studies69 for building 
blocks of the L-rhamnose series. 
 
Scheme 1.8.  Expansion of the armed-disarmed strategy to superdisarmed building 
blocks.68 
 
 
The observed reactivity pattern was rationalized by the occurrence of the so-
called “O-2/O-5 Cooperative Effect”.36  In addition to the “arming/disarming” nature of 
the protecting group at O-2, stabilization of the glycosyl cation intermediate must also be 
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taken into consideration.  If electron withdrawing protecting groups are placed near the 
O-5 ring oxygen (at C-4 and C-6, as in the disarmed donors 1.C or 1.D in Figure 1.1), the 
electron density on O-5 will be decreased, effectively suppressing oxacarbenium ion 
formation.  In this case, the ability of the system to stabilize via the formation of an 
acyloxonium ion intermediate, like in disarmed glycosyl donor 1.C, may become 
increasingly important.  Crich et al.70 emphasized that the anchimeric assistance was 
particular to the 1,2-trans orientation of the 2-O-acyl and 1-SBox leaving group.  If no 
source of secondary stabilization is available, as in case of 2-O-benzyl substituent in 1.D, 
this combination will give rise to the overall “superdisarming” protecting group pattern.   
 
Figure 1.1.  O2/O5 cooperative effect in glycosylation. 
 
 
Along these lines, a glycosyl donor containing a participating benzoyl group at C-2 and 
electron donating groups at the remaining positions was also investigated and these 
glycosyl donors proved to be even more reactive (superarmed) than their armed per-
benzylated counterparts.37,38  This observed reactivity pattern was also rationalized by the 
occurrence of the “O-2/O-5 Cooperative Effect” (see donor 1.A depicted in Figure 1.1).36  
Furthermore, this concept was found to be universal and applicable to glycosidations of 
O-pentenyl, S-ethyl, S-phenyl, S-tolyl and STaz building blocks.71   
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In attempts to employ the SBox moiety with 2-amino-2-deoxy glycoside donors, 
it was observed that 2-N-trichloroethoxycarbonyl (Troc) derivatives are significantly 
more reactive than their 2-N-phthaloyl counterparts in MeOTf-promoted glycosylations.72  
This modified armed-disarmed approach allowed for an efficient chemical synthesis of 
1,2-trans-linked oligosaccharides (Scheme 1.9).  Taking advantage of the reactivity 
differences, the 2-N-Phth-protected glycosyl acceptor 1.40 was glycosylated with 2-N-
Troc-protected glycosyl donor 1.39 in the presence of MeOTf, producing disaccharide 
1.41 in 82% yield.  Then, with AgOTf activation, the disaccharide was coupled with 
acceptor 1.3 affording trisaccharide 1.42 in 73% yield. 
 
Scheme 1.9.  Chemoselective synthesis of 2-amino-2-deoxy SBox glycosides.72 
 
 
It was also demonstrated that SBox-equipped building blocks can be used in both 
glycosyl acceptor and glycosyl donor bound approaches using polymer supports 
(Merrifield’s resin or Tentagel).73  As an extension of this study, a novel approach to 
solid supported synthesis termed surface-tethered iterative carbohydrate synthesis 
(STICS) was developed.34  This methodology employs nanoporous gold (NPG) plates as 
the support to which the glycosyl acceptor is anchored via a thiol linker (Scheme 1.10). 
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The process involves the coupling of the 6-O-TBDPS-protected glycosyl donor with the 
anchored acceptor using MeOTf.  The tethered disaccharide was then desilylated and 
subsequently coupled with per-benzoylated SBox donor, cleaved from the NPG, and 
benzoylated for characterization yielding the trisaccharide in 52% overall on a 7-10 mg 
scale utilizing ten 8 x 8 x 0.2 mm NPG plates assembled in a shelved Teflon mini reactor. 
 
Scheme 1.10.  STICS approach to solid-supported synthesis of oligosaccharides.34 
 
 
1.4  S-Thiazolinyl (STaz) derivatives 
The synthesis of per-acetylated STaz glucopyranosides from acetobromoglucose 
and 2-mercaptothiazoline (HSTaz) in the presence of DIPEA or directly from glucose 
pentaacetate 1.13 and HSTaz in the presence of BF3-Et2O in 64 and 69% yield 
respectively, was first reported by Descotes et al. (Scheme 1.11).74  Ferrieres and 
Plusquellec described the synthesis of per-acetylated thiazolinyl galactofuranosides from 
β-D-galactofuranose pentaacetate in the presence of BF3-Et2O in 53% yield.52,53  
Demchenko et al. reported the synthesis of benzoylated STaz glycosides from the 
corresponding anomeric bromides 1.12 and NaSTaz or KSTaz in the presence of a crown 
ether (Scheme 1.11).27  In these syntheses, the STaz glycosides of the D-gluco, D-galacto, 
and D-manno series were isolated in 60, 90, and 70% yield, respectively.  Subsequently, 
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it was determined that direct conversion of the anomeric acetates into STaz glycosides is 
by far more efficient for the D-gluco and D-galacto series in comparison to the synthesis 
from glycosyl bromides. Thus, the target compounds were obtained in 91 and 85%, 
respectively.27  Lower yields resulted when glycosyl halide donors were employed in the 
synthesis of STaz glycosides, which was due to two side reactions, N-glycosylation and 
β-elimination.  Formation of by-products, N-linked “Taz” and 1,2-anhydro derivatives, 
are probably due to the ambient reactivity of HSTaz and its relatively high basicity.  
Nevertheless, the STaz glycosides were obtained from anomeric chlorides 1.43,27 
thioglycosides (e.g., 1.45),31 1,2-anhydro sugars 1.14,74 or 1,2-orthoesters 1.44 (Scheme 
1.11).33  The formation of 1,2-trans STaz glycosides were found in complete 
stereoselectivity.  
 
Scheme 1.11.  Synthesis of STaz glycosides. 
 
 
The STaz moiety was found to be stable toward common protecting group 
manipulations involving basic and acidic conditions; this including acetylation, 
benzylation, acetal formation and cleavage, among others.31  Moreover, in comparative 
hydrolytic stability studies,  STaz glycosides exhibited even more stability than their 1-S-
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ethyl and 1-S-phenyl counterparts in the presence of NBS or NIS/TfOH.27,75  Studies 
were conducted to determine whether thiazolinyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-
glucopyranoside 1.46 could serve as a common precursor toward the synthesis of an array 
of glycosyl donors.55  It was found that the STaz glycoside 1.46 can be directly converted 
into the following glycosyl donors: acetate 1.47, chloride 1.1, bromide 1.48, fluoride 
1.49, and hemiacetal 1.50 in excellent yields (84–95%, Scheme 1.12).  Moreover, 
glycosyl bromide 1.48 was then used as a precursor for subsequent synthetic steps to 
obtain benzoxazolyl, benzothiazolyl, and ethyl thioglycosides (1.35, 1.2, and 1.51), as 
well as n-pentenyl glycoside 1.52, all with exclusive β-stereoselectivity.  The hemiacetal 
derivative 1.50 was converted into the corresponding glycosyl trichloroacetimidate 1.53.  
 
Scheme 1.12.  Versatile synthesis of other glycosyl donors from STaz precursor 1.46.55 
 
 
Investigation into the properties of the STaz glycosyl donor brought about the 
development of a general methodology for 1,2-cis and 1,2-trans glycosylation.  Early 
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studies by Descotes and co-workers involved the displacement of the STaz functionality 
of per-acetylated derivatives of the D-gluco series using MeOH in the presence of 
HgNO3.74  Further investigation into the glycosylation protocol toward disaccharide and 
oligosaccharide synthesis was reported by Demchenko et al.  Activators such as AgOTf, 
MeOTf, NIS/TfOH, benzyl bromide, methyl iodide, AgBF4 and Cu(OTf)2 have been 
found to be suitable for efficient STaz activation for glycosylation.27  STaz glycosyl 
donors were shown to react smoothly with common glycosyl acceptors.  As shown in 
Scheme 1.13, STaz donor 1.46 was coupled with acceptors 1.54, 1.56, and 1.58 in the 
presence of AgOTf to afford disaccharides 1.55 in 96% yield (α/β = 2.9/1), 1.57 in 97% 
yield (α/β = 4.5/1), and 1.58 in 95% yield (α/β = 3.5/1), respectively.  De Meo et al. 
reported application of the STaz approach to stereoselective α-sialylation.62 
 
Scheme 1.13.  Activation of STaz glycosyl donors. 
 
 
The applicability of the STaz method to selective glycosylation strategies for 
expeditious oligosaccharide synthesis was also evaluated.27  As aforementioned, the STaz 
leaving group remains inert in the presence of NIS in combination with catalytic amount 
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of TfOH, which are common conditions for alkyl/aryl thioglycoside activation.  This 
finding led to the development of a promising combination of orthogonal leaving groups, 
wherein STaz is activated selectively with AgOTf, whereas ethyl thioglycoside is 
activated with NIS and catalytic amount of TfOH.27  This concept was applied to the 
synthesis of pentasaccharide 1.64, as depicted in Scheme 1.14.76  The thioglycoside donor 
1.51 was first activated over the STaz acceptor 1.26 in the presence of NIS/cat. TfOH.  
The resulting disaccharide 1.60, isolated in 98% yield, was in turn activated over 
thioglycoside acceptor 1.61 with AgOTf to give trisaccharide 1.62 in 93% yield.  The 
sequence was then reiterated as follows.  Thioglycoside donor 1.62 was activated over 
STaz acceptor 1.26 in the presence of NIS/cat. TfOH.  The resulting tetrasaccharide 1.63 
was selectively activated over thioglycoside acceptor 1.61 in the presence of AgOTf to 
give pentasaccharide 1.64 in 59% yield.  It should be noted that NIS and stoichiometric 
TfOH are capable of effective activation of the STaz leaving group.27 
The selective activation methodology was further applied in a five-step synthesis 
of a hexasaccharide, wherein two classes of glycosyl thioimidates, STaz and SBox, were 
used as building blocks (Scheme 1.15).77  First, the thiocyanate glycoside donor 1.65 was 
activated with Cu(OTf)2 over STaz acceptor 1.26 in 89% yield.  Subsequently, 
disaccharide 1.66 was coupled with SBox glycosyl donor 1.24 in the presence of benzyl 
bromide to achieve the trisaccharide 1.67 in 67% yield.  The latter was coupled with 
fluoride acceptor 1.68 in the presence of MeOTf to produce tetrasaccharide 1.69 in 87% 
yield.  Tetrasaccharide 1.69 was then reacted with SEt acceptor 1.70 in the presence of 
AgClO4/Cp2ZrCl2 to afford the pentasaccharide 1.71 in 84% yield.  Lastly, the coupling 
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of O-pentenyl acceptor 1.72 with the pentasaccharide 1.71 using MeOTf as an activator 
produced hexasaccharide 1.73 in 72% yield.   
 
Scheme 1.14.  Orthogonality of the STaz and SEt glycosides. 76 
 
The selective activation principle was found beneficial for the synthesis of 
oligosaccharides of Streptococcus pneumoniae serotypes 6A, 6B, and 6C, as well as 
mimetics thereof for the development of synthetic vaccine components,43,45,46 and for the 
synthesis of a tumor associated glycosphingolipid SSEA-3 analog.47  
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Scheme 1.15.  Synthesis of hexasaccharide 1.73 via five-step sequential selective 
activation.77 
 
 
One-pot glycosylation methods, whereby a few sequential glycosylation steps are 
executed in one reaction vessel, are of further advantage because there is no need for 
purification of the intermediates.  Many different leaving groups and methods fit into this 
general concept61 and thioimidate-based one-pot glycosylation procedures have also 
emerged.55,78  For instance, SBox glycoside 1.74 was activated over SEt acceptor 1.18 
with AgOTf (Scheme 1.16).78  Upon completion of the coupling, NIS and catalytic 
amounts of TfOH were added to the reaction mixture along with the STaz glycosyl 
acceptor 1.26. In the final step, glycosyl acceptor 1.3 and AgOTf were added in order to 
glycosidate the STaz moiety of the trisaccharide intermediate.  Upon completion of the 
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one-pot sequence and purification by column chromatography, the tetrasaccharide 1.75 
was isolated in 73% yield over three steps.78   
 
Scheme 1.16.  Thioimidate-based one-pot oligosaccharide synthesis. 78 
 
 
Additionally, the armed and disarmed properties of differently protected STaz 
glycosides were evaluated in the context of chemoselective oligosaccharide synthesis.  It 
was determined that STaz glycosides follow the general concept of the armed-disarmed79 
approach.  The activated (benzylated) STaz derivatives could be promoted over 
electronically disarmed (acylated) STaz glycosyl acceptors in the presence of either 
AgOTf or Cu(OTf)2.33  The scope of this methodology was expanded by the invention of 
a novel arming participating group, which expanded chemoselective activation principle 
to the synthesis of trans-trans sequenced oligosaccharides.33  Thus, it was observed that 
when 2-O-picolinyl protected glycosyl donor 1.76 was activated, the corresponding 
disaccharides were obtained with exclusive β-stereoselectivity.  Extended mechanistic 
study demonstrated that these reactions proceed via the formal intermediacy of the α-
pyridinium salt intermediate that can be stereoselectively opened to provide β-linked 
products.  This finding gave rise to the development of a new strategy for oligosaccharide 
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synthesis termed “inverse armed-disarmed strategy.”33  When STaz donor 1.76 was 
activated over the disarmed acceptor 1.26, disaccharide 1.77 was obtained in 74% yield 
with complete 1,2-trans stereoselectivity (Scheme 1.17).  This is the inverse outcome in 
comparison to the classical armed-disarmed approach resulting in 1,2-cis bond formation 
in the first step (vide supra, see Scheme 1.8).  Subsequent activation of 1.77 with AgOTf 
yielded the trans-trans-linked trisaccharide 1.78 in 91% yield.80  
 
Scheme 1.17.  Chemoselective activation of STaz glycosides.33 
 
 
An interesting observation that STaz glycosides can participate in stable non-
ionizing transition metal complexes led to the development of a temporary deactivation 
concept.31  The outline of this strategy that involves the temporary disarming of a leaving 
group by external deactivation of its active sites is depicted in Scheme 1.18.  Thus, the 
deactivation of the would-be-armed glycosyl acceptor 1.79 was accomplished by 
coordinating its STaz functionality into a stable, non-ionizing metal complex with PdBr2 
1.80.  This allowed for the activation of the “free” STaz moiety of the disarmed glycosyl 
donor 1.81 over the temporarily deactivated (capped) STaz moiety of the complexed 
acceptor 1.80 in the presence of MeOTf.  Upon glycosylation, disaccharide 1.82 was 
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released from the complex by treatment with NaCN yielding a “free” disaccharide 1.83, 
which could be used in subsequent transformations.  
 
Scheme 1.18.  Temporary deactivation concept.31 
 
 
The temporary deactivation concept was further expanded by the development of 
a new generation of leaving groups capable of bidentate bonding, and therefore a more 
stable complexation mode with the deactivating reagent PdBr2.  This approach was 
applied to the synthesis of medicinally relevant oligosaccharides of Streptococcus 
pneumoniae serotype 14 (Scheme 1.19).32  STaz donor 1.84 was reacted with the 
complexed 4-(pyridin-2-yl)thiazole-2-yl thioglycoside  acceptor 1.85 in the presence of 
AgOTf followed by desilylation with TBAF to provide the disaccharide acceptor 1.86. 
The latter was then coupled with SBox lactose donor 1.87 to afford the pneumococcal 
tetrasaccharide repeating unit 1.88.  For the subsequent convergent elongation, one 
portion of tetrasaccharide 1.88 was treated with NaCN to afford thiazolyl donor 1.89, 
whereas another portion of 1.88 was treated with 10% TFA to afford complexed glycosyl 
acceptor 1.90.  The coupling of 1.89 and 1.90 followed by decomplexation under the 
standard reaction conditions afforded octasaccharide 1.91.32 
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Scheme 1.19.  Synthesis of Streptococcus pneumonia serotype 14.32 
 
1.5  S-Benzimidazolyl (SBiz) derivatives 
Per-acetylated SBiz glycosides were first reported by Zinner.81  The SBiz moiety 
was then investigated as a leaving group for phosphorylation of unprotected glycosyl 
donors.52,53    More recently the use of the SBiz moiety as a new platform for active-latent-
like glycosylations was reported.41  For this study, the synthesis SBiz glycosyl donors of 
the D-gluco and D-galacto series 1.12, as well as the 2-amino-2-deoxy-D-gluco series 
1.92 was accomplished from the corresponding anomeric bromides and potassium salt of 
HSBiz (KSBiz).  The synthesis of SBiz building blocks from the anomeric acetate 1.13, 
thioglycoside 1.93, and 1,2-orthoester 1.94 were also reported (Scheme 1.20).41 
Scheme 1.20.  Synthesis of SBiz glycosides. 
Hasty, Scott, 2013, UMSL, p.41 
 
 
 
It was determined that activation of the SBiz leaving group can be readily 
achieved with the use of AgOTf, Cu(OTf)2, and DMTST.  For example, the SBiz 
glycosyl donor 1.95 was coupled with glycosyl acceptor 1.3 in the presence of AgOTf to 
produce disaccharide 1.96 in 98% yield (Scheme 1.21).  Similarly, the activation of the 
N-anisoylated derivative of SBiz (SBizAn) 1.97, obtained by simple acylation of 1.95, 
could be also achieved with AgOTf.  Thus, disaccharide 1.96 was obtained in 98% yield.  
Alkylating reagents, such as methyl iodide, benzyl bromide and allyl bromide are also 
able to promote SBiz leaving group departure (Scheme 1.21).  For instance, the reaction 
between SBiz glycosyl donor 1.95 and acceptor 1.3 in the presence of methyl iodide 
produced disaccharide 1.96 in 89% yield.  Further investigation of the alkylation 
activation pathway led to the discovery that when the SBiz moiety is N-anisoylated, its 
reactivity in the presence of methyl iodide was essentially turned off.  As an example, in 
the attempt to react SBiz donor 1.97 with acceptor 1.3 using methyl iodide, no product 
1.96 was found. 
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Scheme 1.21.  Comparison of reactivity between SBiz glycoside 1.95 and its N-
anisoylated counterpart 1.97.41 
 
 
This differential reactivity of the SBiz vs. SBizAn moieties enabled active-latent-
like oligosaccharide synthesis, a strategy pioneered by Roy et al.82,83  In ordinance with 
this methodology, the active SBiz donor 1.95 was glycosidated with the latent SBizAn 
acceptor 1.98 in the presence of methyl iodide to afford disaccharide 1.99 in 75% yield.  
After subsequent deprotection of the anisoyl group, using NaOMe, the resulting active 
disaccharide 1.100 was coupled with acceptor 1.3, methyl iodide promoted, in 71% yield.  
Since both SBiz and SBizAn donors are activated  smoothly in the presence of AgOTf, 
further activation of the SBizAn disaccharide 1.99 can be also conducted to afford 
trisaccharide 1.101 directly.  An extended mechanistic study led to a conclusion that the 
deactivation effect of N-anisoyl moiety in 1.98 is an electronic effect similar to that 
described for the classical disarming effect in glycosylation.79  Herein, the disarming is 
achieved by acylation of the leaving group, not by introducing the neighboring acyl 
substituents in the sugar moiety.  
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Scheme 1.22.  Selective activation of the SBiz over SBizAn moieties. 
 
 
1.6  Conclusion 
 Glycosyl thioimidates represent a broad class of leaving groups used in 
carbohydrate syntheses.  While the discussion of these compounds was very limited, it 
should be noted that generalization of synthesis, reactivity and application should be 
avoided.  Thioimidates can be prepared from a broad range of precursors including 
acetates, halides, anhydrosugars, hemiacetals, orthoesters, thioglycosides.  Single step 
activation of thioimidates for glycosylation is typically a simple and fast process that 
leads to disaccharides in very high yields and often with superior stereoselectivities.  Due 
to the polyfunctional character of the thioimidoyl leaving group, the activation can be 
achieved via a variety of modes such as with AgOTf, Cu(OTf)2, NIS/TfOH, TfOH, 
MeOTf, Bi(OTf)3, AgBF4 and with alkylating reagents such as benzyl bromide, methyl 
iodide and allyl bromide.  This ultimately allows for fine tuning of the activation 
conditions.  The high stability of glycosyl thioimidates compared with other glycosyl 
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donors permits their use for the temporary protection of the anomeric center of the 
glycosyl acceptor.  Consequently, thioimidates fit into many existing strategies for 
oligosaccharide assembly and conceptually new approaches and methods can be develops 
with them. 
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2.1  Introduction 
 The involvement of complex carbohydrates in a wide variety of disease-
related cellular processes has given this class of natural compounds tremendous 
appeal for their diagnostic and therapeutic potential.1  While scientists have been able 
to successfully isolate certain classes of natural carbohydrates, the availability of pure 
natural isolates is still inadequate to address the challenges offered by modern 
glycosciences.  As a consequence, chemical glycosylation has become a viable means 
to obtain both natural complex carbohydrates and unnatural analogs thereof.2-4  
Unfortunately, chemical synthesis of oligosaccharides of even moderate complexity 
still remains a considerable challenge, and many more complex structures are not 
available at all.  Consequently, the development of efficient strategies for the 
oligosaccharide and glycoconjugates synthesis stands out as a demanding area of 
research.5 
 As a part of the on-going research effort in our laboratory to develop versatile 
methods for chemical glycosylation and expeditious oligosaccharide synthesis, we 
became interested in glycosyl thioimidates, glycosyl donors equipped with 
SCR1=NR2 leaving group.  Among a variety of thioimidates studied by us and 
others,6,7 S-benzoxazolyl (SBox)8 and S-thiazolinyl (STaz)9 moieties were found to be 
excellent building blocks for oligosaccharide synthesis.  We determined that the SBox 
and STaz glycosides fit into existing progressive strategies for oligosaccharide 
synthesis, such as selective (including one-pot10-12 and solid phase synthesis),13-15 
chemoselective (armed-disarmed),16-18 and orthogonal19-22 approaches.  In addition, 
the glycosyl thioimidates led us to the development of conceptually new strategies for 
oligosaccharide synthesis: the inverse armed-disarmed strategy,23,24 the temporary 
deactivation concept,25,26 the O-2/O-5 cooperative effect (superarmed and 
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superdisarmed glycosyl donors),17,27-29 coordination-assisted glycosylation,30 and 
Surface-Tethered Iterative Carbohydrate Synthesis (STICS).31 
 At the core of the study presented here is the development of a new method 
for chemical glycosylation and expeditious oligosaccharide synthesis based on S-
benzimidazolyl (SBiz) glycosides.  The SBiz moiety was previously investigated as a 
leaving group for phosphorylation of unprotected glycosyl donors.32,33  We envisaged 
that the SBiz moiety may be also compatible with a very attractive active-latent 
concept pioneered by Roy,34 Fraser-Reid,16 Boons35 and more recently further 
advanced by Kim36,37 and others.38-40  According to this concept, an active (reactive) 
leaving group (LGa) is selectively activated over its latent (unreactive) counterpart 
(LGb, Scheme 2.1).  Subsequently, the latent LGb of the formed disaccharide is 
converted into an active LGa.   
 
Scheme 2.1.  Outline of the active-latent strategy and the SBiz leaving group explored 
in this work. 
 
 
This modification does not involve substitution at the anomeric center as in the two-
step activation strategy;5 rather it is achieved by a modification of the leaving group, 
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usually at a remote position.  We assumed that in case of the SBiz glycosides, 
deactivation of the leaving group could be achieved by placing an easily removable 
protecting group at the nitrogen atom of the imidazolium ring.  The active SBiz 
leaving group can be then regenerated by simple deprotection as needed. 
 
2.2  Results and Discussion 
 To pursue this concept we obtained a range of differently protected SBiz 
glucosides including per-benzylated 2.1a, per-benzoylated 2.1b, and derivative 2.1c 
equipped with the superarming protecting group pattern.28  We also obtained the SBiz 
donor of the D-galacto 2.1d and 2-amino-2-deoxy-D-gluco series 2.1e.  With glycosyl 
donors 2.1a-e in hand, we began evaluating their applicability to chemical 
glycosidation with standard glycosyl acceptors 2.2-2.5.41  Encouragingly, reaction of 
glycosyl donor 2.1a with the primary glycosyl acceptor 2.2 in the presence of silver(I) 
triflate was completed in 15 min and provided the corresponding disaccharide 2.6a in 
98% yield (Table 2.1, Entry 1).  Copper(II) triflate is a significantly milder promoter 
for thioimidates, and although a significantly lower reaction rate was observed (60 h), 
2.6a was isolated in an excellent yield of 93% (Entry 2).  Subsequently, we 
demonstrated that the SBiz moiety can be efficiently activated under alkylation 
conditions at elevated temperature, similarly to that of STaz glycosides.22  No 
significant difference between AllBr, BnBr, or MeI-promoted glycosidations of 2.1a 
was detected, and 2.6a was obtained in 84-90% yield (Entry 3).  We noticed a 
significantly improved -stereoselectivity (up to 5.3/1 with AllBr) in comparison to 
that of the metal-assisted glycosylations.  Glycosylation of the secondary glycosyl 
acceptors 2.3-2.5 was also proven feasible in the presence of AgOTf, and the 
corresponding disaccharides 2.7a-2.9a were obtained in 81-95% yield (Entries 4-6). 
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Table 2.1.  Glycosidation of SBiz glycosyl donors 2.1a-e with glycosyl acceptors 2.2-
2.5. 
 
entry donor + acceptor Promoter
[a] time Product yield, α/β ratio 
1 2.1a + 2.2 AgOTf 15 min 2.6a 98%, 1.1/1 
2 2.1a + 2.2 Cu(OTf)2 60 h 2.6a 93%, 1.3/1 
3 2.1a + 2.2 AllBr, BnBr, 
MeI (55 °C)[b] 
12 h 2.6a 84-90%, 3.3-
5.3/1 
4 2.1a + 2.3 AgOTf 15 min 2.7a 81%, 1.8/1 
5 2.1a + 2.4 AgOTf 15 min 2.8a 91%, 1.3/1 
6 2.1a + 2.5 AgOTf 15 min 2.9a 95%, 1.6/1 
7 2.1b + 2.2 AgOTf 2 h 2.6b 86%, β only 
8 2.1b + 2.2 Cu(OTf)2 144 h 2.6b 83%, β only 
9 2.1b + 2.2 AllBr, BnBr, 
MeI (55 °C) 
120 h no reaction  
10 2.1b + 2.3 AgOTf 45 min 2.7b 94%, β only 
11 2.1b + 2.4 AgOTf 2 h 2.8b 87%, β only 
12 2.1b + 2.5 AgOTf 2 h 2.9b 84%, β only 
13 2.1c + 2.2 AgOTf <5 min 2.6c 98%, β only 
14 2.1c + 2.2 Cu(OTf)2 2 h 2.6c 93%, β only 
15 2.1c + 2.3 AgOTf <5 min 2.7c 84%, β only 
16 2.1c + 2.4 AgOTf <5 min 2.8c 90%, β only 
17 2.1c + 2.5 AgOTf <5 min 2.9c 88%, β only 
18 2.1d + 2.2 AgOTf 2 h 2.6d 97%, β only 
19 2.1d + 2.3 AgOTf 2 h 2.7d 94%, β only 
20 2.1d + 2.4 AgOTf 3 h 2.8d 89%, β only 
21 2.1d + 2.5 AgOTf 3.5 h 2.9d 89%, β only 
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22 2.1e + 2.2 AgOTf 30 min 2.6e 94%, β only 
23 2.1e + 2.3 AgOTf 30 min 2.7e 92%, β only 
24 2.1e + 2.4 AgOTf 30 min 2.8e 86%, β only 
25 2.1e + 2.5 AgOTf 30 min 2.9e 92%, β only 
[a] performed in the presence of molecular sieves 3 Å at rt, unless noted otherwise;  
[b] reaction at rt was much more sluggish  
 
 Having investigated the reactivity of per-benzylated (armed) glycosyl donor 
2.1a, we turned our attention to testing its per-benzoylated (disarmed) counterpart 
2.1b.  As anticipated, the reactivity of 2.1b was significantly lower than that of 2.1a, 
and only AgOTf-promoted glycosidations were proven to be of preparative value.  
The desired disaccharides 2.6b-2.9b were isolated in 84-94% yield (Entries 7, 10-12).  
Copper(II) triflate–promoted glycosidation was very slow (144 h, Entry 8) while alkyl 
halide-promoted reactions did not proceed at all (Entry 9).  These results suggest that 
the SBiz glycosides can be applied in accordance with the classic armed-disarmed 
strategy.42  In order to develop a more flexible route to the synthesis of 1,2-trans 
glycosides, we also investigated SBiz glycosyl donor 2.1c, bearing the superarming 
protecting group pattern.28  As expected, AgOTf-promoted glycosidation produced 
disaccharides 2.6c-2.9c almost instantaneously in 84-98% yield (Entries 13, 15-17).  
Also in the presence of Cu(OTf)2, the reaction rate was significantly higher than that 
observed with either the armed glycosyl donor 2.1a or its disarmed counterpart 2.1b 
(2 h, 93%, Entry 14). 
 In order to broaden the scope of this glycosylation investigation, we tested its 
applicability to the synthesis of D-galactosides and 2-amino-2-deoxyglucosides, 
highly important and abundant sugar series.43-45  Glycosidation of the SBiz galactose 
donor 2.1d with glycosyl acceptors 2.2-2.5 in the presence of AgOTf proceeded 
smoothly and the corresponding disaccharides 6d-9d were obtained in 89-97% yield 
(Entries 18-21).  Also glycosidation of N-(2,2,2-trichloroethoxy) carbamoyl (N-Troc) 
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protected glycosyl donor 1e with acceptors 2.2-2.5 in the presence of AgOTf was 
successfully accomplished.  The resulting disaccharides 2.6e-2.9e were isolated in 86-
94% yields (Entries 22-25). 
 Having investigated the applicability of the SBiz glycosides for chemical 
glycosylation, we next investigated the effects that N-substitution may have on the 
reactivity of the leaving group.  For this purpose, we investigated a variety of N-acyl 
substituents (acetyl, haloacetyls, benzoyl, substituted benzoyls), and the highest 
yielding results were achieved with the N-anisoylated SBiz building block 2.10a 
obtained from 2.1a by reaction with anisoyl chloride in the presence of pyridine 
(Scheme 2.2).  As projected, no product was formed in glycosidations of 2.10a under 
alkylation conditions (up to 120 h at 55 oC).   
 
Scheme 2.2.  Synthesis and glycosidation of N-anisoylated SBiz glycosyl donor 
2.10a; competition experiment with SBiz donor 2.1a. 
 
 
In addition, competitive glycosylation wherein two glycosyl donors (2.1a and 2.10a) 
were allowed to compete for glycosyl acceptor 2.2 allowed differentiating the 
reactivities of SBiz and anisoylated SBiz leaving groups.  Thus, the competition 
experiment in the presence of MeI allowed for nearly complete recovery of the 
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unreacted 2.10a (98%), while only traces of 2.1a (2%) were remaining.  Less 
expectedly, AgOTf-promoted activation of the N-anisoylated glycosyl donor 2.10a 
was as efficient as that of its SBiz counterpart 2.1a and disaccharide 2.6a was rapidly 
produced (15 min) in 98% yield. 
 
Scheme 2.3.  Activation of SBiz donor 2.1a over N-anisoylated SBiz acceptor 2.11 in 
the active-latent fashion. 
 
 
 With these promising results, we next investigated whether SBiz donor 2.1a 
could be selectively activated in the presence of the N-anisoylated SBiz acceptor: this 
represents the key step for executing the SBiz-based active-latent concept.  For this 
purpose we obtained glycosyl acceptor 2.11 (see experimental).  Very encouragingly, 
MeI-promoted glycosylation between building blocks 2.1a and 2.11 produced the 
expected latent disaccharide 2.12 in 75% yield (α/β = 1/1.8, Scheme 2.3).  After that, 
the N-anisoyl group was removed by the treatment with NaOMe in MeOH yielding 
the active disaccharide 2.13 which was subsequently activated with MeI to afford 
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trisaccharide 2.14 in 71% yield.  This two-step SBiz activation sequence mimics the 
traditional active-latent concept.5   
 It should be noted that although the removal of N-anisoyl moiety in 2.12 with 
NaOMe/MeOH is suitable for the synthesis of benzylated building blocks, it would 
represent a hurdle if the application of the active-latent methodology were attempted 
with acylated compounds.  To broaden the scope of this transformation, we 
investigated other reaction conditions that would not trigger concomitant O-
deacylation.  As depicted in Scheme 2.4, we discovered that N-anisoyl in O-
benzoylated compound 2.10b can be effectively removed in the presence of guanidine 
in MeOH or, alternatively, TBAF in THF.  No competitive O-benzoyl group removal 
was detected under these reaction conditions and the desired SBiz donor 2.1b was 
obtained quantitatively.  In this context, we anticipate that other acyl groups, e.g., 2-
(azidomethyl)benzoyl,46 3-(2′-benzyloxyphenyl)-3,3-dimethylpropanoate,47 or (2-
nitrophenyl)acetyl,48 which can be reductively cleaved in the presence of conventional 
O-acyl substituents (benzoyl), are expected to be suitable for the purpose of the 
temporary N-acylation. 
 
Scheme 2.4.  Removal of N-anisoyl in the presence of O-benzoyl group.  
 
       Conditions Time Yield of 2.1b 
(i)  0.5 M Guanidine/MeOH (0.5 equiv.) in  
      CH2Cl2/MeOH (9/1, v/v) at rt 
5 min Quant 
(ii) 1 M TBAF/THF (2 equiv.) in THF at rt 3 h Quant 
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 Since the N-protected latent SBiz moiety can be activated with a stronger 
promoter (Scheme 2.2), we also pursued this pathway.  AgOTf-promoted activation of 
latent disaccharide 2.12 lead to trisaccharide 2.14 in 84% yield (Scheme 2.3).  By 
exploring this two-way activation approach we showed that the SBiz moiety serves as 
a suitable new platform for the active-latent like activations, but also allows for the 
direct activation of the latent N-acylated leaving group using a stronger promoter. 
 What remained unknown is why alkylating reagents are able to activate SBiz 
but not its N-anisoylated counterpart.  Based on the anticipation that the SBiz is 
activated by the direct activation pathway A (Scheme 2.5) via the anomeric sulfur, as 
in S-alkyl/aryl49 or SBox glycosides,22,50 one possible explanation is the electronic 
effect.  It is possible that upon N-anisoylation the sulfur atom in compound 2.10a will 
become too weak a nucleophile to displace the halogen atom of the alkylating reagent.  
Alternatively, the activation of the SBiz may also take place via the nitrogen atom of 
the imidazole ring representing the remote activation pathway B, as in S-pyridyl51,52 
or STaz22 derivatives.  In this case, the effect of the N-anisoyl group is steric as it will 
block the N-activation site of the SBiz moiety.  To differentiate between the two 
possible reaction pathways we set up a model experiment wherein SBiz donor 2.1a 
reacted with isopropanol in the presence of BnBr (Scheme 2.5).  Upon completion of 
the reaction, judged by the disappearance of 2.1a and formation of 2.16 (TLC),53 we 
separated and analyzed all components of the reaction mixture.  2-Benzylsulfanyl-1H-
benzimidazole 2.1554,55 was isolated and its identity was proven by spectral and X-ray 
methods, whereas no trace of its N-benzylated counterpart 2.1756,57 was detected.  The 
result of this study indicates that activation of SBiz under alkylation conditions takes 
place via the sulfur atom similarly to that found previously for SBox glycosides.22,50  
Therefore, we conclude that the deactivating effect of the N-anisoyl moiety in 2.10a is 
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electronic.  However, whether this effect is due to simple electron-withdrawal or 
distortion of the aromaticity of the imidazole ring is yet to be determined.  What 
differs this disarming effect from the well-documented disarming effect in 
glycosylation42 is that herein the disarming is achieved by acylation of the leaving 
group, not by introducing the neighboring acyl substituents in the sugar moiety. 
 
Scheme 2.5.  Direct pathway A vs. remote pathway B for SBiz activation. 
 
 
2.3  Conclusion 
 In conclusion, we investigated S-benzimidazolyl (SBiz) anomeric moiety as a 
new leaving group that can be activated for chemical glycosylation under a variety of 
conditions including metal-assisted and alkylation pathways.  Differentiation between 
the two possible reaction pathways for the SBiz moiety activation was achieved via an 
extended mechanistic study.  We also demonstrated that the application of the 
substituted SBiz moiety allows executing rapid oligosaccharide assembly via 
active/latent and armed/disarmed-like concepts. 
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2.4  Experimental Section 
General remarks 
Column chromatography was performed on silica gel 60 (EM Science, 70-230 mesh), 
reactions were monitored by TLC on Kieselgel 60 F254 (EM Science).  The 
compounds were detected by examination under UV light and by charring with 10% 
sulfuric acid in methanol.  Solvents were removed under reduced pressure at < 40 oC. 
CH2Cl2 and ClCH2CH2Cl were distilled from CaH2 directly prior to application. 
Anhydrous DMF (EM Science) was used as is.  Methanol was dried by refluxing with 
magnesium methoxide, distilled and stored under argon.  Pyridine and acetonitrile 
were dried by refluxing with CaH2 and then distilled and stored over molecular sieves 
(3 Å). Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and activated 
in vacuo at 390 °C during 8 h in the first instance and then for 2-3 h at 390 °C directly 
prior to application.  AgOTf (Acros) was co-evaporated with toluene (3 x 10 mL) and 
dried in vacuo for 2-3 h directly prior to application.  DOWEX MONOSPHERE 650C 
(H) was washed three times with MeOH and stored under MeOH.  Optical rotations 
were measured using a ‘Jasco P-1020’ polarimeter.  1H-NMR. spectra were recorded 
in CDCl3 at 300 MHz, 13C-NMR spectra were recorded in CDCl3 at 75 MHz (Bruker 
Avance) unless otherwise noted.  HRMS determinations were made with the use of 
JEOL MStation (JMS-700) Mass Spectrometer. 
 
Synthesis of 2-benzimidazolethione, potassium salt (“KSBiz”).  
Anhydrous K2CO3 (0.93 g, 6.7 mmol) was added to a stirred solution of 2-
mercaptobenzoxazole (1.0 g, 6.7 mmol) in dry acetone (7 mL).  The reaction mixture 
was refluxed for 3 h at 60 oC, acetone was then evaporated off and the residue was 
dried in vacuo. 
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Synthesis of glycosyl donors  
Benzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (2.1a).  The 
solution of ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside58 (2.19 g, 3.75 
mmol) and activated molecular sieves (3 Å, 1.88 g) in CH2Cl2 (56 mL) was stirred 
under argon for 1 h at rt.  Freshly prepared solution of Br2 in CH2Cl2 (36 mL, 1/165, 
v/v) was then added and the reaction mixture was stirred for 5 min at rt.  After that, 
the solid was filtered-off and the filtrate was concentrated in vacuo at rt.  Crude 
residue was dissolved in dry MeCN (80 mL) and KSBiz (1.76 g, 9.36 mmol) and 18-
crown-6 (0.20 g, 0.75 mmol) was added.  The resulting reaction mixture was stirred 
under argon for 16 h at rt.  After that, the solid was filtered off and the filtrate was 
concentrated in vacuo.  The residue was diluted with CH2Cl2 (200 mL) and washed 
successively with 10% aq. NaOH (20 mL), water (3 x 20 mL).  The organic layer was 
separated, dried with MgSO4, and concentrated in vacuo.  The residue was purified by 
column chromatography on silica gel (ethyl acetate-toluene gradient elution) to afford 
title compound (1.85 g, 73 %) as an off-white foam.  Analytical data for 2.1a:  Rf = 
0.54 (ethyl acetate/toluene, 3/17, v/v); [α]D28 -28.7 (c = 1.0, CHCl3); 1H-n.m.r.: δ, 3.45 
(dd, 1H, J2,3 = 8.5 Hz, H-2), 3.58-3.82 (m, 5H, H-3, 4, 5, 6a, 6b), 4.57 (dd, 2H, 2J = 
11.5 Hz, CH2Ph), 4.64 (dd, 2H, 2J = 11.1 Hz, CH2Ph), 4.76 (d, 1H, J1,2 = 9.6 Hz, H-1), 
4.76 (dd, 2H, 2J = 10.0 Hz, CH2Ph), 4.82 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 6.38 – 7.38 
(m, 25H, aromatic, NH) ppm; 13C-n.m.r.: δ, 68.8, 74.0, 75.3, 75.8, 76.0, 77.2, 78.3, 
80.9, 84.1, 86.0, 122.5, 127.9 (x3), 128.1 (x4), 128.4, 128.5 (x3), 128.6 (x10), 128.9 
(x3), 129.0, 137.4, 137.5, 137.7, 138.1, 146.5 ppm; HR-FAB MS [M+H]+ calcd for 
C41H41N2O5S 673.2736, found 673.2732. 
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Benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-glucopyranoside (2.1b) was 
obtained from 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranosyl bromide59 in 56% as an 
off-white foam as described in the synthesis of compound 2.1a.  Analytical data for 
2.1b: Rf  = 0.47 (ethyl acetate/toluene, 3/17, v/v); [α]D27 +15.7 (c = 1, CHCl3); 1H-
n.m.r.: δ, 4.21 (m, 1H, J5,6a = 4.7 Hz, J5,6b = 2.6 Hz, H-5), 4.43 (dd, 1H, J6a,6b = 12.4 
Hz, H-6a), 4.85 (dd, 1H, H-6b), 5.45 (d, 1H, J1,2 = 10.0 Hz, H-1), 5.60 (dd, 1H, J2,3 = 
9.4 Hz, H-2), 5.71 (dd, 1H, J4,5 = 9.8 Hz, H-4), 5.96 (dd, 1H, J3,4 = 9.4 Hz, H-3), 7.12-
8.08 (m, 24H, aromatic), 10.28 (s, 1H, NH) ppm; 13C-n.m.r.: δ, 62.6, 69.0, 71.0, 73.9, 
83.9, 119.6, 123.7, 128.4 , 128.5 (x3), 128.6 (x3), 128.7 (x6), 128.8 (x3), 129.2, 129.5, 
129.9 (x2), 130.1 (x3), 130.2 (x2), 133.6, 133.7, 133.8, 133.9, 144.0, 165.3, 165.6, 
165.8, 167.1 ppm; HR-FAB MS [M+H]+ calcd for C41H33N2O9S 729.1907, found 
729.1919. 
 
Benzimidazol-2-yl 2-O-benzoyl-3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside 
(2.1c) was obtained by a procedure similar to those previously reported.23,60,61  A 
mixture of 3,4,6-tri-O-benzyl-1,2-O-methoxybenzylidene-α-D-glucopyranose62 (1.2 g, 
2.05 mmol) and molecular sieves (3Å, 300 mg) in dry acetonitrile (20 mL) was stirred 
under argon for 1 h at rt.  2-Mercaptobenzimidazole (0.768 g, 5.11 mmol) and 
mercuric(II) bromide (0.074 g, 0.205 mmol) were added, and the resulting mixture 
was heated at reflux for 6 h.  After that, the solid was filtered off and the filtrate was 
concentrated in vacuo.  The residue was diluted with CH2Cl2 (200 mL) and washed 
successively with 10% aq. NaOH (20 mL), water (3 x 20 mL).  The organic phase 
was separated, dried over MgSO4, and concentrated in vacuo.  The residue was 
purified by column chromatography on silica gel (ethyl acetate–toluene gradient 
elution) to afford the title compound (1.21 g, 86% yield) as a white foam.  Analytical 
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data for 2.1c: Rf = 0.46 (ethyl acetate/toluene, 3/17, v/v); [α]D27 +26.1 (c = 1, CHCl3); 
1H-n.m.r: δ, 3.48 (dd, 1H, J6a,6b = 9.8 Hz, H-6a), 3.56 (dd, 1H, J4,5 = 8.9 Hz, H-4), 
3.61-3.72 (m, 2H, H-5, 6b), 3.81 (dd, 1H, J3,4 = 8.8 Hz, H-3), 4.48 (s, 2H, CH2Ph), 
4.58 (dd, 2H, 2J = 11.1, CH2Ph), 4.60 (dd, 2H, 2J = 10.9, CH2Ph), 4.92 (d, 1H, J1,2 = 
10.1 Hz, H-1), 5.30 (dd, 1H, J2,3 = 9.6 Hz, H-2), 6.82-7.91 (m, 24H, aromatic) ppm; 
13C-n.m.r.: δ, 69.5, 72.7, 74.2, 75.4, 75.9, 78.0, 79.1, 83.7, 84.1, 128.1, 128.2 (x3), 
128.4 (x4), 128.5, 128.6 (x3), 128.7 (x6), 128.8 (x3), 129.0 (x2), 129.3, 130.2 (x2), 
133.7, 137.4, 137.5, 137.6, 146.4, 165.6 ppm; HR-FAB MS [M+Na]+ calcd for 
C41H38N2O6SNa 709.2348, found 709.2326. 
 
Benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-galactopyranoside (2.1d) 
was obtained from 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl bromide59 in 82% 
as a white foam as described in the synthesis of compound 2.1a.  Analytical data for 
2.1d: Rf  = 0.50 (ethyl acetate/toluene, 1/5, v/v); [α]D25 +23.7 (c = 1, CHCl3); 1H-
n.m.r.: δ, 4.39-4.49 (m, 2 H, H-6a, 6b) , 4.76 (m, 1H, H-5), 5.35 (d, 1H, J1,2 = 9.9 Hz, 
H-1), 5.66 (dd, 1H, J2,3 = 9.9 Hz, J3,4 = 3.2 Hz, H-3), 5.87 (dd, 1H, H-2), 6.02 (d, 1H, 
H-4), 7.13-7.99 (m, 24H, aromatic), 10.50 (s, 1H, NH) ppm; 13C-n.m.r.: δ, 63.0, 68.6, 
72.6, 76.3, 77.4, 83.8, 111.0, 119.9, 122.7, 123.7, 128.5 (x2), 128.6 (x2), 128.7 (x5), 
128.8, 128.9 (x2), 129.4, 129.9 (x2), 130.0 (x3), 130.2 (x2), 133.6, 133.7, 133.8 (x2), 
135.2, 143.6, 143.8, 165.5, 165.6, 165.8, 166.8 ppm; HR-FAB MS [M+H]+ calcd for 
C41H33N2O9S 729.1907, found 729.1895. 
 
Benzimidazol-2-yl  3,4,6-tri-O-acetyl-2-deoxy-2-(2,2,2-trichloroethoxy) 
carbamoyl-1-thio-β-D-glucopyranoside (2.1e) was obtained from 3,4,6-tri-O-acetyl-
2-deoxy-2-(2,2,2-trichloroethoxy)carbamoyl-α-D-glucopyranosyl bromide63 in 53% 
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as a white amorphous solid as described in the synthesis of compound 2.1a.  
Analytical data for 2.1e: Rf  = 0.50 (ethyl acetate/toluene, 1/1, v/v); [α]D25 -6.8 (c = 1, 
CHCl3); 1H-n.m.r.: δ, 2.00, 2.03, 2.06 (3s, 9H, 3 x COCH3), 3.69-3.82 (m, 2H, H-2, 5), 
4.14 (dd, 1H, J6a,6b = 12.4 Hz, H-6a), 4.34 (dd, 1H, H-6b), 4.70 (dd, 2H, 2J = 12.1 Hz, 
CH2CCl3), 5.02 (dd, 1H, J4,5 = 9.7 Hz, H-4), 5.24 (d, 1H, J1,2 = 10.4 Hz, H-1), 5.40 
(dd, 1H, J3,4 = 9.9 Hz, H-3), 6.26 (d, 1H, NH), 7.11-7.32 (m, 4H, aromatic) ppm; 13C-
n.m.r.: δ, 20.8 (x2), 20.9, 55.9, 62.0, 68.5, 73.1, 74.7, 76.9, 83.9, 95.4, 111.0, 119.3, 
122.9, 123.9, 135.1, 143.3, 144.2, 154.9, 169.7, 170.7, 171.5 ppm; HR-FAB MS 
[M+H]+ calcd for C22H25Cl3N3O9S 612.0377, found 612.0381. 
 
(N-Anisoyl)benzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside 
(2.10a).  Anisoyl chloride (0.58 mL, 4.29 mmol) was added dropwise to a stirring 
solution of 2.1a (0.962 g, 1.4 mmol) in pyridine (10 mL).  The resulting reaction 
mixture was stirred under argon for 15 min at rt.  After that, the volatiles were 
removed in vacuo and the residue was co-evaporated with toluene (3 x 10 mL).  The 
residue was diluted with CH2Cl2 (~200 mL), and washed with water (20 mL), 1N aq. 
HCl (20 mL), water (20 mL), sat. aq. NaHCO3 (2 x 20 mL), and water (3 x 10 mL).  
The organic phase was separated, dried over MgSO4, and concentrated in vacuo.  The 
residue was purified by column chromatography on silica gel (ethyl acetate – toluene 
gradient elution) to afford the title compound (1.05 g, 91%) as an off-white foam.  
Analytical data for 2.10a: Rf = 0.50 (ethyl acetate/toluene, 1/9, v/v); [α]D27 +119.5 (c 
= 1.0, CHCl3); 1H-n.m.r.: δ, 3.66 (dd, 1H, J2,3 = 8.67 Hz, H-2), 3.70 - 3.87 (m, 5H, 3 , 
4, 5, 6a, 6b), 3.88 (s, 3H, OCH3), 4.54 (dd, 2H, 2J = 11.9 Hz, CH2Ph), 4.71 (dd, 2H, 2J 
= 10.7 Hz, CH2Ph), 4.87 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 4.88 (dd, 2H, 2J = 10.9 Hz, 
CH2Ph), 5.83 (d, 1H, J1,2 = 10.2 Hz, H-1), 6.89-7.71 (m, 28H, aromatic);  13C-n.m.r.: 
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δ, 55.8, 68.8, 73.5, 75.1, 75.5, 75.9, 77.9, 79.6, 81.2, 85.1, 86.9, 113.4, 114.4 (x3), 
119.3, 123.4, 124.2, 124.9, 127.7, 127.9 (x3), 128.0 (x7), 128.5 (x3), 128.6 (x4), 
129.2, 132.8 (x2), 134.7, 138.1, 138.3 (x2), 138.6, 143.9, 151.8, 164.5, 167.3 ppm; 
HR-FAB MS [M+H]+ calcd for C49H47N2O7S 807.3104, found 807.3081.  
 
(N-Anisoyl)benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-
glucopyranoside (2.10b) was obtained from 2.2b as an off-white foam in 92%, as 
described in the synthesis of compound 2.10a.  Analytical data for 2.10b: Rf  = 0.54 
(ethyl acetate/toluene, 1/9, v/v); [α]D27 +73.1 (c = 1, CHCl3); 1H-n.m.r.: δ, 3.83 (s, 3H, 
OCH3), 4.41-4.61 (m, 3H, H-5, 6a, 6b), 5.71 (dd, 1H, J4,5 = 9.4 Hz, H-4), 5.73 (dd, 1H, 
J2,3 = 9.4 Hz, H-2), 6.09 (dd,1H, J3,4 = 9.4 Hz, H-3), 6.44 (dd, 1H, J1,2 = 10.6 Hz , H-
1), 6.79-7.94 (m, 28H, aromatic) ppm; 13C-n.m.r.: δ, 55.8, 63.5, 69.7, 70.7, 74.5, 77.0, 
83.4, 113.5, 114.4 (x2), 119.1, 123.5, 124.4 (x2), 125.5, 128.4 (x3), 128.5 (x3), 128.6 
(x2), 128.9, 129.0, 129.2, 129.8, 129.9 (x2), 130.0 (x2), 130.1 (x2), 130.2 (x2), 132.8, 
133.1, 133.5 (x2), 133.7,134.7, 143.8, 151.2, 164.6, 165.2, 165.4, 165.9, 166.3, 167.0 
ppm; HR-FAB MS [M+H]+ calcd for C49H38N2O11SH+ 863.2275, found 863.2266. 
 
Synthesis of glycosyl acceptors.   
(N-Anisoyl)benzimidazol-2-yl 2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside 
(2.11).   
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Benzimidazol-2-yl 2,3,4-tri-O-benzoyl-6-O-tert-butyldimethylsilyl-1-thio-β-D-
glucopyranoside (2.A) was obtained from 2,3,4-tri-O-benzoyl-6-O-tert-
butyldimethylsilyl-β-D-glucopyranosyl bromide64 as a clear film in 53%, as described 
in the synthesis of compound 2.1a: Rf = 0.41 (ethyl acetate/toluene, 1/9, v/v); [α]D27 -
35.7 (c = 1.0, CHCl3); 1H-n.m.r.: δ, 0.10 (s, 6H, 2CH3), 0.91(s, 9H, C(CH3)3), 3.47 
(dd, 1H, J2,3 = 9.4 Hz, H-2), 3.47 (m, 1H, J5,6a = 4.3 Hz, J5,6b = 1.9 Hz, H-5),  3.62 (dd, 
1H, J3,4 = 9.0 Hz, H-3), 3.70 (dd, 1H, J4,5 = 8.7 Hz, H-4), 3.83 (dd, 1H, J6a,6b = 11.3 Hz, 
H-6a), 3.93 (dd, 1H, H-6b), 4.73 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 4.76 (dd, 1H, J1,2 = 
9.6 Hz, H-1), 4.78 (dd, 2H, 2J = 10.0 Hz, CH2Ph), 4.81 (dd, 2H, 2J = 9.6 Hz, CH2Ph), 
7.15-7.59 (m, 22H, NH, aromatic) ppm; 13C-n.m.r.: δ, -4.8, -4.7, 18.9, 26.3 (x3), 62.6, 
75.3, 75.9, 76.2, 77.1, 80.8, 81.2, 84.9, 86.6, 123.0, 128.0 (x4), 128.1 (x4), 128.2, 
128.3, 128.7 (x4), 128.8 (x6), 137.6, 138.1, 138.2, 146.6 ppm; HR-FAB MS [M+H]+ 
calcd for C40H48N2O5SSiNa 729.2945, found 719.2937. 
 
Benzimidazol-2-yl 2,3,4-tri-O-benzoyl-1-thio-β-D-glucopyranoside (2.B).  To a 
stirred solution of 2.A (1.134 g, 1.63 mmol) in THF (10 mL) was added TBAF (2.12 
mL, 2.12 mmol).  The reaction mixture was stirred under argon for 3 h at rt. Upon 
completion, the reaction was diluted with CH2Cl2 (200 mL), and washed with water 
(20 mL), sat. aq. NaHCO3 (20 mL), and water (3 x 20 mL).  The organic phase was 
separated, dried over MgSO4, and concentrated in vacuo.  The residue was purified by 
column chromatography on silica gel (ethyl acetate-toluene gradient elution) to afford 
the title compound (0.778 g, 92 %) as a white solid.  Analytical data for 2.B: Rf = 0.59 
(ethyl acetate/toluene, 2/5, v/v); [α]D27 -24.5 (c = 1.0, CHCl3); 1H-n.m.r.: δ, 3.03 (br. s, 
1H, OH), 3.48 (dd, 1H, J2,3 = 8.9 Hz, H-2), 3.51 (m, 1H, J5,6a = 4.5, J5,6b = 1.7 Hz, H-
5), 3.58 (dd, 1H, J4,5 = 9.8 Hz, H-4), 3.70 (dd, 1H, J3,4 = 8.7, H-3), 3.73 (dd, 1H, J6a,6b 
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= 11.1, H-6a), 3.96 (dd, 1H, H-6b), 4.72 (dd, 2H, 2J = 11.1 Hz, CH2Ph), 4.80 (dd, 2H, 
2J = 10.3 Hz, CH2Ph), 4.81 (dd, 1H, J1,2 = 9.6 Hz, H-1), 4.86 (dd, 2H, 2J = 11.0 Hz, 
CH2Ph), 7.15-7.72 (m, 20H, aromatic), 10.66 (s, 1H, NH) ppm ; 13C-n.m.r.: δ, 61.2, 
75.2, 75.7, 76.0, 80.1, 81.2, 84.7, 86.3, 122.9, 127.9 (x4), 128.2 (x5), 128.6 (x9), 
128.7 (x3), 137.6, 137.9, 138.3, 146.4 ppm; HR-FAB MS [M+H]+ calcd for 
C34H35N2O5S 583.2267, found 583.2264.  
 
(N-Anisoyl)benzimidazol-2-yl 2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside 
(2.11).  To a stirred solution of 2.B (1.033 g, 1.77 mmol) in pyridine (10 mL) was 
added dropwise TMS chloride (3.4 mL, 26.6 mmol).  The reaction mixture was stirred 
under argon for 1 h at rt.  Then, dropwise was added anisoyl chloride (0.571 mL, 3.55 
mmol) and stirred for an additional 1h at rt.  After that, the volatiles were removed in 
vacuo and the residue was co-evaporated with toluene (3 x 10 mL).  The residue was 
then diluted with CH2Cl2 (~200 mL), and washed with water (20 mL), 1N HCl (20 
mL), water (20 mL), sat. aq. NaHCO3 (2 x 20 mL), and water (3 x 20 mL).  The 
organic phase was separated, dried over MgSO4, and concentrated in vacuo.  The 
residue was purified by column chromatography on silica gel (ethyl acetate-toluene 
gradient elution) to afford the title compound (1.128 g, 89 %) as a white solid.  
Analytical data for 2.7: Rf = 0.44 (ethyl acetate/toluene, 1/4, v/v); [α]D27 -5.0 (c = 1.0, 
CHCl3); 1H-n.m.r.: δ, 3.59-3.94 (m, 9H, H-2, 3, 4, 5, 6a, 6b, OCH3), 4.78 (dd, 2H, 2J 
= 11.0 Hz, CH2Ph), 4.82 (dd, 2H, 2J = 10.6 Hz, CH2Ph), 4.91 (dd, 2H, 2J = 11.8 Hz, 
CH2Ph), 5.64 (d, 1H, J1,2=10.2 Hz, H-1), 6.93-7.75 (m, 24H, aromatic) ppm; 13C-
n.m.r.: δ, 55.8, 62.1, 75.2, 75.6, 76.0, 77.8, 80.0, 81.0, 84.8, 86.7, 113.3, 114.4, 119.4, 
123.6, 124.3, 124.8, 127.9 (x2), 128.0 (x2), 128.1 (x3), 128.2 (x3), 128.5 (x2), 128.6 
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(x3), 128.7 (x2), 132.9, 134.6, 137.9, 138.1, 138.5, 143.8, 151.1, 164.6, 167.4 ppm; 
HR-FAB MS [M+H]+ calcd for C42H41N2O7S 717.2629, found 717.2631.  
 
Synthesis of glycosides 
Typical AgOTf-promoted glycosylation procedure (Method A).  A mixture of glycosyl 
donor (0.045 mmol), glycosyl acceptor (0.030 mmol), and freshly activated molecular 
sieves (3Å, 125 mg) in 1,2-dichloroethane (1.0 mL) was stirred under argon for 1 h.  
AgOTf (0.090 mmol) was added and the reaction mixture was monitored by TLC.  
Upon completion (see Table 2.1), the solid was filtered off and rinsed sucessively 
with CH2Cl2. The combined filtrate (~15 mL) was washed with 1% NaOH (5.0 mL) 
and water (3 x 5.0 mL).  The organic layer was separated, dried with MgSO4 and 
concentrated in vacuo.  The residue was purified by silica gel column chromatography 
(ethyl acetate-toluene gradient elution) to afford the corresponding oligosaccharide. 
 
Typical Cu(OTf)2-promoted glycosylation procedure (Method B).  A mixture of 
glycosyl donor (0.045 mmol), glycosyl acceptor (0.030 mmol), and freshly activated 
molecular sieves (4Å, 125 mg) in 1,2-dichloroethane (1.0 mL) was stirred under 
argon for 1 h. Cu(OTf)2 (0.045 mmol) was added and the reaction mixture was 
monitored by TLC.  Upon completion (see Table 2.1), the solid was filtered off and 
rinsed sucessively with CH2Cl2. The combined filtrate (~15 mL) was washed with 1% 
NaOH (5.0 mL) and water (3 x 5.0 mL).  The organic layer was separated, dried with 
MgSO4 and concentrated in vacuo.  The residue was purified by silica gel column 
chromatography (ethyl acetate-toluene gradient elution) to afford the corresponding 
disaccharide. 
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Typical alkyl halide-promoted glycosylation procedure (Method C).  A mixture of 
glycosyl donor (0.045 mmol), glycosyl acceptor (0.030 mmol), and freshly activated 
molecular sieves (4Å, 125 mg) in 1,2-dichloroethane (1.0 mL) was stirred under 
argon for 1 h.  Alkyl halide (0.027 mmol) was added and the reaction mixture was 
monitored by TLC. Upon completion (see Table 2.1), the solid was filtered off and 
rinsed sucessively with CH2Cl2. The combined filtrate (~15 mL) was washed with 1% 
NaOH (5.0 mL) and water (3 x 5.0 mL).  The organic layer was separated, dried with 
MgSO4 and concentrated in vacuo.  The residue was purified by silica gel column 
chromatography (ethyl acetate-toluene gradient elution) to afford the corresponding 
disaccharide. 
 
Methyl 3-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-2,4,6-tri-O-benzyl-α-
D-glucopyranoside (2.8d) was synthesized by method A from glycosyl donor 2.1d 
(50 mg, 0.069 mmol) and glycosyl acceptor 2.4 (21 mg, 0.046 mmol) in 89% (42 mg) 
yield.  Analytical data for 2.8d: Rf = 0.45 (ethyl acetate/toluene, 1/5, v/v); [α]D25  
+10.5 (c = 1.0, CHCl3); 1H-n.m.r.: δ, 3.24 (s, 1H, OCH3), 3.35 (dd, 1H, J2,3 = 9.6 Hz, 
H-2), 3.53-3.71 (m, 3H, H-5, 6a, 6b), 3.61 (dd, 1H, J4,5 = 8.7 Hz, H-4), 4.26-4.39 (m, 
2H, H-5’, 6b’), 4.29 (d, 1H, J1,2 = 3.4, H-1), 4.39 (dd, 2H, 2J = 12.2 Hz, CH2Ph), 4.44 
(dd, 1H, J3,4 = 8.5 Hz, H-3), 4.51 (dd, 2H, 2J = 12.1 Hz, CH2Ph), 4.53-3.59 (m, 1H, H-
6a’), 4.91 (dd, 2H, 2J = 10.6 Hz, CH2Ph), 5.49 (d, 1H, J1’,2’ = 7.9Hz, H-1’), 5.66 (dd, 
1H, J3’,4’ = 3.4 Hz, H-3’), 5.86 (dd, 1H, J2’,3’ = 10.6 Hz, H-2’), 5.98 (d, 1H, J4’,5’ = 3.3 
Hz, H-4’), 7.04-8.03 (m, 35H, aromatic) ppm; 13C-n.m.r.: δ, 55.2, 61.7, 68.3, 68.6, 
69.8, 70.8, 71.1, 71.9, 73.7, 74.0, 75.1, 75.5, 77.4, 78.8, 81.0, 98.0, 101.2, 127.8, 
127.9, 128.0 (x2), 128.2 (x6), 128.4 (x4), 128.5 (x2), 128.6 (x3), 128.7 (x4), 129.0, 
129.2, 129.6, 129.7, 129.9 (x2), 130.0 (x3), 130.1 (x2), 133.3, 133.4, 133.5, 138.1, 
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138.8, 165.5, 165.6, 165.8, 166.1 ppm; HR-FAB MS [M+Na]+ calcd for 
C62H58O15SNa 1065.3673, found 1065.3644.  
 
Methyl 2-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-3,4,6-tri-O-benzyl-α-
D-glucopyranoside (2.9d) was synthesized by method A from glycosyl donor 2.1d 
(50 mg, 0.069 mmol) and glycosyl acceptor 5 (21 mg, 0.046 mmol) in 89% (43 mg) 
yield. Analytical data for 2.9d: Rf = 0.48 (ethyl acetate/toluene, 1/5, v/v); [α]D25  +92.4 
(c = 1.0, CHCl3); 1H-n.m.r.: δ, 3.40 (s, 1H, OCH3), 3.61 (dd, 1H, J4,5 = 8.9 Hz, H-4), 
3.66-3.78 (m, 3H, H-5, 6a, 6b), 3.82 (dd, 1H, J2,3 = 9.8 Hz, H-2), 3.95 (dd, 1H, J3,4 = 
9.0 Hz, H-3), 4.29-4.35 (m, 1H, H-5’), 4.42-4.48 (m, 1H, H-6b’), 4.48 (dd, 2H, 2J = 
10.9 Hz, CH2Ph), 4.53 (dd, 2H, 2J = 12.2 Hz, CH2Ph), 4.55-4.60 (m, 1H, H-6a’), 
4.53-3.59 (m, 1H, H-6a’), 4.56 (dd, 2H, 2J = 11.3 Hz, CH2Ph), 5.07 (d, 1H, J1,2 = 3.4, 
H-1), 5.13 (d, 1H, J1’,2’ = 8.1Hz, H-1’), 5.56 (dd, 1H, J3’,4’ = 3.4 Hz, H-3’), 5.96 (dd, 
1H, J2’,3’ = 8.1 Hz, H-2’), 5.98 (d, 1H, J4’,5’ = 3.4 Hz, H-4’), 6.92-8.12 (m, 35H, 
aromatic) ppm, 13C-n.m.r.: δ, 55.6, 62.4, 68.4, 68.7, 69.9, 70.2, 71.7, 72.3, 73.7, 75.1, 
75.4, 77.4, 77.9, 81.1, 82.4, 99.7, 103.0, 127.3 (x3), 127.7, 127.9, 128.0 (x2), 128.2 
(x2), 128.4 (x6), 128.6 (x2), 128.7 (x2), 128.8 (x2), 129.1, 129.2, 129.4, 129.8 (x2), 
129.9 (x2), 130.0 (x2), 130.3 (x2), 133.2, 133.4, 133.5, 133.8, 138.2, 138.3, 138.7, 
165.3, 165.7, 165.8, 166.2 ppm; HR-FAB MS [M+Na]+ calcd for C62H58O15SNa 
1065.3673, found 1065.3690. 
 
N-Anisoylbenzimidazol-2-yl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-glucopyranosyl)-
2,3,4-tri-O-benzyl-β-D-glucopyranoside (2.12). A mixture of glycosyl donor 2.1a 
(0.142 g, 0.212 mmol), glycosyl acceptor 2.11 (0.101 g, 0.141 mmol), and freshly 
activated molecular sieves (3Å, 426 mg), in 1,2-dichloroethane (4 mL) was stirred 
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under argon for 1h.  After that, methyl iodide (1.272 mmol) was added, and the 
reaction mixture was monitored by TLC.  Upon disappearance of the glycosyl 
acceptor, the solid was filtered off and the filtrate was diluted with CH2Cl2 (60 mL), 
washed with sat. aq. NaHCO3 (20 mL) and water (3 x 20 mL).  The organic layer was 
separated, dried with MgSO4, filtered and concentrated in vacuo.  The residue was 
purified by column chromatography on silica gel to afford the title compound (0.131 g, 
75%, α/β = 1/1.8) as a clear film.  Selected analytical data for α-2.8: 1H-n.m.r.: δ,  
5.14 (d, 1H, J1’,2’ = 3.4 Hz, H’-1), 5.77 (d, 1H, J1,2 = 10.3 Hz, H-1) ppm;  13C-n.m.r.: δ, 
86.7 (C-1), 97.1 (C’-1) ppm; Selected analytical data for β-2.8: 1H n.m.r.: δ, 5.87 (d, 
1H, J1,2 = 10.3 Hz, H-1) ppm;  13C-n.m.r.: δ, 86.9 (C-1), 103.6 (C’-1) ppm; HR-FAB 
MS [M+Na]+ calcd for C68H68N2O10SNa+ 1127.4492, found 1127.4475.  
 
2-Benzimidazolyl 6-O-(2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-
benzyl-β-D-glucopyranoside (2.13). To a stirred solution of a 2.8 (0.044 g, 0.035 
mmol) in CH2Cl2/MeOH (2 mL, 1/1, v/v) was added NaOMe until pH ~8.  The 
reaction mixture was stirred under argon for 1 h at rt.  After that, the reaction was 
neutralized with Dowex.  The solid was filtered off and the filtrate was concentrated 
in vacuo.  The residue was diluted with CH2Cl2 (~30 mL), washed with sat. aq. 
NaHCO3 (10 mL) and water (3 x 10 mL).  The organic phase was separated, dried 
over MgSO4, and concentrated in vacuo.  The residue was purified by column 
chromatography on silica gel (ethyl acetate-toluene gradient elution) to afford the title 
compound (0.037 g, 95 %) as a clear film.  Selected analytical data for α-2.9: 13C-
n.m.r.: δ, 86.5 (C-1), 97.9 (C’-1) ppm; (β anomer): 13C-n.m.r.: δ, 86.2 (C-1), 104.9 
(C’-1) ppm; HR-FAB MS [M+Na]+ calcd for C68H68N2O10SNa 1127.4492, found 
1127.4475.  
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Procedure for competitive glycosylation 
Methyl 6-O-(2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-
D-glucopyranoside (2.6a).  A mixture of glycosyl donor 2.1a (0.045 mmol), glycosyl 
donor 2.10a (0.045 mmol), glycosyl acceptor 2.2 (0.041 mmol), and freshly activated 
molecular sieves (3Å, 130 mg), in 1,2-dichloroethane (1.5 mL) was stirred under 
argon for 1h.  After that, methyl iodide (0.135 mmol) was added, and the reaction 
mixture was monitored by TLC.  Upon disappearance of the glycosyl acceptor, the 
solid was filtered off and the filtrate was diluted with CH2Cl2 (30 mL), washed with 
sat. aq. NaHCO3 (10 mL) and water (3 x 10 mL). The organic layer was separated, 
dried with MgSO4, filtered and concentrated in vacuo.  The residue was purified by 
column chromatography on silica gel. 
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Chapter 3 
 
 
Expanding upon the S-Benzimidazolyl (SBiz) 
platform for expeditious oligosaccharide 
synthesis: active-latent, armed-disarmed, selective 
and orthogonal activations 
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3.1  Introduction 
 The involvement of complex carbohydrates in a wide variety of disease-related 
cellular processes has given this class of natural compounds tremendous diagnostic and 
therapeutic potential.1  Certain classes of natural carbohydrates can be isolated, but in the 
most general sense, the availability of complex carbohydrates is still inadequate to 
address the challenges offered by modern glycosciences.  Chemical and enzymatic 
synthesis glycosylation have become viable means to obtain both natural carbohydrates 
and unnatural analogs thereof.2-4  Nevertheless, chemical synthesis of oligosaccharides of 
even moderate complexity still remains a considerable challenge, and many more 
complex structures are not yet available at all.  Because of this, the development of new 
effective methods for chemical and enzymatic glycosylation, as well as efficient 
strategies for the oligosaccharide and glycoconjugates synthesis stand out as timely and 
demanding areas of research in chemical, biological and medical sciences.5 
 As a part of the ongoing research effort in our laboratory to develop versatile 
building blocks for chemical glycosylation and expeditious oligosaccharide synthesis, we 
have been studying glycosyl thioimidates which are glycosyl donors equipped with 
SCR1=NR2 leaving group.  Among a variety of leaving groups studied by us and 
others,6,7 we determined that S-benzimidazolyl (SBiz) glycosides offer a new class of 
potent glycosyl donors.8  We also demonstrated that SBiz glycosides offer a very 
effective new platform for an attractive active-latent concept for expeditious 
oligosaccharide synthesis pioneered by Roy,9 Fraser-Reid,10 Boons,11 and more recently 
further advanced by Kim12,13 and others.14-16  As described in Chapter 2, we have 
acquired a convincing set of experimental data showing that MeI can activate only 
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glycosyl donor 3.1 equipped with unprotected SBiz (HSBiz) leaving group.  In the direct 
competition experiment, we have clearly shown that the N-anisoylated SBiz (AnSBiz) 
donor 3.2 remains intact and can be recovered nearly quantitatively (98%, Scheme 3.1).8  
 
Scheme 3.1.  Competition experiment between SBiz donor 3.1 (active) and its N-
anisoylated counterpart 3.2 (latent) in the presence of MeI. 
 
 
 Direct chemoselective activations clearly demonstrated the viability of the SBiz-
based active-latent concept.  Thus, MeI-promoted glycosylation between building blocks 
3.1 and 3.5 produced disaccharide 3.6 containing the AnSBiz anomeric moiety in 75% 
yield (Scheme 3.2).  After that, the N-anisoyl group was removed by treatment with 
tetrabutylammonium fluoride (TBAF); it should be noted that NaOMe or guanidine are 
also effective reagents.  The resulting disaccharide 3.7 bearing the HSBiz moiety was 
subsequently activated with MeI to afford trisaccharide 3.8 in 71% yield.  This two-step 
SBiz activation sequence with the intermediate deprotection step (3.1  3.6  3.7  
3.8) mimics the traditional active-latent pathway for oligosaccharide synthesis.8  
Additionally, we demonstrated that the intermediate disaccharide 3.6 can be directly 
activated for reaction with acceptor 3.3.  This activation required the stronger promoter 
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silver(I) triflate (AgOTf), which is able to activate both HSBiz and AnSBiz, and the 
requisite trisaccharide 3.8 was isolated in 84% yield.8  The extended mechanistic study 
made us believe that the deactivation effect of the N-anisoyl moiety is electronic, and the 
latter pathway for the synthesis of trisaccharide 3.8 (3.1  3.6  3.8) resembles an 
armed-disarmed-like activation.  The disarming effect discovered herein from the well-
documented disarming effect in glycosylation,17 in that the disarming is achieved by 
acylation of the leaving group, not by introducing neighboring acyl substituents in the 
sugar moiety. 
 
Scheme 3.2.  Synthesis of disaccharide 3.8 via the active-latent and an armed-disarmed 
fashion. 
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3.2  Results and Discussion  
 Building upon this earlier discovery that the application of the SBiz moiety allows 
executing rapid oligosaccharide assembly via active/latent and armed/disarmed concepts 
we continued screening for new systems and platforms for orthogonal activation.  This 
will be timely and innovative as it will help universalize this promising concept for 
oligosaccharide synthesis.  Therefore, studying SBiz glycosides as a new platform for 
orthogonal synthesis appealed to us as an important and timely venue.  Promoters 
selected included silver tetrafluoroborate (AgBF4) that was shown to be a potent activator 
for thioimidates18 and common promoters for thioglycoside activation: methyl triflate 
(MeOTf), N-iodosuccinimide (NIS) /triflic acid (TfOH), iodonium dicollidine perchlorate 
(IDCP), and dimethyl(thiomethyl) sulfonium triflate (DMTST).19  The gylcosides 
choosen were the perbenzylated HSBiz donor 3.1 and AnSBiz donor 3.2 were coupled 
with glycosyl acceptor 3.3 under various reaction conditions (Table 3.1).  Both glycosyl 
donors 3.1 and 3.2 were found to be readily activated with MeOTf, NIS/TfOH, IDCP and 
AgBF4 producing disaccharide 3.4 in 15 min to 12 h in 81-96% yield.  It is noteworthy 
that DMTST failed to activate the HSBiz glycoside 3.1, even after 120 h (entry 5, Table 
3.1).  When AnSBiz donor 3.2 was subjected to DMTST-mediated activation 
disaccharide 3.4 was smoothly produced in 12 h in 86% yield (entry 10).  This result is 
opposite to that obtained for MeI-mediated reactions.8  Hence, the subsequent study 
focuses on MeI and DMTST, promoters that showed the greatest difference in the 
activation profile between donors 3.1 and 3.2 
 To our surprize, when a competition experiment between glycosyl donors 3.1 and 
3.2, similar to that described in Scheme 3.1, was set up in the presence of DMTST, only 
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the AnSBiz donor 3.2 reacted!  This is opposite to that of the earlier results: HSBiz donor 
3.1 remained intact and could be recovered nearly quantitatively (96%, Scheme 3.3).  In 
our opinion, the set of competition experiments presented in Schemes 3.1 and 3.3 are 
clearly indicative of the purely orthogonal character of the HSBiz and AnSBiz leaving 
groups. 
 
Table 3.1.  Glycosidation of glycosyl donors 3.1 and 3.2 with glycosyl acceptor 3.3 in the 
presence of various promoters. 
 
entry donor promoter[a] time, h yield of 4 (α/β ratio) 
1 3.1 MeOTf 0.25 94% (1.7/1) 
2 3.1 NIS/TfOH 0.25 91% (1.2/1) 
3 3.1 IDCP 12 89% (1/1.1) 
4 3.1 AgBF4 0.25 81% (2.3/1) 
5 3.1 DMTST 120 no reaction 
6 3.2 MeOTf 1.5 92% (1.5/1) 
7 3.2 NIS/TfOH 0.25 96% (1.6/1) 
8 3.2 IDCP 12 87% (1/1.5) 
9 3.2 AgBF4 0.25 94% (1.3/1) 
10 3.2 DMTST 12 86% (3.3/1) 
[a] Performed in 1,2-dichloroethane the presence of molecular sieves 3 Å at rt.  
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Scheme 3.3.  Opposite reactivity of glycosyl donors 3.1 (latent) and 3.2 (active) observed 
in the presence of DMTST. 
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 Selective activation wherein one leaving group is activated over another offers a 
relatively straightforward access to oligosaccharides although aligning multiple leaving 
groups is not always feasible.  In this respect, the orthogonal strategy that relies on two 
orthogonal leaving groups, and requires a pair of orthogonal activators, is conceptually 
the most attractive.20-23  Yet, this strategy remains somewhat underdeveloped with too 
few known examples to become universally applicable.  Only the following examples are 
known to date: originally reported S-phenyl vs. fluoride,20,21,24 thioimidate-based 
approaches developed by us,25-28 Hotha’s O-pentenyl vs. O-propargyl,29 and O-
allylphenyl-based approach introduced by our group.30  We also reported a related, albeit 
less flexible, semi-orthogonal approach using S-ethyl vs. O-pentenyl,31 which was 
extended to fluoride vs. O-pentenyl by Fraser-Reid and Lopez.32  
 To determine the relative reactivity of differentially protected SBiz glycosides 
toward glycosidation we investigated the 2,3,4,6-O-benzoylated (disarmed) HSBiz donor 
3.9 and its N-anisoylated counterpart 3.10.8  When attempting to glycosidate HSBiz 
donor 3.9 in the presence of DMTST, no disaccharide 3.11 formation was expected based 
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on our observation with the armed benzylated donor 3.2.  Strickingly, donor 3.9 
“disappeared“ within 2 h (entry 5)!  An in depth study showed that no disaccharide 3.11 
was produced; instead donor 3.9 was entirely converted into its N-thiomethylated 
derivative 3.15 (see Table 3.2 footnote and discussion vide infra).  When donor 3.9 was 
subjected to MeI-promoted activation, no reaction took place (entry 6).  Since the per-
benzylated donor 3.1 was smoothly glycosylated within 12 h (entry 2) we attribute this 
result to the electron-withdrawing nature of benzoyl substituents (Fraser-Reid’s armed-
disarmed concept). 
 Results obtained with AnSBiz donor 3.10 were more predictable.  DMTST-
promoted activation was completed within 24 h and afforded disaccharide 3.11 in 88% 
yield.  For comparison, the armed donor 3.2 reacted faster (12 h, entry 3), which is also 
indicative of the armed-disarmed-like activation.  No glycosidation of 3.10 took place 
with MeI even after 120 h (entry 8).  We then began investigating glycosidation of 
glycosyl donors of the superarmed series.33-35  Glycosidation of the HSBiz donor 3.12 
resulted in an interesting outcome: both DMTST and MeI were effective and the 
corresponding disaccharide 3.14 was obtained in 8 and 15 h respectively (entries 9 and 
10).  Once again results obtained with AnSBiz donor 3.13 were more predictable: very 
fast reaction with DMTST that produced disaccharide 3.14 in 45 min (entry 11) and no 
reaction with MeI (entry 12). 
 To investigate these seemingly mixed results obtained with HSBiz donors 3.1, 
3.9, and 3.12 in the presence of DMTST, we first set out to determine how the O-
protecting groups influence the outcome of the reaction: no reaction for 3.1, formation of 
a stable intermediate 3.15 for 3.9, and smooth glycosylation for 3.12.  Since the disarmed 
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Table 3.2.  Glycosidation of differentially protected SBiz and N-anisoyl SBiz glycosyl 
donors. 
 
entry donor promoter[a] time, h product (yield, α/β ratio) 
1 3.1 DMTST 120 no reaction 
2 3.1 MeI 12 3.4 (89%, 4.8/1)8 
3 3.2 DMTST 12 3.4 (86%, 3.3/1) 
4 3.2 MeI 120 no reaction8 
5 3.9 DMTST 2 no disaccharide[b] 
6 3.9 MeI 120 no reaction 
7 3.10 DMTST 24 3.11 (88%, β only) 
8 3.10 MeI 120 no reaction 
9 3.12 DMTST 8 3.14 (94%, β only) 
10 3.12 MeI 15 3.14 (88%, β only) 
11 3.13 DMTST 0.75 3.14 (92%, β only) 
12 3.13 MeI 120 no reaction 
[a] performed in 1,2-dichloroethane in the presence of molecular sieves 3 Å at 35 °C 
(MeI) or rt (DMTST) 
[b] The following compound was produced as the only product 
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donor 3.9 produced a stable intermediate 3.15, we attempted to search a similar 
intermediate 3.16 in glycosidation with other series of HSBiz donors (Scheme 3.4).  
Upon a more detailed investigation by NMR, we determined that small amounts of the 
unstable compound 3.16 were present in the reaction mixture that originated from 3.1.  
This unstable reaction intermediate could not be glycosidated (since no disaccharide 3.4 
was produced), but instead it is rapidly equillibrated into the starting material 3.1.  
Therefore, the reaction outcome is overall indicative of DMTST being deactivated by the 
interaction with donor 3.1. 
 
Scheme 3.4.  Activation of HBiz donors with DMTST. 
 
 
 In case of the superarmed glycosyl donor 3.12, the reaction intermediate 3.17 is 
highly reactive.  It is possible that it equillibrates back to the starting material 3.12, but it 
can also be glycosidated to form disaccharide 3.14.  In our opinion, the relatively slow 
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reaction time of 8 h is indicative of the high rate of the competitive equillibration. For 
comparison, the anisoylated superarmed donor 3.13 is glycosidated in 45 min. 
 To build upon this discovery, we began studying the activation pathway of 
AnSBiz donor 3.2.  The DMTST-mediated activation of donor 3.2 resulted in the 
formation of disulfide 1-methyl-2-(methyldisulfanyl)-1H-benzimidazole 18 as the 
departing aglycone (Scheme 3.5).  To further investigate this finding, N-methylated donor 
3.19 was obtained and subjected to glycosidation with DMTST.  This reaction smoothly 
produced disaccharide 3.4 (15 h, 79%) along with the departed aglycone 1-anisoyl-2-
(methyldisulfanyl)-1H-benzimidazole 3.20. 
 
Scheme 3.5.  Activation of HSBiz, AnSBiz, and MeSBiz donors with DMTST. 
 
‚ 
 With the set of results presented in Schemes 3.4 and 3.5, it became apparent that 
nitrogen protection is required for the activation of SBiz glycosides with DMTST (except 
for those of the superarmed series).  The nature of the substituent is somewhat less 
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importance as both electron-withdrawing N-anisoyl and electron-donating N-methyl 
protection produced similar results. 
 
Scheme 3.6.  Activation of HSBiz, AnSBiz, and MeSBiz donors with MeI. 
 
 
 We then attempted to compare the activation pathways for the armed donors 3.1, 
3.2, and 3.19 with MeI.  Previously, we reported that benzyl bromide-mediated 
glycosylation of HSBiz donor 3.1 produced 3.2-benzylsulfanyl-1H-benzimidazole36,37 
indicating the activation via the sulfur atom.8  Similarly, when donor 3.1 was 
glycosidated in the presence of MeI, disaccharide 3.4 was obtained along with the 
departed aglycone 2-methylsulfanyl-1H-benzimidazole 3.21 (Scheme 3.6).  This result 
also indicates that the MeI-mediated activation formally follows the direct activation 
pathway.  When a similar experiment was conducted with donor 3.2, neither disaccharide 
nor products derived from the departed aglycone were detected in the reaction mixture.  
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When N-methylated donor 3.19 was subjected to glycosidation with MeI, disaccharide 
3.4 was smoothly produced (15 h, 79%) along with the departed aglycone that was 
determined to be 1-methyl-2-methylsulfanyl-1H-benzimidazole 3.22 (Scheme 3.6).  
 Overall, this mechanistic work has ultimately proven the activation pathways of 
the differentally N- and O-substituted SBiz glycosides.  We also discovered that the N-
methylated SBiz leaving group can be smoothly activated independently of the type of 
the activation conditions used.  The extended study of the N-methylated SBiz donors as 
well as the N-allyl and N-benzyl counterparts thereof will be reported in chapter four. 
 
3.3 Conclusions 
 In conclusion, we have performed further reactivity exploitations of SBiz 
glycosides in the presence of DMTST. Extended mechanistic study of the DMTST-
mediated activation pathway made us believe that the nitrogen protection is essential to 
achieve glycosylations with SBiz glycosides. Also demonstrated was an orthogonal 
strategy wherein N-protection along with careful promoter selection allow for essentially 
the same anomeric group to be used for both the donor and the acceptor conterparts.  
 
3.4  Experimental Section 
General remarks 
Column chromatography was performed on silica gel 60 (EM Science, 70-230 mesh), 
reactions were monitored by TLC on Kieselgel 60 F254 (EM Science). The compounds 
were detected by examination under UV light and by charring with 10% sulfuric acid in 
methanol. Solvents were removed under reduced pressure at < 40 oC. CH2Cl2 and 
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ClCH2CH2Cl were distilled from CaH2 directly prior to application. Anhydrous DMF 
(EM Science) was used as is. Methanol was dried by refluxing with magnesium 
methoxide, distilled and stored under argon. Pyridine and acetonitrile were dried by 
refluxing with CaH2 and then distilled and stored over molecular sieves (3 Å). Molecular 
sieves (3 Å or 4 Å), used for reactions, were crushed and activated in vacuo at 390 °C 
during 8 h in the first instance and then for 2-3 h at 390 °C directly prior to application. 
DOWEX MONOSPHERE 650C (H) was washed three times with MeOH and stored 
under MeOH. Optical rotations were measured using a ‘Jasco P-1020’ polarimeter. 1H-
n.m.r. spectra were recorded in CDCl3 at 300 MHz, 13C-n.m.r. spectra were recorded in 
CDCl3 at 75 MHz (Bruker Avance) unless otherwise noted. HRMS determinations were 
made with the use of JEOL MStation (JMS-700) Mass Spectrometer. 
 
Synthesis of glycosyl donors  
1-Anisoylbenzimidazol-2-yl 2-O-benzoyl-3,4,6-tetra-O-benzyl-1-thio-β-D-
glucopyranoside (3.13). Anisoyl chloride (0.58 mL, 4.29 mmol) was added dropwise to 
a stirring solution of benzimidazol-2-yl 2-O-benzoyl-3,4,6-tetra-O-benzyl-1-thio-β-D-
glucopyranoside (3.12, 1.0 g, 1.4 mmol) in pyridine (10 mL).  The resulting reaction 
mixture was stirred under argon for 15 min at rt.  After that, the volatiles were removed 
in vacuo and the residue was co-evaporated with toluene (3 x 10 mL).  The residue was 
diluted with CH2Cl2 (~200 mL), and washed with water (20 mL), 1 N aq. HCl (20 mL), 
water (20 mL), sat. aq. NaHCO3 (2 x 20 mL), and water (3 x 10 mL).  The organic phase 
was separated, dried over Na2SO4, and concentrated in vacuo.  The residue was purified 
by column chromatography on silica gel (ethyl acetate-toluene gradient elution) to afford 
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the title compound (1.05 g, 91%) as an off-white foam.  Analytical data for 3.13: Rf = 
0.52 (ethyl acetate/toluene, 1/9, v/v); [α]D27 +119.5 (c = 1.0, CHCl3); 1H-n.m.r.: δ, 3.89-
4.08 (m, 4H, H-4, 5, 6a, 6b), 4.11 (dd, 1H, J3,4 = 8.7 Hz, H-3) 4.68 (dd, 2H, 2J = 12.0 Hz, 
CH2Ph), 4.85 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 4.85 (dd, 2H, 2J = 11.1 Hz, CH2Ph), 5.63 
(dd, 1H, J2,3 = 9.8 Hz, H-2), 6.27 (d, 1H, J1,2 = 10.4 Hz, H-1), 6.93-7.67 (m, 28H, 
aromatic) ppm; 13C-n.m.r.: δ, 55.7, 68.7, 72.8, 73.5, 75.1, 75.4, 77.8, 80.1, 83.6, 84.3, 
113.3, 114.2, 118.9, 123.3, 124.1, 124.4, 127.7, 127.8, 127.9, 128.0 (x6), 128.2 (x2), 
128.4 (x3), 128.5 (x2), 129.6 (x2), 130.0 (x3), 132.6 (x2), 132.9, 133.3, 134.6, 137.8, 
138.1, 143.6, 151.6, 164.4, 165.2 ppm; HR-FAB MS [M+Na]+ calcd for C49H44N2O8SNa 
843.2716, found 843.2699.  
 
1-Thiomethylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-glucopyranoside 
(3.15). Dimethyl(thiomethyl)sulfonium triflate (0.024 g, 0.094 mmol) was added to a 
solution of benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-glucopyranoside (3.9, 
0.035 g, 0.047 mmol) in 1,2-dichloroethane (1.0 mL) and the resulting reaction mixture 
was stirred for 2 h at rt.  After that, triethylamine (~0.25 mL) and CH2Cl2 (~100 mL) 
were added and the resulting mixture was washed water (2 x 20 mL).  The organic phase 
was separated, dried with Na2SO4 and concentrated in vacuo.  The crude residue was 
used to obtain 1H-n.m.r. and 13C-n.m.r. without further purification.  Selected analytical 
data for 3.15: Rf = 0.66 (ethyl acetate/toluene, 1/5, v/v); 1H-n.m.r.: δ, 2.44 (s,3H, SCH3), 
4.50 (m, 2H, J5,6b = 4.9 Hz, J6a,6b = 14.3 Hz, H-5, 6a), 4.62 (dd, 1H, H-6b), 5.76 (dd, 1H, 
J4,5 = 9.5 Hz, H-4), 5.84 (dd, 1H, J2,3 = 9.4 Hz, H-2), 6.15 (dd, 1H, J3,4 = 9.4 Hz, H-3), 
6.36 (d, 1H, J1,2 = 10.4 Hz, H-1), 7.18-7.88 (m, 24H, aromatic) ppm; 13C-n.m.r.: δ, 23.0, 
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63.3, 69.6, 70.9, 74.3, 83.9, 110.2, 119.0, 123.2, 128.4 (x2), 128.5 (x4), 128.6 (x3), 128.8 
(x2), 128.9, 129.7, 129.8 (x3), 129.9 (x2), 130.0 (x2), 130.1 (x2), 133.1, 133.5, 133.6, 
133.7, 138.7, 143.9, 155.3, 165.4 (x2), 165.6, 165.8 ppm; HR-FAB MS [M+H]+ calcd for 
C42H35N2O9S+ 775.1784, found 775.1773. 
 
1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside 
(3.19).  Methyl iodide (0.14 mL, 2.2 mmol) was added to a solution of 3.1 (0.25 g, 0.37 
mmol) and KOH (0.10 g, 1.9 mmol) in tetrahydrofuran (5.0 mL) and the resulting 
mixture was stirred under argon for 30 min at rt.  Upon completion (TLC), the reaction 
mixture was diluted with CH2Cl2 (~100 mL) and washed with water (20 mL), sat. aq. 
NaHCO3 (20 mL), and water (3 x 20 mL).  The organic phase was separated, dried over 
NaSO4, and concentrated in vacuo.  The residue was purified by column chromatography 
on silica gel (ethyl acetate – hexane gradient elution) to afford the title compound (0.229 
g, 90% yield) as a colorless syrup.  Analytical data for 3.19: Rf = 0.55 (ethyl 
acetate/hexane 3/7, v/v); [α]D18 +3.7 (c 1.0, CHCl3); 1H-n.m.r.: δ, 3.51-3.79 (m, 6H, H-2, 
3, 4, 5, 6a, 6b), 3.74 (s, 3H, NCH3), 4.44 (dd, 2H, 2J = 11.9 Hz, CH2Ph), 4.66 (dd, 2H, 2J 
= 10.9 Hz, CH2Ph), 4.87 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 5.02 (dd, 2H, 2J = 10.7 Hz, 
CH2Ph), 5.68 (d, 1H, J1,2 = 9.0 Hz, H-1), 7.14-7.78 (m, 24H, aromatic) ppm; 13C-n.m.r.: 
δ, 31.0, 68.9, 73.5, 75.1, 75.5, 75.9, 79.2, 81.0, 86.2, 86.7, 109.5, 119.6, 122.4, 122.9, 
127.8, 127.9 (x2), 128.0 (x3), 128.2 (x2), 128.4, 128.5 (x6), 128.6 (x6), 129.1, 136.8, 
138.1, 138.2, 138.3, 138.5, 143.4, 147.2 ppm; HRMS–MS (m/z): [M + Na]+ calcd for 
C42H42N2O5SNa, 709.2712; found, 709.2719  
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1-Methyl-2-(methylthio)-1H-benzimidazole (3.22) was isolated by column 
chromatography from the reaction mixture resulting from the glycosylation between 3.19 and 
3.3 in the presence of MeI.  Analytical data for 3.22: Rf = 0.43 (ethyl acetate/hexane, 1/1, 
v/v); m. p. 121-124 °C (dichloromethane-toluene); 1H-n.m.r.: δ, 2.80 (s, 3H, SCH3), 3.67 
(s, 3H, NCH3), 7.15-7.71 (m, 4H, aromatic) ppm; 13C-n.m.r.: δ, 14.8, 30.1, 108.5, 118.2, 
121.9 (x2), 137.1, 143.6, 153.4 ppm; HR-FAB MS [M+H]+ calcd for C9H10N2S+ 
179.0643, found 179.0645. 
 
General procedure for DMTST-promoted glycosylations  
A mixture of glycosyl donor (0.045 mmol), glycosyl acceptor (0.038 mmol), and freshly 
activated molecular sieves (4Å, 100 mg) in 1,2-dichloroethane (1.0 mL) was stirred under 
argon for 1 h.  DMTST (0.090 mmol) was added and the reaction mixture was monitored 
by TLC.  Upon completion (see Tables), Et3N (0.3 mL) was added and the resulting 
mixture was stirred for 30 min.  The solid was filtered off and rinsed sucessively with 
CH2Cl2.  The combined filtrate (~30 mL) was washed with sat. aq. NaHCO3 (10 mL) and 
water (3 x 10 mL).  The organic phase was separated, dried with sodium sulfate, and 
concentrated in vacuo.  The residue was purified by column chromatography on silica gel 
(ethyl acetate - toluene gradient elution).  Anomeric ratios were determined by 
comparison of the integral intensities of relevant signals in 1H NMR spectra.  
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Chapter 4 
 
 
 
Extending the S-benzimidazolyl platform: N-
alkylated SBiz glycosyl donors with the 
universal activation profile 
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4.1  Introduction 
 The development of efficient and practical building blocks for chemical 
glycosylation is instrumental in obtaining complex carbohydrates.1  During the 
designing of synthetic routes to acquire oligosaccharides, multiple components, 
conditions, and other features have to be considered.  Ideally, glycosides should be 
generated from easily accessible starting material and would require a minimal 
number of steps.2  Furthermore, selection of an appropriate leaving group at the 
anomeric position is needed to ensure that its activation can be conducted by reliable 
methods using common promoters.3  Carefully designed building blocks and refined 
reaction conditions help to obtain high yields and ensure the reproducibility of 
syntheses.   
 In our previous studies dedicated to the development of a new glycosylation 
methodology based on S-benzimidazolyl glycosides, we found that the 
unfuntionalized HSBiz leaving group can be readily activated with methyl iodide 
(MeI, Chapter 2).4  Conversely, a more recent study showed that the N-anisoylated 
SBiz (AnSBiz) leaving group is activated with dimethyl(thiomethyl)sulfonium 
triflate5 (DMTST), but not with methyl iodide (Chapter 3).  This cooperative finding 
allowed us to create a new SBiz-based orthogonal approach to expeditious 
oligosaccharide synthesis.6  While conducting a mechanistic study to understand the 
driving forces for this differential reactivity, we obtained N-methylated SBiz 
(MeSBiz) derivatives.  These compounds were initially intended to perform a 
comparative study to understand the effect of the electron-withdrawing anisoyl group 
in AnSBiz derivatives.  The most intriguing outcome of that study was the discovery 
that both MeI and DMTST could smoothly activate MeSBiz.  Since this feature is 
unavailable with neither HSBiz nor AnSBiz donors, this finding creates a very 
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promising avenue for further study of SBiz glycosides and derivatives thereof.  The 
main purpose of the study described in this Chapter is to investigate the scope of a 
new series of the SBiz moiety-based glycosyl donors with a universal activation 
profile.  
 
4.2  Results and Discussion 
 A set of side-by-side comparison experiments was performed to confirm the 
viability of our previous observation that MeSBiz can be universally activated both 
with MeI and DMTST.  As aforementioned, other glycosyl donors of this series 
demonstrate affinity towards only one activator of these activators, but not both.  For 
instance, no disaccharide 4.57 was obtained when DMTST was employed to activate 
HSBiz glycosyl donor 4.1 for reaction with acceptor 4.48 (Table 4.1, entry 1).  When 
donor 4.1 was activated in the presence of MeI, disaccharide 4.5 was obtained in 89% 
yield (α/β = 4.8/1, entry 2).  Conversely, when the N-anisoylated counterpart 4.2 was 
subjected to the same promoters, disaccharide 4.5 was obtained from the DMTST-
mediated experiment only, but not from the one involving MeI-mediated activation 
(entries 3 and 4, respectively).  The working hypothesis to explain these findings is 
that the electron-withdrawing anisoyl group deactivates the SBiz moiety to prevent 
MeI from initiating the glycosidation process, even after 120 h.  
 When donor 4.3 was promoted with DMTST, dissacharide 4.5 was isolated in 
79% yield (α/β = 2.5/1, entry 5).  While we have yet been unable to isolate aglycone 
4.6 to confirm the activation pathway, we theorize that the leaving group is activated 
via the anomeric sulfur.  Interestingly, a decrease in reaction time was observed in this 
experiment in comparison to that involving DMTST-mediated activation of AnSBiz 
donor 4.2 (8 h versus 15 h, entries 5 and 3, respectively).  When donor 4.3 was 
activated with MeI, disaccharide 4.5 was produced in 79% yield (α/β = 6.1/1, entry 6).  
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The outcome of the latter reaction was deemed similar to that of MeI-mediated 
activation of HSBiz donor 4.1. The activation mode via the anomeric sulfur was 
ultimately determined by isolation and characterization of departed aglycone 4.7 
(entry 2).  
 
Table 4.1.  Summary of glycosidation of donors 4.1-4.3 in the presence of DMTST or 
MeI.  
 
Entry Donor Promoter[a] Time, h Product (yield, α/β ratio) 
1 4.1 DMTST 120 no reaction 
2 4.1 MeI 12 4.5 (89%, 4.8/1) 
3 4.2 DMTST 15 4.5 (86%, 3.3/1) 
4 4.2 MeI 120 no reaction 
5 4.3 DMTST 8 4.5 (79%, 2.5/1) 
6 4.3 MeI 15 4.5 (79%, 6.1/1) 
[a] performed in 1,2-dichloroethane in the presence of molecular sieves 3 Å at 35 °C 
(MeI) or rt (DMTST) 
 
 While the discovery of the universal activation profile of N-methylated SBiz 
donor 4.3 was promising, its synthesis remained cumbersome.  Since methylation of 
the imidazole ring of HSBiz glycoside 4.1 with MeI required a strong base (NaH), this 
protocol was mainly compatible with compounds of the O-benzylated series.  All 
Hasty, Scott, 2013, UMSL, p.113 
 
attempts to access O-acylated building blocks resulted in very low yields or even 
failed entirely due to a low stability of the ester groups in the presence of NaH.  
Additionally, even with the O-benzylated series, these conditions (MeI/NaH) could 
lead low yield of 4.3 due to the competitive HSBiz leaving group activation taking 
place via the S-methylation pathway4 instead of the desired N-methylation.  Therefore, 
prior to undertaking further steps for investigating glycosyl donors containing N-
methylated SBiz leaving group in glycosylations, we decided to conduct a systematic 
study to improve their synthesis.  Alongside, we were curious to investigate other N-
alkylated derivatives to gain better understanding of the reactivity and other properties 
of these compounds.  
 We theorized that advantages of the alkylation of 2-mercaptobenzoxazole 
prior to introducing it to the anomeric position would be two-fold.  First, since one of 
the nitrogen atoms is protected, the subsequent synthesis of glycosyl thioimidates will 
be simplified because the main competing reaction leading to the N-linked glycoside 
would become less likely.  Second, this protocol should be compatible with acylated 
derivatives because a base-mediated reaction is conducted prior to conjugation with 
the sugar moiety.  Additionally, we were curious to investigate whether introducing 
the aglycone via an anomeric acetate would be a viable pathway.  Although the 
synthesis of glycosyl thioimidates via bromides is broadly used in the field, this 
reaction often leads to the formation the glycal by-product.4,9-12  Since bromides are 
also obtained from the acetate precursors,13 the direct synthesis of thioimidates from 
glycosyl acetates would be shorter. 
 With these considerations in mind, we first synthesized aglycones 4.9a-c 
according to known protocols.14  Commercially available 2-mercaptobenzimidazole 
was first S-tritylated with trityl chloride in the presence of triethylamine in 
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tetrahydrofuran.  After filtration of solids, the imidazole nitrogen was alkylated using 
KOH in acetone.  Finally, the trityl group was removed by refluxing in a 10% acetic 
acid/methanol solution for 30 min to afford aglycones 4.9a-c in 58-87% yield.  
 Glucose pentaacetate 4.8 was then reacted with the N-methyl aglycone 4.9a in 
the presence of boron trifluoride diethyl etherate (BF3•Et2O) at reflux to afford 
glycosyl donor 4.10a in 97% yield (Table 4.2, entry 1).  Similarly, allylated glycosyl 
donor 4.10b (AllSBiz) and benzylated donor 4.10c (BnSBiz) were obtained in 94% 
and 92% yields respectively (entries 2 and 3).  The allylated and benzylated 
derivatives were obtained for studying their reactivity alongside their methylated 
counterpart 4.10a.  If the anticipated similarity in reactivity were confirmed, 
derivatives 4.10b and 4.10c would allow for more synthetic versatility than MeSBiz 
4.10a.  Furthermore, having temporary N-protecting groups, rather than the permanent 
N-methyl, provides straightforward access to building blocks of the HSBiz and, 
consequently, N-anisoyl SBiz series.   
 
Table 4.2.  Synthesis of N-alkylated SBiz donors with BF3•Et2O. 
 
Entry Product Yield 
1 4.10a 97% 
2 4.10b 94% 
3 4.10c 92% 
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 With peracetylated N-alkyl SBiz glycosides in hand, we turned our attention to 
determine the stability of the leaving group toward Zemplen conditions.  For this 
purpose, compounds 4.10a, 4.10b, and 4.10c were treated with a 1 N NaOMe/MeOH 
solution until the reaction mixture reached a pH=9.  Removal of O-acetyl protecting 
groups proceeded cleanly and no visible by-products were observed (TLC).  With a 
straightforward access to the unprotected glycosides, we were set to investigate the 
synthesis of different O-substituted derivatives of this class.   
 
Table 4.3.  Synthesis of per-benzoylated and per-benzylated N-alkyl SBiz donors. 
 
Entry Product Yield 
1 4.11a 87% 
2 4.11b 90% 
3 4.11c 87% 
4 4.3 83% 
5 4.12b 87% 
6 4.12c 89% 
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 We first attempted O-benzoylation using benzoyl chloride in the presence of 
pyridine: all three unprotected SBiz glycosides derived from 4.10a-c produced their 
respective O-benzoylated counterparts 4.11a-c in 87-90% yield for two steps (Table 
4.3, entries 1-3). 
 Having synthesized per-O-benzoylated glycosides 4.11a-c, we set out to 
acquire their per-O-benzylated counterparts 4.3, 4.12b, and 4.12c by O-alkylation of 
the deprotected precursors using benzyl bromide in the presence of NaH.  The three 
donors (4.3, 4.12b, and 4.12c) were isolated in respectable yields of 83-89% (entries 
4-6).  These successful syntheses imply that all N-alkylated SBiz moieties are stable 
toward strongly basic reaction conditions, NaOMe required for deprotection and NaH 
used for benzylation.  Pleased with these routes and overall yields, we turned our 
attention to investigating the reactivity of these glycosyl donors employing common 
promoters that have been utilized in previous studies of SBiz glycosides: DMTST, 
MeI, copper(II) triflate (Cu(OTf)2), and silver(I) triflate (AgOTf).  
 First, per-benzoylated (disarmed)15 glycosyl donors 4.11a-c were subjected to 
glycosidation with glycosyl acceptor 4.4 in the presence of various activators and the 
results of this study are summarized in Table 4.4.  Thus, with DMTST promotion all 
three donors activated quite readily and afforded the corresponding disaccharide 
4.1316 in 83-88% yield (entries 1-3).  MeI failed to activate donor 4.11a (entry 4).  
Perhaps, O-acyl substituents rendered the MeSBiz moiety unreactive in the presence 
of this very weak promoter.  A similar outcome (no reaction) was obtained with other 
O-benzylated glycosyl donors 4.11b and 4.11c (entries 5 and 6).   
 We then turned our efforts toward investigating the activation of the N-
alkylated SBiz moieties with metal-based promoters, which were expected to be more 
powerful reagents for the activation of thioimidates.12  Indeed, when we conducted 
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glycosylations using AgOTf all alkylated donors 4.11a-c reacted readily (2.5-3 h) and 
afforded disaccharide 4.13 in high yields of 92-94% (entries 7-9).  Lastly, when 
employing Cu(OTf)2, a mild metal-based promoter, glycosylation reactions with 
donors 4.11a-c required longer reaction time (60 h), but still afforded disaccharide 
4.13 in good yields (82-89%, entries 10-12).   
 
Table 4.4.  Glycosidations of per-benzoylated N-alkyl SBiz glycosides. 
 
Entry Donor Promoter Time Yield α/β ratio 
1 4.11a DMTST 9 h 87% β only 
2 4.11b DMTST 12 h 83% β only 
3 4.11c DMTST 15 h 88% β only 
4 4.11a MeI 120 h NR - 
5 4.11b MeI 120 h NR - 
6 4.11c MeI 120 h NR - 
7 4.11a AgOTf 3 h 92% β only 
8 4.11b AgOTf 2.5 h 94% β only 
9 4.11c AgOTf 2.5 h 92% β only 
10 4.11a Cu(OTf)2 60 h 89% β only 
11 4.11b Cu(OTf)2 60 h 84% β only 
12 4.11c Cu(OTf)2 60 h 82% β only 
 
 We next turned our efforts toward studying per-O-benzylated (armed)15 
glycosyl donors 4.3, 4.12b, and 4.12c.  This study employed the same set of 
promoters as that used for studying per-benzoylated (disarmed) counterparts and the 
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key results are summarized in Table 4.5.  When DMTST was utilized, the trio of the 
armed donors glycosidated with acceptor 4.4 to afford disaccharide 4.5 in 8-9 h and 
79-91% yield (α/β = 1.6-2.3/1, entries 1-3).  Since no glycosylation took place with 
the disarmed donors 4.11a-c in the presence of MeI (see Table 4.4), we were 
particularly curious about studying this promoter with the armed glycosyl donors.  In 
this case, MeI-promoted activations of donors 4.3, 4.12b, and 4.12c were smoothly 
completed in 15 h and produced disaccharide 4.14 in 79-90% yield (entries 4-6, Table 
4.5).   
 
Table 4.5.  Glycosidations of per-benzylated N-alkyl SBiz glycosides. 
 
Entry Donor Promoter Time Yield α/β ratio 
1 4.3 DMTST 8 h 79% 2.5/1 
2 4.12b DMTST 9 h 91% 1.6/1 
3 4.12c DMTST 9 h 87% 2.3/1 
4 4.3 MeI 15 h 79% 6.1/1 
5 4.12b MeI 15 h 90% 1.0/1 
6 4.12c MeI 15 h 84% 2.2/1 
7 4.3 AgOTf 15 min 92% 1.0/1 
8 4.12b AgOTf 15 min 92% 1.3/1 
9 4.12c AgOTf 15 min 94% 1.2/1 
10 4.3 Cu(OTf)2 15h 80% 2.3/1 
11 4.12b Cu(OTf)2 18 h 83% 1.8/1 
12 4.12c Cu(OTf)2 18 h 86% 1.7/1 
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 Expectedly, all AgOTf-promoted glycosylations with the armed glycosyl 
donors were very fast and disaccharide 4.5 was obtained in 15 min in 92-94% yield 
(α/β = 1-1.3/1, entries 10-12).  In the presence of Cu(OTf)2, the per-O-benzylated 
donors afforded disaccharide 4.5 in 15 h (vs. 60 h for the disarmed counterparts) and 
in good yields (80-86% yield, α/β = 1.7-2.3/1, entries 7-9).   
 As a means to provide an efficient route to access HSBiz glycosides, we 
investigated if deprotection of the imidizole nitrogen was probable.  Adapting 
procedures developed for carbohydrates17 and heterocycles,18 deprotection of the N-
benzyl protecting group was conducted in DMSO with 1 M potassium tert-butoxide in 
the presence of O2 to afford glycoside 4.1 in 92% yield. 
 
4.3  Conclusion 
 In conclusion, we have demonstrated that N-alkylated SBiz glycosides can be 
synthesized in an efficient and concise manner.  All glycosyl donors were synthesized 
from N-protected SBiz aglycones by Lewis acid-mediated coupling with 
commercially available penta-O-acetyl glucopyranose precursor.  The N-alkylated 
SBiz moiety was found to be stable under strong basic conditions and can survive 
common protecting group manipulations.  This, in turn, allowed us to obtain both 
armed and disarmed N-alkylated SBiz donors.  Glycosylations with these donors gave 
good yields and displayed properties that bridge our previous studies.  
 
4.4  Experimental Section 
General remarks 
Column chromatography was performed on silica gel 60 (EM Science, 70-230 mesh), 
reactions were monitored by TLC on Kieselgel 60 F254 (EM Science).  The 
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compounds were detected by examination under UV light and by charring with 10% 
sulfuric acid in methanol.  Solvents were removed under reduced pressure at < 40 oC. 
CH2Cl2 and ClCH2CH2Cl were distilled from CaH2 directly prior to application. 
Anhydrous DMF (EM Science) was used as is.  Methanol was dried by refluxing with 
magnesium methoxide, distilled and stored under argon.  Pyridine was dried by 
refluxing with CaH2 and then distilled and stored over molecular sieves (3 Å). 
Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and activated in 
vacuo at 390 °C during 8 h in the first instance and then for 2-3 h at 390 °C directly 
prior to application.  AgOTf (Acros) was co-evaporated with toluene (3 x 10 mL) and 
dried in vacuo for 2-3 h directly prior to application.  DOWEX MONOSPHERE 650C 
(H) was washed three times with MeOH and stored under MeOH.  Optical rotations 
were measured using a ‘Jasco P-1020’ polarimeter.  1H-NMR. spectra were recorded 
in CDCl3 at 300 MHz, 13C-NMR spectra were recorded in CDCl3 at 75 MHz (Bruker 
Avance) unless otherwise noted.  HRMS determinations were made with the use of 
JEOL MStation (JMS-700) Mass Spectrometer. 
 
1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside 
(4.10a).  2-Mercapto-1-methylbenzimidazole14 (1.26 g, 7.7 mmol) and BF3-OEt2 (2.6 
mL, 20.5 mmol) were added to a solution of 1,2,3,4,6-penta-O-acetyl-β-D-
glucopyranose (2.00 g, 5.12 mmol) in CH2Cl2 (20 mL) and the resulting reaction 
mixture was heated at reflux for 2 h.  After that, the reaction mixture was diluted with 
CH2Cl2 (~30 mL) and washed with water (10 mL), sat. aq. NaHCO3 (10 mL), and 
water (3 × 10 mL).  The organic phase was separated, dried over MgSO4, and 
concentrated in vacuo.  The residue was purified by column chromatography on silica 
gel (ethyl acetate-hexane gradient elution) to afford the title compound (2.26 g, 89% 
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yield) as white crystals.  Analytical data for 4.10a: Rf = 0.37 (ethyl acetate/hexane, 
3/5, v/v); m.p. 148–149 °C (diethyl ether-hexanes); [α]D24 +33.2 (c 1.0, CHCl3); 1H-
n.m.r.: δ, 1.90 (s, 3H, CH3), 2.02 (s, 3H, CH3), 2.03 (s, 3H, CH3), 2.07 (s, 3H, CH3), 
3.76 (s, 3H, NCH3), 3.80-3.87 (m, 1H, H-5), 4.06 (dd, 1H, J6a,6b = 12.4 Hz, J5,6a = 2.1 
Hz, H-6a), 4.22 (dd, 1H, J5,6b = 4.9 Hz, H-6b), 5.12 (dd, 1H, J4,5 = 9.4 Hz, H-4), 5.22 
(dd, 1H, J2,3 = 10.1 Hz, H-2), 5.33 (dd, 1H, J3,4 = 9.2 Hz, H-3), 5.68 (d, 1H, J1,2 = 10.0 
Hz, H-1), 7.24-7.77 (m, 5H, aromatic) ppm; 13C-n.m.r.: δ, 20.7 (x2), 20.8 (x2), 30.1, 
61.8, 68.2, 70.1, 73.8, 76.2, 84.8, 109.4, 119.2, 122.5, 123.0, 136.7, 143.2, 147.0, 
169.6, 169.9, 170.1, 170.6 ppm; HRMS–MS (m/z): [M + Na]+ calcd for C22H26N2O9S, 
494.1359; found, 495.1437. 
 
1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside 
(4.10b) was obtained from 1-allyl-2-mercapto-benzimidazole14 and 1,2,3,4,6-penta-O-
acetyl-β-D-glucopyranose as described for the synthesis of 4.10a in 94% yield as 
white crystals.  Analytical data for 4.10b: Rf = 0.46 (ethyl acetate/hexane, 3/5, v/v); 
m.p. 108 °C (diethyl ether-hexanes); [α]D24 -16.2 (c 1.0, CHCl3); 1H-n.m.r.: δ, 1.88 (s, 
3H, CH3), 2.02 (s, 3H, CH3), 2.03 (s, 3H, CH3), 2.06 (s, 3H, CH3), 3.82 (m, 1H, J5,6a = 
2.2 Hz, J5,6b = 5.0 Hz , H-5), 4.06 (dd, 1H, J6a,6b = 12.4 Hz, H-6a), 4.21 (dd, 1H, , H-
6b), 4.73-4.89 (m, 2H, CH=CH2), 5.12 (dd, 1H, J4,5 = 10.1 Hz, H-4), 5.13 (dd, 2H, 2J 
= 17.1 Hz, -CH=CH2), 5.21 (dd, 1H, J2,3 = 9.3 Hz, H-2), 5.33 (dd, 1H, J3,4 = 9.2 Hz, 
H-3), 5.67 (d, 1H, J1,2 = 10.2 Hz, H-1), 5.90 (m, 1H, -CH=CH2), 7.23-7.78 (m, 4H, 
aromatic) ppm; 13C-n.m.r.: δ, 20.7 (x2), 20.8 (x2), 46.8, 61.8, 68.2, 70.2, 73.9, 76.2, 
85.0, 110.0, 118.2, 119.3, 122.7, 123.2, 131.6, 136.0, 143.2, 146.9, 169.6, 169.9, 
170.1, 170.7 ppm; HRMS–MS (m/z): [M + H]+ calcd for C24H28N2O9S+, 521.1594; 
found, 521.1591.  
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1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside 
(4.10c) was obtained from 1-benzyl-2-mercapto-benzimidazole14 and 1,2,3,4,6-penta-
O-acetyl-β-D-glucopyranose as described for the synthesis of 4.10a in 90% yield as 
white crystals.  Analytical data for 4.10c: Rf  = 0.37 (ethyl acetate/ hexane, 3/5, v/v); 
m.p. 139-144 °C (diethyl ether-hexanes); [α]D24 -17.2 (c 1.0, CHCl3); 1H-n.m.r.: δ, 
1.89 (s, 3H, CH3), 2.04 (s, 3H, CH3), 2.05 (s, 3H, CH3), 2.05 (s, 3H, CH3), 3.80-3.87 
(m, 1H, J5,6a = 2.1 Hz, J5,6b = 4.9 Hz , H-5), 4.06 (dd, 1H, J6a,6b = 12.4 Hz, H-6a), 4.22 
(dd, 1H, H-6b), 5.14 (dd, 1H, J4,5 = 9.4 Hz, H-4), 5.23 (dd, 1H, J2,3 = 10.2 Hz, H-2), 
5.35 (dd, 1H, J3,4 = 9.3 Hz, H-3), 5.42 (s, 2H, NCH2Ph) 5.76 (d, 1H, J1,2 = 9.5 Hz, H-
1), 7.14-7.79 (m, 9H, aromatic) ppm; 13C-n.m.r.: δ, 20.7 (x2), 20.8 (x2), 48.1, 61.8, 
68.2, 70.2, 73.9, 76.3, 85.3, 110.2, 119.4, 122.7, 123.2, 126.9 (x2), 128.2, 129.0 (x2), 
135.7, 136.2, 143.6, 147.2, 169.6, 169.8, 170.1, 170.7 ppm; HRMS–MS (m/z): [M + 
H]+ calcd for C28H31N2O9S, 571.1750; found, 571.1744. 
 
1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-glucopyranoside 
(4.11a).  Compound 4.10a (1.00 g, 2.02 mmol) was dissolved in methanol (10 mL), 
and the pH was adjusted (pH 9) by addition of a 1 M solution of NaOCH3 in MeOH 
(~0.25 mL).  The reaction mixture was stirred for 1.5 h at rt, then Dowex (H+) was 
added until neutral pH was achieved.  The resin was filtered off and rinsed with 
methanol (3 × 5 mL).  The combined filtrate (~25 mL) was concentrated in vacuo and 
dried.  The residue was dissolved in pyridine (10 mL) and benzoyl chloride (1.1 mL, 
10.1 mmol) was added.  The resulting reaction mixture was stirred under argon for 3.5 
h at rt.  After that, methanol was added (~1 mL) and the volatiles were removed in 
vacuo.  The residue was co-evaporated with toluene (3 x 5 mL), then diluted with 
CH2Cl2 (~150 mL), and washed with water (15 mL), 1 M aq. HCl (15 mL), water (15 
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mL), sat. aq. NaHCO3 (2 x 20 mL), and water (3 x 10 mL).  The organic phase was 
separated, dried over Na2SO4, and concentrated in vacuo.  The residue was purified by 
column chromatography on silica gel (ethyl acetate-hexanes gradient elution) to 
afford the title compound (1.30 g, 87% yield) as a white amorphous solid.  Analytical 
data for 4.11a: Rf = 0.55 (ethyl acetate/hexane, 3/7, v/v); [α]D21 +68.0 (c 1.0, CHCl3); 
1H-n.m.r.: δ, 3.66 (s, 3H, OCH3), 4.34 (m, 1H, J5,6a = 5.9, J5,6b = 2.1 Hz, H-5), 4.45 
(dd, 1H, J6a,6b = 11.9 Hz, H-6a), 4.60 (dd, 1H, H-6b), 5.77 (dd, 1H, J4,5 = 9.6 Hz, H-4), 
5.80 (dd, 1H, J2,3 = 10.2 Hz, H-2), 6.11 (dd, 1H, J3,4 = 9.5 Hz, H-3), 6.21 (dd, 1H, J1,2 
= 10.3 Hz, H-1), 7.13-7.97 (m, 24H, aromatic) ppm; 13C-n.m.r.: δ, 30.6, 63.2, 69.4, 
71.1, 74.1, 85.1, 109.4, 119.0, 122.6, 122.9, 128.5 (x7), 128.6 (x2), 128.7 (x2), 128.9, 
129.5, 129.8 (x2), 129.9 (x2), 130.0 (x2), 130.1 (x2), 130.3, 133.2, 133.5, 133.7, 
136.7, 143.2, 147.4, 165.3, 165.6, 165.8, 166.2 ppm; HR-FAB MS [M+Na]+ calcd for 
C42H34N2O9S+ 743.2063, found 743.2062. 
 
1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-glucopyranoside 
(4.11b) was obtained from 4.10b as described for the synthesis of 4.11a in 90% yield 
as a white amorphous solid.  Analytical data for 4.11b: Rf = 0.56 (ethyl 
acetate/toluene, 1/9, v/v); [α]D22 +45.5 (c 1.0, CHCl3); 1H-n.m.r.: δ, 4.33 (m, 1H, J5,6a 
= 5.8, J5,6b = 2.4 Hz, H-5), 4.40 (dd, 1H, J6a,6b = 12.1 Hz, H-6a), 4.54 (dd, 1H, H-6b), 
4.62-4.69 (m, 2H, CH=CH2), 4.98 (dd, 2H, 2J = 17.1 Hz, CH2-CH), 5.66-5.81 (m, 3H, 
H-2, 4, CH=CH2), 6.06 (dd, 1H, J3,4 = 9.5 Hz, H-3), 6.14 (dd, 1H, J1,2 = 10.3 Hz, H-1), 
7.13-7.95 (m, 29H, aromatic) ppm; 13C-n.m.r.: δ, 46.6, 63.2, 69.4, 71.1, 74.1, 79.2, 
85.1, 109.9, 118.1, 119.1, 122.6, 122.9, 128.4 (x2), 128.5 (x4), 128.6 (x2), 128.7 (x2), 
128.8, 129.1, 129.5, 129.8 (x2), 129.9 (x2), 130.0 (x2), 130.1 (x2), 131.3, 133.1, 
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133.4, 133.7, 135.9, 143.4, 147.3, 165.3, 165.6, 165.8, 166.2 ppm; HR-FAB MS 
[M+H]+ calcd for C44H37N2O9S+ 769.2220, found 769.2230. 
 
1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-glucopyranoside 
(4.11c) was obtained from 4.10c as described for the synthesis of 4.11a in 87% yield 
as a white amorphous solid.  Analytical data for 4.11c: Rf = 0.57 (ethyl acetate/toluene, 
3/5, v/v); [α]D22 +32.8 (c 1.0, CHCl3); 1H-n.m.r.: δ, 4.35 (m, 1H, J5,6a = 5.9 Hz, J5,6b = 
2.1 Hz, H-5), 4.40 (dd, 1H, J6a,6b  = 11.9 Hz, H-6a), 4.55 (dd, 1H, H-6b), 5.25 (s, 2H, 
NCH2Ph), 5.72 (dd, 1H, J4,5 = 9.6 Hz, H-4), 5.75 (dd, 1H, J2,3 = 9.5 Hz, H-2), 6.07 (dd, 
1H, J3,4 = 9.5 Hz, H-3), 6.19 (d, 1H, J1,2 = 10.3 Hz, H-1), 6.99-7.97 (m, 29H, 
aromatic) ppm; 13C-n.m.r.: δ, 47.9, 63.2, 71.0, 74.0, 85.3, 110.1, 119.1, 122.7, 123.0, 
126.8 (x2), 128.0, 128.4 (x5), 128.5 (x2), 128.6 (x3), 128.7, 128.8, 128.9, 129.0 (x3), 
129.5, 129.7 (x2), 129.8 (x2), 130.0 (x2), 130.1 (x2), 133.1, 133.4, 133.6, 135.4, 
136.0, 143.5, 147.7, 165.3, 165.5, 165.8, 166.2 ppm; HRMS–MS (m/z): [M + H]+ 
calcd for C48H39N2O9S+, 819.2376; found, 819.2369. 
 
1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside 
(4.12a).  Compound 4.10a (1.00 g, 2.02 mmol) was dissolved in methanol (10 mL), 
and the pH was adjusted (pH 9) by addition of a 1 M solution of NaOCH3 in MeOH 
(~0.25 mL).  The reaction mixture was stirred for 1.5 h at rt, then Dowex (H+) was 
added until neutral pH was achieved.  The resin was filtered off and rinsed with 
methanol (3 × 5 mL).  The combined filtrate (~25 mL) was concentrated in vacuo and 
dried.  The residue was dissolved in dimethylformamide (15 mL) and benzyl bromide 
(1.2 mL, 10.1 mmol) added.  The mixture was cooled to 0° C, sodium hydride (ca. 
60% dispersion in mineral oil; 0.606 g, 15.2 mmol) was added portionwise, and the 
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resulting mixture was stirred for 3 h at rt.  After that, the reaction mixture was 
quenched with ice-water (150 mL) and extracted with cold ether/ethyl acetate (3 x 80 
mL, 1/1, v/v).  The combined extract (~250 mL) was washed successively with ice-
cold water (20 mL), sat. aq. NaHCO3 (20 mL), and water (2 x 20 mL).  The organic 
layer was separated, dried with NaSO4, and concentrated in vacuo.  The residue was 
purified by column chromatography on silica gel (ethyl acetate-hexane gradient 
elution) to afford the title compound (1.25 g, 83% yield) as a white amorphous solid.  
Analytical data for 4.12a: Rf = 0.55 (ethyl acetate/hexane, 3/7, v/v); [α]D18 +3.7 (c 1.0, 
CHCl3); 1H-n.m.r.: δ, 3.51-3.79 (m, 6H, H-2, 3, 4, 5, 6a, 6b), 3.74 (s, 3H, NCH3), 4.44 
(dd, 2H, 2J = 11.9 Hz, CH2Ph), 4.66 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 4.87 (dd, 2H, 2J = 
10.9 Hz, CH2Ph), 5.02 (dd, 2H, 2J = 10.7 Hz, CH2Ph), 5.68 (d, 1H, J1,2 = 9.0 Hz, H-1), 
7.14-7.78 (m, 24H, aromatic) ppm; 13C-n.m.r.: δ, 31.0, 68.9, 73.5, 75.1, 75.5, 75.9, 
79.2, 81.0, 86.2, 86.7, 109.5, 119.6, 122.4, 122.9, 127.8, 127.9 (x2), 128.0 (x3), 128.2 
(x2), 128.4, 128.5 (x6), 128.6 (x6), 129.1, 136.8, 138.1, 138.2, 138.3, 138.5, 143.4, 
147.2 ppm; HRMS–MS (m/z): [M + Na]+ calcd for C42H42N2O5SNa, 709.2712; found, 
709.2719 
 
1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside 
(4.12b) was obtained from 4.10b as described for the synthesis of 4.12a in 89% yield 
as a white amorphous solid.  Analytical data for 4.12b: Rf = 0.65 (ethyl acetate/hexane, 
3/7, v/v); [α]D22 -10.9 (c = 1.0, CHCl3); 1H-n.m.r.: δ, 3.60-3.87 (m, 6H, H-2, 3, 4, 5, 
6a, 6b), 4.51 (dd, 2H, 2J = 11.9 Hz, CH2Ph), 4.74 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 4.87 
(dd, 1H, 2J = 10.2 Hz, CH=CH2a), 4.93 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 5.03 (dd, 2H, 
CH2-CH), 5.07 (dd, 2H, 2J = 10.6 Hz, CH2Ph), 5.23 (dd, 1H, 2J = 10.2 Hz, CH=CH2b), 
5.35 (d, 1H, J1,2 = 9.4 Hz, H-1), 5.94 (m, 1H, -CH=CH2), 7.15-7.89 (m, 24H, 
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aromatic) ppm; 13C-n.m.r.: δ, 46.9, 68.5, 73.5, 75.1, 75.4, 75.9, 77.6, 79.4, 81.0, 86.3, 
86.7, 110.0, 117.7, 119.6, 122.4, 127.7, 127.8 (x 2), 127.9 (x 4), 128.0 (x 4), 128.2 (x 
2), 128.4 (x 3), 128.5 (x 2), 128.6 (x 3), 132.1, 136.0, 138.2 (x 2), 138.2, 138.5, 143.6, 
147.2 ppm.; HR-FAB MS [M+H]+ calcd for C44H45N2O5S+ 713.3049, found 713.3054. 
 
1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside 
(4.12c) was obtained from 4.10c as described for the synthesis of 4.12a in 89% yield 
as a white amorphous solid.  Analytical data for 4.12c: Rf = 0.65 (ethyl acetate/hexane, 
3/7, v/v); [α]D22 -14.7 (c = 1.0, CHCl3); 1H-n.m.r.: δ, 3.58-3.87 (m, 6H, H-2, 3, 4, 5, 
6a, 6b), 4.48 (dd, 2H, 2J = 11.9 Hz, CH2Ph), 4.74 (dd, 2H, 2J = 10.9 Hz, CH2Ph), 4.94 
(dd, 2H, 2J = 11.0 Hz, CH2Ph), 5.02 (dd, 2H, 2J = 10.6 Hz, CH2Ph), 5.39 (d, 1H, J1,2 = 
9.4 Hz, H-1), 5.46 (dd, 2H, 2J = 16.5 Hz, CH2Ph), 7.12-7.89 (m, 29H, aromatic) ppm; 
13C-n.m.r.: δ, 48.1, 68.9, 73.6, 75.2, 75.5, 75.9, 79.4, 81.0, 86.4, 86.7, 110.1, 119.7, 
122.5, 123.0, 127.0 (x3), 127.8, 127.9 (x6), 128.0 (x3), 128.1 (x3), 128.3 (x2), 128.5 
(x3), 128.6 (x6), 129.0 (x2), 136.1, 136.2, 138.1, 138.2 (x2), 138.5, 143.7, 147.8 ppm; 
HR-FAB MS [M+H]+ calcd for C48H47N2O5S+ 763.31206, found 763.3195.  
 
General procedures for glycosylations  
Typical DMTST-promoted glycosylation procedure. A mixture of glycosyl donor 
(0.036 mmol), glycosyl acceptor (0.030 mmol), and freshly activated molecular sieves 
(4Å, 100 mg) in 1,2-dichloroethane (1.0 mL) was stirred under argon for 1 h.  
DMTST (0.090 mmol) was added and the reaction mixture was monitored by TLC.  
Upon completion (see Tables), Et3N (0.3 mL) was added and the resulting mixture 
was stirred for 30 min.  The solid was filtered off and rinsed sucessively with CH2Cl2.  
The combined filtrate (~30 mL) was washed with sat. aq. NaHCO3 (10 mL) and water 
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(3 x 10 mL).  The organic phase was separated, dried with sodium sulfate, and 
concentrated in vacuo.  The residue was purified by column chromatography on silica 
gel (ethyl acetate - toluene gradient elution).  Anomeric ratios were determined by 
comparison of the integral intensities of relevant signals in 1H NMR spectra. 
 
Typical methyl iodide-promoted glycosylation procedure.  A mixture of glycosyl 
donor (0.036 mmol), glycosyl acceptor (0.030 mmol), and freshly activated molecular 
sieves (4Å, 125 mg) in 1,2-dichloroethane (1.0 mL) was stirred under argon for 1 h.  
Methyl iodide (0.216 mmol) was added and the reaction mixture was monitored by 
TLC.  Upon completion (see Tables), the solid was filtered off and rinsed sucessively 
with CH2Cl2.  The combined filtrate (~30 mL) was washed with sat. aq. NaHCO3 (10 
mL) and water (3 x 10 mL).  The organic phase was separated, dried with sodium 
sulfate, and concentrated in vacuo.  The residue was purified by column 
chromatography on silica gel (ethyl acetate - toluene gradient elution).  Anomeric 
ratios were determined by comparison of the integral intensities of relevant signals in 
1H NMR spectra. 
 
Typical AgOTf-promoted glycosylation procedure.  A mixture of glycosyl donor 
(0.036 mmol), glycosyl acceptor (0.030 mmol), and freshly activated molecular sieves 
(3Å, 125 mg) in 1,2-dichloroethane (1.0 mL) was stirred under argon for 1 h.  AgOTf 
(0.072 mmol) was added and the reaction mixture was monitored by TLC.  Upon 
completion (see Tables), the solid was filtered off and rinsed sucessively with CH2Cl2.  
The combined filtrate (~30 mL) was washed with sat. aq. NaHCO3 (10 mL) and water 
(3 x 10 mL).  The organic phase was separated, dried with sodium sulfate, and 
concentrated in vacuo.  The residue was purified by column chromatography on silica 
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gel (ethyl acetate - toluene gradient elution).  Anomeric ratios were determined by 
comparison of the integral intensities of relevant signals in 1H NMR spectra. 
 
Typical Cu(OTf)2-promoted glycosylation procedure.  A mixture of glycosyl donor 
(0.036 mmol), glycosyl acceptor (0.030 mmol), and freshly activated molecular sieves 
(4Å, 125 mg) in 1,2-dichloroethane (1.0 mL) was stirred under argon for 1 h. 
Cu(OTf)2 (0.036 mmol) was added and the reaction mixture was monitored by TLC.  
Upon completion (see Tables), the solid was filtered off and rinsed sucessively with 
CH2Cl2.  The combined filtrate (~30 mL) was washed with sat. aq. NaHCO3 (10 mL) 
and water (3 x 10 mL).  The organic phase was separated, dried with sodium sulfate, 
and concentrated in vacuo.  The residue was purified by column chromatography on 
silica gel (ethyl acetate - toluene gradient elution).  Anomeric ratios were determined 
by comparison of the integral intensities of relevant signals in 1H NMR spectra. 
 
Preparation of 4.1 via N-debenzylation of 4.12c  
Potassium tert-butoxide (0.39 mmol, 1 M soln. in THF) was added to a stirring 
solution of 4.12c (0.043 g, 0.056 mmol) in DMSO (0.25 mL).  Oxygen was then 
bubbled through the reaction mixture for 15 min.  Upon completion (TLC), the 
reaction was diluted with CH2Cl2 (~30 mL) and washed with water (10 mL), sat. aq. 
NaHCO3 (10 mL) and water (3 x 10 mL).  The organic phase was separated, dried 
with sodium sulfate, and concentrated in vacuo.  The residue was purified by column 
chromatography on silica gel (ethyl acetate - toluene gradient elution) to afford 
glycoside 4.1 in 92% yield. 
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Chapter 5 
 
 
 
A study of silver(I) perchlorate as an effective 
promoter for chemical glycosylation with 
thioimidates and thioglycosides 
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5.1  Introduction 
 An aspiration to understand the involvement of carbohydrates in practically all 
life-sustaining and many life-threatening biological processes has been the major 
driving force in the field of glycoscience.1  A key to the understanding the biological 
roles that carbohydrates play, is to have a straightforward access to synthetic 
oligosaccharides and conjugates thereof.  Acquiring complex oligosaccharides, 
particularly those containing 1,2-cis glycosidic linkages, in high purity and significant 
quantity has long been considered a major challenge.2 
 Monosaccharide units in complex carbohydrates are connected via O-
glycosidic linkages that can be formed by the glycosylation reaction.  It is already 
appreciated that various factors, such as protecting and leaving groups, 
promoter/activator, solvent, temperature, etc. may have a significant effect on the 
course and the outcome of the glycosylation reaction.3  Nevertheless, there are still 
significant gaps in our knowledge of the glycosylation reactions and its mechanism.  
For instance, the effect of the counter-anion remains quite elusive.  A vast majority of 
promoters rely on the use of triflates and the role of triflate as the counter-anion, or as 
the covalently-bound reaction intermediate, has been acknowledged and studied quite 
extensively.  The effect of other counter-ions, in particular that of perchlorate derived 
from tritylium,4-6 iodonium(di-γ-collidine),7,8 and lithium,9-13 salts on the 
stereoselectivity of glycosylation has also been documented.14  However, the exact 
nature of this effect that often favors the formation of 1,2-cis glycosides remains 
unclear.  To the best of our knowledge, no systematic studies of perchlorate salts as 
promoters of glycosylation have yet been reported.  Expanding upon previous use of 
silver(I) perchlorate (AgClO4) as a promoter15 or as an additive in glycosylations,12,16 
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herein we report the systematic study of this promoter for the activation of various 
thioimidoyl and thioglycosyl donors. 
 
5.2  Results and Discussion 
 Over the last decade, we have been interested in the syntheses and applications 
of various glycosyl thioimidates as new versatile donors for chemical glycosylation 
and expeditious oligosaccharide synthesis.17 S-Benzoxazolyl (SBox),18 S-thiazolinyl 
(STaz),19 O-methyl phenylcarbamothioate (SNea),20 and S-benzimidazolyl (SBiz)21 
are all commonly activated with silver(I) triflate (AgOTf), and this activation pathway 
often gives superior yields and stereoselectivity to that of other activators based on 
metal salts, thiophilic or alkylating reagents. AgOTf, however, is very sensitive to 
moisture, and typically requires thorough conditioning prior to use.  To address this, 
we introduced the use of silver(I) tetrafluoroborate (AgBF4) as a powerful activator 
for thioimidates.22  Nevertheless, the synthesis of 1,2-cis glycosides in a majority of 
applications provided only marginal stereoselectivity.  
 In our preliminary evaluation of a series of other silver(I) salts, AgClO4 
provided consistently superior 1,2-cis selectivity, which stimulated our interest in a 
systematic study of this compound as promoter in glycosylations with thioimidate and 
thioglycosides donors.  To pursue this aim, we obtained SBox donor 5.123 that was 
subjected to a series of parallel glycosylations using various silver(I) salts (Table 5.1).  
Thus, the reaction of glycosyl donor 5.1 with primary glycosyl acceptor 5.220 in the 
presence of AgClO4 afforded disaccharide 5.3 in 95% yield and a very commendable 
stereoselectivity of α/β = 11.9/1 (entry 1, Table 5.1).  Very similar outcomes in terms 
of yields and reactivity were detected in cases when AgOTf, AgPF6, and AgBF4 were 
used as promoters of glycosylation of acceptor 5.2 with SBox donor 5.1 (entries 2-4).  
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In all cases, disaccharide 5.3 was isolated in good yields (87-94%), but with 
significantly reduced selectivity ranging from good (α/β = 7.8/1, entry 2) for AgOTf 
to poor (α/β = 2.1/1, entry 3 and α/β = 1.6/1, entry 4) for AgPF6, and AgBF4, 
respectively.  Since all other reaction conditions remained essentially the same and no 
significant changes in the reaction rate were observed (all reactions completed within 
1 h), this differential stereoselectivity is indicative of the effect of the counter anion.  
 
Table 5.1.  Comparative study of AgClO4 vs. other silver(I) salts. 
 
Entry Donor AgX Time Yield of 5.3 α/β ratio 
1 5.1 AgClO4 1 h 95% 11.9/1 
2 5.1 AgOTf 1 h 94% 7.8/1 
3 5.1 AgPF6 1 h 87% 2.1/1 
4 5.1 AgBF4 1 h 91% 1.6/1 
5a 5.4 AgClO4 1.25 h 89% 10.1/1 
6a 5.4 AgOTf 1.3 h 91% 7.3/1 
7a 5.4 AgPF6 1.75 h 82% 2.6/1 
8a 5.4 AgBF4 2 h 87% 2.4/1 
   a – performed in the presence of MeSBr  
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 The results surveyed clearly indicate that perchlorate creates the most 
favorable environment for the formation of α-glucoside 5.3.  In general, the counter 
anion may have an effect on glycosylation in a variety of modes, although this key 
effect is often overlooked apart from triflate that has been thoroughly studied by Crich 
and co-workers.24,25  As it was previously demonstrated for AgOTf, the activation of 
the SBox leaving group takes place via the anomeric sulfur.26  The resultant glycosyl 
cation is often stabilized via the oxacarbenium ion and anion (X) interaction (5.A, 
Scheme 5.1) or even via formal covalent attachment of X (5.B).  If the neighboring 
substituent at C-2 is an acyl group, glycosylations may also proceed via acyloxonium 
intermediate (5.C).  The glycosyl acceptor attack in principle can be then influenced 
by the steric and electronic properties of X, particularly if the reaction proceeds via 
intermediates 5.A and 5.B.  It should be noted that all reaction intermediates are quite 
unstable, therefore, the exact mechanism of chemical glycosylation remains 
elusive.27,28 
 
Scheme 5.1.  Schematic representation of the reaction mechanism. 
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 Practically the same trend was observed in the glycosidation of thioglycoside 
donor 5.4.  Since a silver(I) salt alone fails to activate thioglycosides, therefore its 
inclusion into the promoter system has been explored.  Herein, we chose to 
investigate a combination of MeSBr, introduced by Garegg as a co-promoter of 
glycosylation,29 and AgX (Table 5.1).  Another possibility would be to use NIS/AgX 
combination because NIS/AgOTf is a rather common promoter system for 
thioglycoside activation.30  To carry out this reaction, the glycosyl donor and acceptor 
were initially stirred in the presence of AgX.  Subsequently, MeSBr is added and the 
formation of insoluble yellow AgBr precipitate can be detected momentarily.  
Apparently, MeSX is also formed at this time (Scheme 5.1), which then undergoes a 
nucleophilic attack by the anomeric sulfur forming the glycosyl sulfonium 
intermediate.  According to the generally accepted protocol of the activation 
mechanism,31 the leaving group then departs as a disulfide PhSSMe leading to the 
activated intermediates (5.A-5.C) or a combination thereof depending on the original 
structure and other factors (vide supra).   
 Following this pathway, activation of SPh donor 5.4 with MeSBr/AgClO4 for 
reaction with primary acceptor 5.2 afforded disaccharide 5.3 in 89% yield and a very 
commendable stereoselectivity of α/β =10.1/1 (entry 5, Table 5.1).  Very similar 
outcomes in terms of yields and reactivity were detected in cases when AgOTf, 
AgPF6, and AgBF4 were used as promoters of glycosylation of acceptor 5.2 with SPh 
donor 4 (entries 6-8).  Thus, disaccharide 5.3 was isolated in good yields (82-91%), 
but with significantly reduced selectivity (α/β =2.4-7.3/1).  Since the difference in the 
reaction rates between different promoters was insignificant, it is very likely that it is 
the effect of the counter anion that influences the stereoselectivity of glycosylations.  
Once again, the results indicate that perchlorate is the most favorable counter ion for 
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the formation of α-glucoside 5.3.  We deemed these results both practical and 
intriguing and decided to undergo subsequent comprehensive investigation of this 
promising promoter. 
 To determine the efficacy of AgClO4 in the context of other classes of 
glycosidic linkages we examined a wider range of glycosyl donors.  The key findings 
of this study are summarized in Table 5.2.  As a direct continuation of our preliminary 
work, we set up a series of experiments with superdisarmed 2-O-benzyl-3,4,6-O-
benzoyl thioimidoyl donors.32  First, we performed glycosylation of the secondary 
glycosyl acceptor 5.520 with SBox donor 5.1.  This coupling produced disaccharide 
5.6 in 92% yield and an impressive stereoselectivity of α/β = >20/1 (entry 1, Table 
5.2).  Likewise, the glycosyl donor bearing the SBiz moiety 5.7 readily underwent 
coupling with acceptor 5.2 producing disaccharide 5.3 in 93% yield in 2 h (α/β = 
11.2/1, entry 2).  It was observed that glycosidation involving the acyclic SNea donor 
5.8 took substantially longer (7 h), but nevertheless disaccharide 5.3 was isolated in 
92% yield (α/β = 6.6/1, entry 3). 
 Pleased with the activation of the unreactive superdisarmed series, we turned 
our attention to glycosidations involving the per-benzoylated (disarmed) glycosyl 
donors.  Here we found that thioimidate donors 5.9,23 5.12,21 and 5.1320 underwent 
coupling smoothly producing the expected 1,2-trans-linked disaccharides 5.1020 and 
5.1120 in excellent yields (88-94%, entries 4-7).  All reactions were relatively swift 
and completed in 30-45 min. Disarmed thioglycoside 5.1433 reacted even quicker (20 
min) in the presence of MeSBr and AgClO4 (86%, entry 8).    We then began studying 
a series of per-benzylated (armed) glycosyl donors.  Although all yield recorded were 
very commendable, the stereoselectivity observed was rather poor, most likely due to 
our inability to slow this reaction.   
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Table 5.2.  Investigation of AgClO4 as a promoter of glycosylation. 
Entry Donor Acceptor Time Product Yield 
α/β 
ratio
1  
5.1 
 
5.5 
1 h  
5.6 
92% >20/1 
2  
5.7 5.2 
2 h  
5.3
93% 11.2/1
3 
O
OBz
S
BzO
BzO
OBn O
N
 
5.8 
5.2 7 h 5.3 92% 6.6/1 
4  
5.9 
5.2 
30 
min  
5.10 
91% 
β 
only 
5 5.9 5.5 
30 
min 
 
5.11
88% 
β 
only 
6  
5.12 
5.2 
45 
min 
5.10 94% 
β 
only 
7 
O
OBz
S
BzO
BzO
OBz O
N
 
5.13 
5.2 
45 
min 
5.10 92% 
β 
only 
8a  
5.14 
5.2 
20 
min 
5.10 86% 
β 
only 
9  
5.15 
5.2 
15 
min 
O
OBn
O
BnO
BnO
BnO O
OMe
BnO
BnO
BnO  
5.16 
96% 1.3/1 
10 5.15 5.5 
15 
min  
5.17 
89% 1.6/1 
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11  
5.18 
5.2 
15 
min 
5.16 89% 1.4/1 
12  
5.19 
5.2 
15 
min 
5.16 91% 1.3/1 
13a  
5.20 
5.2 
20 
min 
5.16 86% 1.5/1 
14  
5.21 
5.2 
15 
min  
5.22
83% 1/1.2 
15  
5.23 
5.2 
15 
min 
O
BnO
O
BnO
BnO
OBn
O
OMe
BnO
BnO
BnO  
5.24
87% 1/1.1 
16  
5.25 
5.2 2 h  
5.26
89% 3.4/1 
17  
5.27 
5.2 
5 
min 
O
OBn
O
BnO
BnO
BzO O
OMe
BnO
BnO
BnO  
5.28
97% 
β 
only 
18 5.27 5.5 
5 
min 
 
5.29 
95% 
β 
only 
19  
5.30 
5.2 
5 
min 
5.28 88% 
β 
only 
20  
5.31 
5.2 
5 
min 
5.28 82% 
β 
only 
21a  
5.32 
5.2 
5 
min 
5.28 82% 
β 
only 
a – performed in the presence of MeSBr 
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 Lowering the reaction temperature did not help here because it was favoring 
the formation of kinetic (β-linked) product.  Thus, coupling of SBox donor 5.1523 
with acceptor 5.2 produced disaccharide 5.1634 in 96% yield within 15 min (α/β = 
1.3/1, entry 9).  Similarly, donor 5.15 glycosidated with secondary glycosyl acceptor 
5.5 to afford disaccharide 5.1734 in 89% yield in 15 min (α/β = 1.6/1, entry 10).  
Evaluation of per-benzylated thioimidoyl donors bearing the SBiz 5.18 and SNea 5.19 
moieties was conducted and their reactivity was found to be similar to that of the 
previously mentioned donors (89% and 91% yield, α/β = 1.4/1 and 1.3/1, entries 18 
and 19, respectively).  Thiophenyl donor 5.2035 also rapidly underwent coupling with 
AgClO4/MeSBr producing disaccharide 5.16 in 86% yield in 20 min (α/β = 1.5/1, 
entry 13). 
 Glycosylations with SBox galactosyl 5.21, mannosyl 5.23, and 2-azido-2-
deoxy 5.25 donors were also conducted.  It was observed that galactosyl and 
mannosyl glycosyl donors 5.21 and 5.23 underwent coupling with glycosyl acceptor 
5.2 in the presence of AgClO4 in 15 min with the corresponding disaccharides 5.22 
and 5.24 isolated in 83% and 87% yield, respectively.  Unfortunately, no 
stereoselectivity was observed in these couplings (α/β = 1/1.2 and 1/1.1, entries 14 
and 15, respectively).  When we glycosidated 2-azido-2-deoxy donor 5.25 with 
acceptor 5.2, disaccharide 5.26 was produced in 89% yield (α/β = 3.4/1). 
 Finally, we investigated highly reactive, superarmed glycosyl donors equipped 
with the 2-O-benzoyl-3,4,6-O-benzyl protecting group pattern.  All glycosidations of 
SBox 5.27, SBiz 5.30, and SNea 5.31 donors with glycosyl acceptors 5.2 and 5.5 in 
the presence of AgClO4 were exceptionally swift (less than 5 min).  The respective 
disaccharides 5.28 or 5.29 were isolated in 82-97% yield (entries 17-20).  A similar 
reaction rate was observed when SPh glycosyl donor 5.32 was subjected to the 
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AgClO4/MeSBr activation conditions affording disaccharide 5.28 in 82% yield (entry 
21).  As anticipated, all glycosylations with glycosyl donors of the superarmed series 
proceeded with complete β-selectivity. 
 Based on these results, we also determined that a two-step, one-pot sequential 
activation using building blocks with thioimidoyl and thioglycosyl leaving groups was 
attainable by proper choice of promoter.  The sequence we envisioned was to first 
selectively activate thioimidoyl donor with thioglycoside acceptor in the presence of 
AgClO4.  The expectation was that the resulting disaccharide could be activated 
directly followed by the addition of BrSMe and a new acceptor.  To explore this 
possibility, we coupled SBox thioimidate donor 5.9 with SEt thioglycosyl acceptor 
5.33 employing AgClO4 as the promoter.  Upon disappearance of acceptor 5.33,36 as 
judged by TLC, the newly formed disaccharide 5.34 (not isolated) was then activated 
by the addition of BrSMe and glycosyl acceptor 5.35. Resultantly, trisaccharide 5.36 
was obtained in 65% yield. 
 
Scheme 5.2.  One-pot synthesis of trisaccharide 5.36 via selective two-step activation 
in one pot.  
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5.3  Conclusion 
In conclusion, we demonstrated the effectiveness of silver(I) perchlorate as a powerful 
promoter towards glycosyl thioimidate activation.  It has been utilized with a variety 
of donors of the gluco, galato, manno and amino series.  Also investigated was the use 
of AgClO4 as an additive when paired with methyl sulfenyl bromide to activate 
glycosyl thioglycosides.  With superdisarmed glycosyl donors equipped with the 
3,4,6-tri-O-benzoyl-2-O-benzyl protecting group pattern AgClO4 was found to display 
superior 1,2-cis selectivity to compared that of other silver(I) salts including the very 
commonly used AgOTf.  The cooperative use of these activation protocols was 
applied to a one-pot two-step sequential activation of thioimidates and thioglycosides.   
 
5.4  Experimental Section 
General Remarks.   
Column chromatography was performed on silica gel 60 (EM Science, 70-230 mesh); 
reactions were monitored by TLC on Kieselgel 60 F254 (EM Science).  The 
compounds were detected by examination under UV light and by charring with 10% 
sulfuric acid in methanol.  Solvents were removed under reduced pressure at < 40 oC. 
CH2Cl2 and ClCH2CH2Cl were distilled from CaH2 directly prior to application.  
Acetonitrile was dried by refluxing with CaH2, distilled and stored over molecular 
sieves (3 Å).  THF was refluxed for 2 h and distilled over sodium using benzophenone 
as an indicator under argon directly before use.  Acetone was dried by refluxing with 
K2CO3, distilled and stored over molecular sieves (3 Å).  Molecular sieves (3 Å), used 
for reactions, were crushed and activated in vacuo at 390 °C during 8 h in the first 
instance and then for 2-3 h at 390 °C directly prior to application.  AgClO4 (Aldrich), 
AgPF6 (Acros), and AgBF4 (Acros) were used as is.  AgOTf (Acros) was co-
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evaporated with toluene (3 x 10 mL) and dried in vacuo for 2-3 h directly prior to 
application.  Optical rotations were measured using a ‘Jasco P-1020’ polarimeter.  1H-
n.m.r. spectra were recorded in CDCl3 at 300 MHz, 13C-n.m.r. spectra were recorded 
in CDCl3 at 75 MHz (Bruker Avance) unless otherwise noted.  HRMS determinations 
were made with the use of JEOL MStation (JMS-700) Mass Spectrometer. 
 
Synthesis of glycosyl donors  
Phenyl 3,4,6-tri-O-benzoyl-2-O-benzyl-1-thio-β-D-glucopyranoside (5.4).  A 
solution of NaSPh in THF (5.0 mL, freshly prepared from 60% NaH, 2.36 mmol and 
HSPh, 2.36 mmol) and 15-crown-5 (0.16 mL, 0.8 mmol) were added to a solution of 
3,4,6-tri-O-benzoyl-2-O-benzyl-α-D-glucopyranosyl bromide20 (0.85 g, 1.6 mmol) in 
dry THF (5.0 mL) and the resulting mixture was stirred under argon for 2.5 h at rt.  
Upon completion, the reaction mixture was diluted with CH2Cl2 (~100 mL) and 
washed with water (10 mL), sat. aq. NaHCO3 (10 mL), and water (3 x 10 mL).  The 
organic phase was separated, dried over Na2SO4, and concentrated in vacuo.  The 
residue was purified by column chromatography on silica gel (ethyl acetate-hexane 
gradient elution) to afford the title compound in 73% yield (0.65 g) as a white foam.  
Analytical data for 5.4: Rf = 0.48 (ethyl acetate/hexanes, 3/7, v/v); [α]D22 10.4 (c = 1.0, 
CHCl3); 1H-n.m.r: δ, 3.78 (dd, 1H, J2,3 = 9.4 Hz, H-2), 4.07 (m, 1H, J5,6a = 6.1, J5,6b = 
2.8 Hz, H-5), 4.45 (dd, 1H, J6a,6b = 12.2 Hz, H-6a), 4.61 (dd, 1H, H-6b), 4.72 (dd, 2H, 
2J = 10.7 Hz, CH2Ph), 4.91 (d, 1H, J1,2 = 9.7 Hz, H-1), 5.50 (dd, 1H, J4,5 = 9.8 Hz, H-
4), 5.78 (dd, 1H, J3,4 = 9.3 Hz, H-3), 7.02-8.12 (m, 25H, aromatic) ppm; 13C-n.m.r: δ, 
63.5, 69.6, 75.3, 75.9, 76.1, 78.5, 87.8, 127.9, 128.0, 128.1, 128.4 (x 3), 128.5 (x 7), 
128.9, 129.1 (x 2), 129.4, 129.8 (x 2), 129.9 (x 3), 130.0 (x 2), 130.3, 132.5, 133.0, 
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133.3, 133.6, 137.2, 165.6, 165.7, 166.2 ppm; HR-FAB MS [M+Na]+ calcd for 
C40H34O8SNa+ 697.1872, found 697.1868. 
 
2-Benzimidazolyl 3,4,6-tri-O-benzoyl-2-O-benzyl-1-thio-β-D-glucopyranoside 
(5.7).  Potassium 2-benzimidazolethione21 (KSBiz, 0.66 g, 3.5 mmol) and 18-crown-6 
(0.12 mg, 0.46 mmol) were added to a solution of 3,4,6-tri-O-benzoyl-2-O-benzyl-α-
D-glucopyranosyl bromide (1.25 g, 2.3 mmol) in dry acetone (10 mL) and the 
resulting mixture was stirred under argon for 4 h at rt.  Upon completion, the solid 
was filtered-off and rinsed successively with CH2Cl2.  The combined filtrate (~250 
mL) was washed with water (20 mL), sat. aq. NaHCO3 (20 mL), and water (3 x 20 
mL).  The organic phase was separated, dried over Na2SO4, and concentrated in vacuo.  
The residue was purified by column chromatography on silica gel (ethyl acetate-
toluene gradient elution) to afford the title compound in 62% yield (0.82 g) as a white 
foam.  Analytical data for 5.7: Rf = 0.51 (ethyl acetate/hexanes, 1/1, v/v); [α]D22 -
130.9 (c = 1.0, CHCl3); 1H-n.m.r: δ, 3.75 (d, 1H, J2,3 = 9.3 Hz, H-2), 4.18 (m, 1H, J5,6a 
= 6.6 Hz, J5,6b = 2.2 Hz, H-5), 4.62 (dd, 1H, J6a,6b = 12.5 Hz, H-6a), 4.77 (dd, 1H, H-
6b), 4.85 (dd, 2H, 2J = 10.8 Hz, CH2Ph), 5.05 (d, 1H, J1,2 = 9.5 Hz, H-1), 5.53 (dd, 1H, 
J4,5 = 9.8 Hz, H-4), 5.83 (dd, 1H, J3,4 = 9.3 Hz, H-3), 7.06-8.18 (m, 24H, aromatic), 
10.64 (br. s, 1H, NH) ppm; 13C-n.m.r: δ, 62.9, 68.9, 75.3, 75.5, 78.5, 84.5, 123.1, 
128.1, 128.4 (x 4), 128.5 (x 3), 128.7 (x 2), 128.8 (x 4), 128.9 (x 2), 129.2, 129.6, 
129.9 (x 3), 130.0 (x 3), 130.2 (x 3), 133.4, 133.8, 140.0, 143.8, 165.4, 165.7, 167.4 
ppm; HR-FAB MS [M+Na]+ calcd for C41H34N2O8SNa+ 737.1934, found 737.1930. 
 
3,4,6-tri-O-Benzoyl-2-O-benzyl-1-thio-β-D-glucopyranosyl O-methyl 
phenylcarbamothioate (5.8).  O-Methyl phenylcarbamothioate (HSNea, 0.22 g, 1.29 
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mmol) and KOH (0.048 g, 0.85 mmol) were added to a stirring solution of 3,4,6-tri-
O-benzoyl-2-O-benzyl-α-D-glucopyranosyl bromide (0.46 g, 0.85 mmol) in dry 
acetone (6.0 mL) and the reaction mixture was stirred under argon for 2.5 h at rt.  
Upon completion, the solid was filtered-off and rinsed successively with CH2Cl2.  The 
combined filtrate (~100 mL) was washed with water (10 mL), sat. aq. NaHCO3 (10 
mL), and water (3 x 10 mL).  The organic phase was separated, dried over Na2SO4, 
and concentrated in vacuo. The residue was purified by column chromatography on 
silica gel (ethyl acetate-hexane gradient elution) to afford the title compound in 42% 
yield (0.22 g) as a white foam.  Analytical data for 5.8: Rf = 0.42 (ethyl 
acetate/hexanes, 3/7, v/v); [α]D22 -14.3 (c = 1.0, CHCl3); 1H-n.m.r: δ, 3.69 (dd, 1H, J2,3 
= 9.1 Hz, H-2), 3.90 (s, 3H, OCH3), 4.13 (m, 1H, J5,6a = 5.9, J5,6b = 2.9 Hz, H-5), 4.44 
(dd, 1H, J6a,6b = 12.2 Hz, H-6a), 4.54 (dd, 2H, 2J = 10.6 Hz, CH2Ph), 4.58 (dd, 1H, H-
6b), 5.41 (d, 1H, J1,2 = 10.0 Hz, H-1), 5.47 (dd, 1H, J4,5 = 9.8 Hz, H-4), 5.77 (dd, 1H, 
J3,4 = 9.4 Hz, H-3), 6.79-8.07 (m, 25H, aromatic) ppm; 13C-n.m.r: δ, 56.6, 63.5, 69.7, 
75.4, 76.0, 76.3, 83.1, 121.7 (x 2), 124.12, 128.1, 128.4 (x 8), 128.5 (x 3), 128.9, 
129.2 (x 2), 129.3, 129.8 (x 4), 129.9 (x 2), 133.3, 133.4, 133.5, 136.8, 146.8, 155.2, 
165.5, 165.7, 166.2 ppm; HR-FAB MS[M+Na]+ calcd for C42H37NO9SNa+ 754.2081, 
found 754.2089. 
 
2-Benzoxazolyl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-1-thio-β-D-glucopyranoside 
(5.25).  Potassium 2-mercaptobenzoxazole37 (KSBox, 0.600 g, 3.17 mmol) and 18-
crown-6 (0.67 g, 0.25 mmol) were added to a stirring solution of 3,4,6-tri-O-acetyl-2-
amino-2-deoxy-α-D-glucopyranosyl bromide38 (0.50 g, 1.27 mmol) in dry acetone (10 
mL) and the reaction mixture was stirred under argon for 2.5 h at rt.  Upon completion, 
the solid was filtered-off and rinsed successively with CH2Cl2. The combined filtrate 
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(~250 mL) was washed with water (20 mL), sat. aq. NaHCO3 (20 mL), and water (3 x 
20 mL).  The organic phase was separated, dried over Na2SO4, and concentrated in 
vacuo.  The residue was purified by column chromatography on silica gel (ethyl 
acetate-hexane gradient elution) to afford the title compound in 37% yield (0.218 g) 
as an off-white foam.  Analytical data for 5.25: Rf = 0.49 (ethyl acetate/hexanes, 1/1, 
v/v); [α]D22 9.1 (c = 1.0, CHCl3); 1H-n.m.r: δ, 1.99, 2.05, 2.13 (3 s, 9H, 3 x CH3), 3.91 
(m, 1H, J5,6a = 2.2, J5,6b = 4.7 Hz, H-5) 3.94 (dd, 1H, J2,3 = 9.5 Hz, H-2), 4.12 (dd, 1H, 
J6a,6b = 12.5 Hz, H-6a), 4.27 (dd, 1H, H-6b), 5.12 (dd, 1H, J4,5 = 9.5 Hz, H-4), 5.25 
(dd, 1H, J3,4 = 9.5 Hz, H-3), 5.42 (d, 1H, J1,2 = 10.5 Hz, H-1), 7.27-7.68 (m, 4H, 
aromatic) ppm; 13C-n.m.r: 20.7, 20.8 (x 2), 61.8, 63.1, 70.0, 74.7, 76.6, 84.1, 110.4, 
119.3, 124.8, 124.9, 141.7, 152.1, 160.1, 169.8, 170.0, 170.7 ppm; HR-FAB 
MS[M+H]+ calcd for C19H21N4O8S+ 465.1080, found 465.1072. 
 
Typical procedure for glycosidation of thioimidates. 
A mixture of glycosyl donor (0.045 mmol), glycosyl acceptor (0.030 mmol), and 
freshly activated molecular sieves (3Å, 125 mg) in 1,2-dichloroethane (1.0 mL) was 
stirred under argon for 1 h. Silver(I)-salt (0.068 mmol) was added and the reaction 
was monitored by TLC.  Upon completion (see Tables), the solid was filtered off and 
rinsed sucessively with CH2Cl2.  The combined filtrate (~15 mL) was washed with 
1% NaOH (5 mL) and water (3 x 5 mL).  The organic layer was separated, dried with 
Na2SO4, and concentrated in vacuo.  The residue was purified by column 
chromatography on silica gel (ethyl acetate-hexane gradient elution) to afford the 
corresponding oligosaccharide. 
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Typical procedure for glycosidation of thioglycosides. 
A mixture of glycosyl donor (0.045 mmol), glycosyl acceptor (0.030 mmol), and 
freshly activated molecular sieves (3Å, 125 mg) in 1,2-dichloroethane (1.0 mL) was 
stirred under argon for 1 h. Silver(I)-salt (0.068 mmol) and freshly prepared MeSBr29 
(amount) and the reaction mixture was monitored by TLC.  Upon completion (see 
Tables), the solid was filtered off and rinsed sucessively with CH2Cl2.  The combined 
filtrate (~15 mL) was washed with 1% NaOH (5 mL) and water (3 x 5 mL).  The 
organic layer was separated, dried with Na2SO4, and concentrated in vacuo.  The 
residue was purified by column chromatography on silica gel (ethyl acetate-hexane 
gradient elution) to afford the corresponding oligosaccharide. 
 
5.6  References 
 (1) Varki, A.; Cummings, R. D.; Esko, J. D.; Freeze, H. H.; Bertozzi, C. R.; 
Stanley, P.; Hart, G. W.; Etzler, M. E.: Essentials of Glycobiology; Second 
ed.; CSH Laboratory Press: New York, 2009. 
 (2) Demchenko, A. V.: 1,2-cis O-Glycosylation: methods, strategies, principles. 
Curr. Org. Chem. 2003, 7, 35-79. 
 (3) Demchenko, A. V.: General aspects of the glycosidic bond formation. In 
Handbook of Chemical Glycosylation; Demchenko, A. V., Ed.; Wiley-VCH: 
Weinheim, Germany, 2008; pp 1-27. 
 (4) Kochetkov, N. K.; Klimov, E. M.; Malysheva, N. N.; Demchenko, A. V.: A 
novel highly stereospecific method of 1,2-cis-glycosylation - synthesis of -
D-glucosyl-D-hexoses and -D-galactosyl-D-hexoses. Bioorg. Khim. 1990, 16, 
701-710. 
Hasty, Scott, UMSL, p.149 
 
 (5) Kochetkov, N. K.; Klimov, E. M.; Malysheva, N. N.: Novel highly 
stereospecific method of 1,2-cis-glycosylation. Synthesis of -D-glucosyl-D-
glucoses. Tetrahedron Lett. 1989, 30, 5459-5462. 
 (6) Kaeothip, S.; Akins, S. J.; Demchenko, A. V.: On the stereoselectivity of 
glycosidation of thiocyanates, thioglycosides, and thioimidates. Carbohydr. 
Res. 2010, 345, 2146-2150. 
 (7) Veeneman, G. H.; van Boom, J. H.: An efficient thioglycoside-mediated 
formation of a-glycosidic linkages promoted by iodonium dicollidine 
perchlorate. Tetrahedron Lett. 1990, 31, 275-278. 
 (8) Demchenko, A.; Stauch, T.; Boons, G. J.: Solvent and other effects on the 
stereoselectivity of thioglycoside glycosidations. Synlett 1997, 818-820. 
 (9) Mukaiyama, T.; Matsubara, K.: Stereoselective glycosylation reaction starting 
from 1-O-trimethylsilyl sugars by using diphenyltin sulfide and a catalytic 
amount of active acidic species. Chem. Lett. 1992, 1041-1044. 
 (10) Adinolfi, M.; Barone, G.; Guariniello, L.; Iadonisi, A.: Efficient activation of 
armed glycosyl trichloroacetimidates with Sm(OTf)3 in the stereoselective 
glycosidation of saccharidic acceptors. Tetrahedron Lett. 2000, 41, 9005-9008. 
 (11) Schene, H.; Waldmann, H.: Activation of glycosyl phosphites under neutral 
conditions in solutions of metal perchlorates in organic solvents. Eur. J. Org. 
Chem. 1998, 1227-1230. 
 (12) Fukase, K.; Hasuoka, A.; Kinoshita, I.; Aoki, Y.; Kusumoto, S.: A 
stereoselective glycosidation using thioglycosides, activation by combination 
of N-bromosuccinimide and strong acid salts. Tetrahedron 1995, 51, 4923-
4932. 
Hasty, Scott, UMSL, p.150 
 
 (13) Worm-Leonhard, K.; Larsen, K.; Jensen, K. J.: 4,6-O-Benzylidene Directed b-
Mannosylation Without Intermediate Triflate Formation? Comparison of 
Trichloroacetimidate and DISAL Donors in Microwave-Promoted 
Glycosylations under Neutral Conditions. J. Carbohydr. Chem. 2007, 26, 349–
368. 
 (14) Dalpozzo, R.; Bartoli, G.; Sambri, L.; Melchiorre, P.: Perchloric Acid and Its 
Salts: Very Powerful Catalysts in Organic Chemistry. Chem. Rev. 2010, 110, 
3501-3551. 
 (15) Igarashi, K.; Honma, T.; Irisawa, J.: Reaction of glycosyl chlorides with silver 
perchlorate. Carbohydr. Res. 1970, 15, 329-337. 
 (16) Mukaiyama, T.; Murai, Y.; Shoda, S.-i.: An efficient method for glucosylation 
of hydroxy compounds using glucopyranosyl fluoride. Chem. Lett. 1981, 431-
432. 
 (17) Hasty, S. J.; Demchenko, A. V.: Glycosyl thioimidates as versatile building 
blocks for organic synthesis. Chem. Heterocycl. Compd. 2012, 48, 220-240. 
 (18) Demchenko, A. V.; Malysheva, N. N.; De Meo, C.: S-Benzoxazolyl (SBox) 
glycosides as novel, versatile glycosyl donors for stereoselective 1,2-cis 
glycosylation. Org. Lett. 2003, 5, 455-458. 
 (19) Demchenko, A. V.; Pornsuriyasak, P.; De Meo, C.; Malysheva, N. N.: Potent, 
versatile, and stable: thiazolyl thioglycosides as glycosyl donors. Angew. 
Chem. Int. Ed. 2004, 43, 3069-3072. 
 (20) Ranade, S. C.; Kaeothip, S.; Demchenko, A. V.: Glycosyl alkoxythioimidates 
as complementary building blocks for chemical glycosylation. Org. Lett. 2010, 
12, 5628-5631. 
Hasty, Scott, UMSL, p.151 
 
 (21) Hasty, S. J.; Kleine, M. A.; Demchenko, A. V.: S-Benzimidazolyl glycosides 
as a platform for oligosaccharide synthesis by an active-latent strategy Angew. 
Chem. Int. Ed. 2011, 50, 4197-4201. 
 (22) Kaeothip, S.; Pornsuriyasak, P.; Demchenko, A. V.: Silver(I) tetrafluoroborate 
as a potent promoter for chemical glycosylation. Tetrahedron Lett. 2008, 49, 
1542-1545. 
 (23) Kamat, M. N.; Demchenko, A. V.: Revisiting the armed-disarmed concept 
rationale: chemoselective activation of the S-benzoxazolyl glycosides in 
oligosaccharide synthesis. Org. Lett. 2005, 7, 3215-3218. 
 (24) Crich, D.: Chemistry of glycosyl triflates: Synthesis of -mannopyranosides 
(Reprinted from Glycochemistry: Principles, Synthesis, and Applications, pg 
53-75, 2001). J. Carbohydr. Chem. 2002, 21, 667-690. 
 (25) Crich, D.: Methodology Development and Physical Organic Chemistry: A 
Powerful Combination for the Advancement of Glycochemistry. J. Org. Chem. 
2011, 76, 9193-9209. 
 (26) Kamat, M. N.; Rath, N. P.; Demchenko, A. V.: Versatile synthesis and 
mechanism of activation of S-benzoxazolyl glycosides. J. Org. Chem. 2007, 
72, 6938-6946. 
 (27) Mydock, L. K.; Demchenko, A. V.: Mechanism of chemical O-glycosylation: 
from early studies to recent discoveries. Org. Biomol. Chem. 2010, 8, 497-510. 
 (28) Crich, D.: Mechanism of a chemical glycosylation reaction. Acc. Chem. Res. 
2010, 43, 1144-1153. 
 (29) Dasgupta, F.; Garegg, P. J.: Use of sulfenyl halides in carbohydrate reactions.  
Part I.  Alkyl sulfenyl triflate as activator in the thioglycoside-mediated 
Hasty, Scott, UMSL, p.152 
 
formation of   -glycosidic linkages during oligosaccharide synthesis.    
Carbohydrate. Carbohydr. Res. 1988, 177, C13-C17. 
 (30) Zhong, W.; Boons, G.-J.: Glycoside synthesis from 1-sulfur/selenium-
substituted derivatives: thioglycosides in oligosaccharide synthesis. In 
Handbook of Chemical Glycosylation; Demchenko, A. V., Ed.; Wiley-VCH: 
Weinheim, Germany, 2008; pp 261-303. 
 (31) Ranade, S. C.; Demchenko, A. V.: Mechanism of chemical glycosylation: 
focus on the mode of activation and departure of anomeric leaving groups. J. 
Carbohydr. Chem. 2013, 32, 1-43. 
 (32) Premathilake, H. D.; Demchenko, A. V.: Superarmed and superdisarmed 
building blocks in expeditious oligosaccharide synthesis. In Topics in Current 
Chemistry: Reactivity Tuning in Oligosaccharide Assembly; Fraser-Reid, B., 
Lopez, J. C., Eds.; Springer-Verlag: Berlin-Heidelberg, 2011; Vol. 301; pp 
189-221. 
 (33) Ferrier, R. J.; Furneaux, R. H.: Synthesis of 1,2-trans-related 1-thioglycoside 
esters. Carbohydr. Res. 1976, 52, 63-68. 
 (34) Garcia, B. A.; Gin, D. Y.: Dehydrative glycosylation with activated diphenyl 
sulfonium reagents. Scope, mode of C(1)-hemiacetal activation, and detection 
of reactive glycosyl intermediates. J. Am. Chem. Soc. 2000, 122, 4269-4279. 
 (35) Pfaeffli, P. J.; Hixson, S. H.; Anderson, L.: Thioglycosides having O-benzyl 
blocking groups as intermediates for the systematic, sequential synthesis of 
oligosaccharides.  Synthesis of isomaltose. Carbohydr. Res. 1972, 23, 195-206. 
 (36) Agoston, K.; Kroeger, L.; Dekany, G.; Thiem, J.: On Resin Modification of 
Monosaccharides. J. Carbohydr. Chem. 2007, 26, 513-525. 
Hasty, Scott, UMSL, p.153 
 
 (37) Demchenko, A. V.; Kamat, M. N.; De Meo, C.: S-Benzoxazolyl (SBox) 
glycosides in oligosaccharide synthesis: novel glycosylation approach to the 
synthesis of -D-glucosides, -D-galactosides, and -D-mannosides. Synlett 
2003, 1287-1290. 
 (38) Kochetkov, N. K.; Klimov, E. M.; Malysheva, N. N.; Demchenko, A. V.: 
Stereospecific synthesis of 1,2-cis-glycosides of 2-amino sugars. Carbohydr. 
Res. 1993, 242, C7-C10. 
 
 
Hasty, Scott, 2013, UMSL, p.154 
 
 
 
 
Appendix 
 
 
  
Hasty, Scott, 2013, UMSL, p.155 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5
Chemical Shift (ppm)
1.003.961.034.545.4925.86
 
CDCl3 at 300 MHz 
Figure A-1:  1H NMR spectrum of Benzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-
glucopyranoside (2.1a). 
145 140 135 130 125 120 115 110 105 100 95 90 85 80 75 70 65
Chemical Shift (ppm)  
CDCl3 at 75 MHz 
Figure A-2:  13C NMR spectrum of Benzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-
glucopyranoside (2.1a). 
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CDCl3 at 300 MHz 
Figure A-3:  2-D NMR COSY spectrum of Benzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-
D-glucopyranoside (2.1a). 
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Figure A-4:  1H NMR spectrum of Benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-
glucopyranoside (2.1b). 
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Figure A-5:  13C NMR spectrum of Benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-
glucopyranoside (2.1b). 
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CDCl3 at 300 MHz 
Figure A-6:  2-D NMR COSY spectrum of Benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-
D-glucopyranoside (2.1b). 
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Figure A-7:  1H NMR spectrum of Benzimidazol-2-yl 2-O-benzoyl-3,4,6-tri-O-benzyl-1-thio-β-
D-glucopyranoside (2.1c). 
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Figure A-8:  13C NMR spectrum of Benzimidazol-2-yl 2-O-benzoyl-3,4,6-tri-O-benzyl-1-thio-β-
D-glucopyranoside (2.1c). 
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CDCl3 at 300 MHz 
Figure A-9:  2-D NMR COSY spectrum of Benzimidazol-2-yl 2-O-benzoyl-3,4,6-tri-O-benzyl-
1-thio-β-D-glucopyranoside (2.1c). 
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CDCl3 at 300 MHz 
Figure A-10:  1H NMR spectrum of Benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-
galactopyranoside (2.1d). 
 
CDCl3 at 75 MHz 
Figure A-11:  13C NMR spectrum of Benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-D-
galactopyranoside (2.1d). 
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CDCl3 at 300 MHz 
Figure A-12:  2-D NMR COSY spectrum of Benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-
β-D-galactopyranoside (2.1d). 
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CDCl3 at 300 MHz 
Figure A-13:  1H NMR spectrum of Benzimidazol-2-yl 3,4,6-tri-O-acetyl-2-deoxy-2-(2,2,2-
trichloroethoxy)carbamoyl-1-thio-β-D-glucopyranoside (2.1e). 
 
CDCl3 at 75 MHz 
Figure A-14:  13C NMR spectrum of Benzimidazol-2-yl 3,4,6-tri-O-acetyl-2-deoxy-2-(2,2,2-
trichloroethoxy)carbamoyl-1-thio-β-D-glucopyranoside (2.1e). 
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CDCl3 at 300 MHz 
Figure A-15:  2-D NMR COSY spectrum of Benzimidazol-2-yl 3,4,6-tri-O-acetyl-2-deoxy-2-
(2,2,2-trichloroethoxy)carbamoyl-1-thio-β-D-glucopyranoside (2.1e). 
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CDCl3 at 300 MHz 
Figure A-16:  1H NMR spectrum of Methyl 3-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-
2,4,6-tri-O-benzyl-α-D-glucopyranoside (2.8d). 
 
CDCl3 at 75 MHz 
Figure A-17:  13C NMR spectrum of Methyl 3-O-(2,3,4,6-tetra-O-benzoyl-β-D-
galactopyranosyl)-2,4,6-tri-O-benzyl-α-D-glucopyranoside (2.8d). 
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CDCl3 at 300 MHz 
Figure A-18:  2-D NMR COSY spectrum of Methyl 3-O-(2,3,4,6-tetra-O-benzoyl-β-D-
galactopyranosyl)-2,4,6-tri-O-benzyl-α-D-glucopyranoside (2.8d). 
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CDCl3 at 300 MHz 
Figure A-19:  1H NMR spectrum of Methyl 2-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-
3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.9d). 
 
CDCl3 at 75 MHz 
Figure A-20:  13C NMR spectrum of Methyl 2-O-(2,3,4,6-tetra-O-benzoyl-β-D-
galactopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.9d). 
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CDCl3 at 300 MHz 
Figure A-21:  2-D NMR COSY spectrum of Methyl 2-O-(2,3,4,6-tetra-O-benzoyl-β-D-
galactopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (2.9d). 
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Figure A-22:  1H NMR spectrum of (N-Anisoyl)benzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-
β-D-glucopyranoside (2.10a). 
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56
Chemical Shift (ppm)  
CDCl3 at 75 MHz 
Figure A-23:  13C NMR spectrum of (N-Anisoyl)benzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-
thio-β-D-glucopyranoside (2.10a). 
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CDCl3 at 300 MHz 
Figure A-24:  2-D NMR COSY spectrum of (N-Anisoyl)benzimidazol-2-yl 2,3,4,6-tetra-O-
benzyl-1-thio-β-D-glucopyranoside (2.10a). 
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CDCl3 at 300 MHz 
Figure A-25:  1H NMR spectrum of (N-Anisoyl)benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-
thio-β-D-glucopyranoside (2.10b). 
 
CDCl3 at 75 MHz 
Figure A-26:  13C NMR spectrum of (N-Anisoyl)benzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-
thio-β-D-glucopyranoside (2.10b). 
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CDCl3 at 300 MHz 
Figure A-27:  2-D NMR COSY spectrum of (N-Anisoyl)benzimidazol-2-yl 2,3,4,6-tetra-O-
benzoyl-1-thio-β-D-glucopyranoside (2.10b). 
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CDCl3 at 300 MHz 
Figure A-28:  1H NMR spectrum of (N-Anisoyl)benzimidazol-2-yl 2,3,4-tri-O-benzyl-1-thio-β-
D-glucopyranoside (2.11). 
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48
Chemical Shift (ppm)  
CDCl3 at 75 MHz 
Figure A-29:  13C NMR spectrum of (N-Anisoyl)benzimidazol-2-yl 2,3,4-tri-O-benzyl-1-thio-β-
D-glucopyranoside (2.11). 
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CDCl3 at 300 MHz 
Figure A-30:  2-D NMR COSY spectrum of (N-Anisoyl)benzimidazol-2-yl 2,3,4-tri-O-benzyl-1-
thio-β-D-glucopyranoside (2.11). 
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CDCl3 at 300 MHz 
Figure A-31:  1H NMR spectrum of (N-Anisoyl)benzimidazol-2-yl 6-O-(2,3,4,6-tri-O-benzyl-
α/β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-β-D-glucopyranoside (2.12). 
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Chemical Shift (ppm)  
CDCl3 at 75 MHz 
Figure A-32:  13C NMR spectrum of (N-Anisoyl)benzimidazol-2-yl 6-O-(2,3,4,6-tri-O-benzyl-
α/β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-β-D-glucopyranoside (2.12). 
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CDCl3 at 300 MHz 
Figure A-33:  2-D NMR COSY spectrum of (N-Anisoyl)benzimidazol-2-yl 6-O-(2,3,4,6-tri-O-
benzyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-β-D-glucopyranoside (2.12). 
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CDCl3 at 300 MHz 
Figure A-34:  1H NMR spectrum of Benzimidazol-2-yl 6-O-(2,3,4,6-tetra-O-benzyl-α/β-D-
glucopyranosyl)-2,3,4-tri-O-benzyl-β-D-glucopyranoside (2.13). 
 
CDCl3 at 75 MHz 
Figure A-35:  13C NMR spectrum of Benzimidazol-2-yl 6-O-(2,3,4,6-tetra-O-benzyl-α/β-D-
glucopyranosyl)-2,3,4-tri-O-benzyl-β-D-glucopyranoside (2.13). 
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CDCl3 at 300 MHz 
Figure A-36:  2-D NMR COSY spectrum of Benzimidazol-2-yl 6-O-(2,3,4,6-tetra-O-benzyl-α/β-
D-glucopyranosyl)-2,3,4-tri-O-benzyl-β-D-glucopyranoside (2.13). 
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CDCl3 at 300 MHz 
Figure A-37:  1H NMR spectrum of Benzimidazol-2-yl 2,3,4-tri-O-benzoyl-6-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (2.A). 
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CDCl3 at 75 MHz 
Figure A-38:  13C NMR spectrum of Benzimidazol-2-yl 2,3,4-tri-O-benzoyl-6-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (2.A). 
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CDCl3 at 300 MHz 
Figure A-39:  2-D NMR COSY spectrum of Benzimidazol-2-yl 2,3,4-tri-O-benzoyl-6-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (2.A). 
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CDCl3 at 300 MHz 
Figure A-40:  1H NMR spectrum of Benzimidazol-2-yl 2,3,4-tri-O-benzoyl-1-thio-β-D-
glucopyranoside (2.B). 
144 136 128 120 112 104 96 88 80 72 64 56 48
Chemical Shift (ppm)  
CDCl3 at 75 MHz 
Figure A-41:  13C NMR spectrum of Benzimidazol-2-yl 2,3,4-tri-O-benzoyl-1-thio-β-D-
glucopyranoside (2.B). 
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CDCl3 at 300 MHz 
Figure A-42:  2-D NMR COSY spectrum of Benzimidazol-2-yl 2,3,4-tri-O-benzoyl-1-thio-β-D-
glucopyranoside (2.B). 
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CDCl3 at 300 MHz 
Figure A-43:  1H NMR spectrum of (N-Anisoyl)benzimidazol-2-yl 2-O-benzoyl-3,4,6-tetra-O-
benzyl-1-thio-β-D-glucopyranoside (3.13). 
 
CDCl3 at 75 MHz 
Figure A-44:  13C NMR spectrum of (N-Anisoyl)benzimidazol-2-yl 2-O-benzoyl-3,4,6-tetra-O-
benzyl-1-thio-β-D-glucopyranoside (3.13). 
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CDCl3 at 300 MHz 
Figure A-45:  2-D NMR COSY spectrum of (N-Anisoyl)benzimidazol-2-yl 2-O-benzoyl-3,4,6-
tetra-O-benzyl-1-thio-β-D-glucopyranoside (3.13). 
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CDCl3 at 300 MHz 
Figure A-46:  1H NMR spectrum of 1-Thiomethylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-
thio-β-D-glucopyranoside (3.15). 
 
CDCl3 at 75 MHz 
Figure A-47:  13C NMR spectrum of 1-Thiomethylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-
thio-β-D-glucopyranoside (3.15). 
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CDCl3 at 300 MHz 
Figure A-48:  2-D NMR COSY spectrum of 1-Thiomethylbenzimidazol-2-yl 2,3,4,6-tetra-O-
benzoyl-1-thio-β-D-glucopyranoside (3.15). 
  
ppm
2.53.03.54.04.55.05.56.06.57.07.58.0 ppm
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
Hasty, Scott, 2013, UMSL, p.187 
 
 
CDCl3 at 300 MHz 
Figure A-49:  1H NMR spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-
β-D-glucopyranoside (3.19). 
 CDCl3 at 75 MHz 
Figure A-50:  13C NMR spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-
β-D-glucopyranoside (3.19). 
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CDCl3 at 300 MHz 
Figure A-51:  2-D NMR COSY spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-
1-thio-β-D-glucopyranoside (3.19). 
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CDCl3 at 300 MHz 
Figure A-52:  1H NMR spectrum of 1-methyl-2-(methylthio)-1H-benzimidazole (3.22). 
 
 
CDCl3 at 75 MHz 
Figure A-53:  13CNMR spectrum of 1-methyl-2-(methylthio)-1H-benzimidazole (3.22). 
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CDCl3 at 300 MHz 
Figure A-54:  2-D NMR COSY spectrum of 1-methyl-2-(methylthio)-1H-benzimidazole (3.22). 
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CDCl3 at 300 MHz 
Figure A-55:  1H NMR spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-thio-β-
D-glucopyranoside (4.10a). 
.  
CDCl3 at 75 MHz 
Figure A-56:  13C NMR spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-thio-β-
D-glucopyranoside (4.10a). 
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CDCl3 at 300 MHz 
Figure A-57:  2-D NMR COSY spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-
1-thio-β-D-glucopyranoside (4.10a).   
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CDCl3 at 300 MHz 
Figure A-58:  1H NMR spectrum of 1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-
glucopyranoside (4.10b). 
 
CDCl3 at 75 MHz 
Figure A-59:  13C NMR spectrum of 1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-
glucopyranoside (4.10b). 
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CDCl3 at 300 MHz 
Figure A-60:  2-D NMR COSY spectrum of 1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-
thio-β-D-glucopyranoside (4.10b). 
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CDCl3 at 300 MHz 
Figure A-61:  1H NMR spectrum of 1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-
thio-β-D-glucopyranoside (4.10c). 
 
CDCl3 at 75 MHz 
Figure A-62:  13C NMR spectrum of 1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-thio-β-
D-glucopyranoside (4.10c). 
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CDCl3 at 300 MHz 
Figure A-63:  2-D NMR COSY spectrum of 1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-acetyl-1-
thio-β-D-glucopyranoside (4.10c). 
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CDCl3 at 300 MHz 
Figure A-64:  1H NMR spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-
β-D-glucopyranoside (4.11a). 
 CDCl3 at 75 MHz 
Figure A-65:  13C NMR spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-
β-D-glucopyranoside (4.11a). 
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Figure A-66:  2-D NMR COSY spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-
1-thio-β-D-glucopyranoside (4.11a). 
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CDCl3 at 300 MHz 
Figure A-67:  1H NMR spectrum of 1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-
D-glucopyranoside (4.11b). 
 CDCl3 at 75 MHz 
Figure A-68:  13C NMR spectrum of 1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-β-
D-glucopyranoside (4.11b). 
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CDCl3 at 300 MHz 
Figure A-69:  2-D NMR COSY spectrum of 1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-
thio-β-D-glucopyranoside (4.11b). 
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CDCl3 at 300 MHz 
Figure A-70:  1H NMR spectrum of 1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-
β-D-glucopyranoside (4.11c). 
 CDCl3 at 75 MHz 
Figure A-71:  13C NMR spectrum of 1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-1-thio-
β-D-glucopyranoside (4.11c). 
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CDCl3 at 300 MHz 
Figure A-72:  2-D NMR COSY spectrum of 1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzoyl-
1-thio-β-D-glucopyranoside (4.11c). 
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CDCl3 at 300 MHz 
Figure A-73:  1H NMR spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-
D-glucopyranoside (4.12a). 
 
CDCl3 at 75 MHz 
Figure A-74:  13C NMR spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-
D-glucopyranoside (4.12a). 
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CDCl3 at 300 MHz 
Figure A-75:  2-D NMR COSY spectrum of 1-Methylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-
1-thio-β-D-glucopyranoside (4.12a). 
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CDCl3 at 300 MHz 
Figure A-77:  1H NMR spectrum of 1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-
glucopyranoside (4.12b). 
 CDCl3 at 75 MHz 
Figure A-78:  13C NMR spectrum of 1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-
D-glucopyranoside (4.12b). 
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CDCl3 at 300 MHz 
Figure A-78:  2-D NMR COSY spectrum of 1-Allylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-
thio-β-D-glucopyranoside (4.12b). 
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CDCl3 at 300 MHz 
Figure A-79:  1H NMR spectrum of 1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-
D-glucopyranoside (4.12c). 
 
 
CDCl3 at 75 MHz 
Figure A-80:  13C NMR spectrum of 1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-1-thio-β-
D-glucopyranoside (4.12c). 
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CDCl3 at 300 MHz 
Figure A-81:  2-D NMR COSY spectrum of 1-Benzylbenzimidazol-2-yl 2,3,4,6-tetra-O-benzyl-
1-thio-β-D-glucopyranoside (4.12c). 
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CDCl3 at 300 MHz 
Figure A-82:  1H NMR spectrum of Phenyl 3,4,6-tri-O-benzoyl-2-O-benzyl-1-thio-β-D-
glucopyranoside (5.4). 
 
CDCl3 at 75 MHz 
Figure A-83:  13C NMR spectrum of Phenyl 3,4,6-tri-O-benzoyl-2-O-benzyl-1-thio-β-D-
glucopyranoside (5.4). 
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CDCl3 at 300 MHz 
Figure A-84:  2-D NMR COSY spectrum of Phenyl 3,4,6-tri-O-benzoyl-2-O-benzyl-1-thio-β-D-
glucopyranoside (5.4). 
.  
ppm
4.04.55.05.56.06.57.07.58.0 ppm
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
Hasty, Scott, 2013, UMSL, p.211 
 
 
CDCl3 at 300 MHz 
Figure A-85:  1H NMR spectrum of Benzimidazol-2-yl 3,4,6-tri-O-benzoyl-2-O-benzyl-1-thio-β-
D-glucopyranoside (5.7). 
 C 
CDCl3 at 75 MHz 
Figure A-86:  13C NMR spectrum of Benzimidazol-2-yl 3,4,6-tri-O-benzoyl-2-O-benzyl-1-thio-
β-D-glucopyranoside (5.7). 
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CDCl3 at 300 MHz 
Figure A-87:  2-D NMR COSY spectrum of Benzimidazol-2-yl 3,4,6-tri-O-benzoyl-2-O-benzyl-
1-thio-β-D-glucopyranoside (5.7). 
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CDCl3 at 300 MHz 
Figure A-88:  1H NMR spectrum of 3,4,6-Tri-O-benzoyl-2-O-benzyl-1-thio-β-D-glucopyranosyl 
O-methyl phenylcarbamothioate (5.8). 
  
CDCl3 at 75 MHz 
Figure A-89:  1C NMR spectrum of 3,4,6-Tri-O-benzoyl-2-O-benzyl-1-thio-β-D-glucopyranosyl 
O-methyl phenylcarbamothioate (5.8). 
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CDCl3 at 300 MHz 
Figure A-90:  2-D NMR COSY spectrum of 3,4,6-Tri-O-benzoyl-2-O-benzyl-1-thio-β-D-
glucopyranosyl O-methyl phenylcarbamothioate (5.8). 
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CDCl3 at 300 MHz 
Figure A-91:  1H NMR spectrum of Benzoxazol-2-yl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-1-thio-
β-D-glucopyranoside (5.25).  
.  
CDCl3 at 75 MHz 
Figure A-92:  1C NMR spectrum of Benzoxazol-2-yl 3,4,6-tri-O-acetyl-2-azido-2-deoxy-1-thio-
β-D-glucopyranoside (5.25).  
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CDCl3 at 300 MHz 
Figure A-93:  2-D NMR COSY spectrum of Benzoxazol-2-yl 3,4,6-tri-O-acetyl-2-azido-2-
deoxy-1-thio-β-D-glucopyranoside (5.25). 
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